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Abstract 
 
The subject of this thesis is the identification and functional 
characterization of sea urchin neuropeptides. Neuropeptides are important 
mediators of neural signalling in all known animals with a nervous system, 
including bilaterians, ctenophorans, and cnidarians. Sea urchin 
neuropeptides are of particular interest for three significant reasons; 
echinoderms have a radically different secondarily-derived pentaradial 
body structure, sea urchins have served as model organisms for research 
into embryonic development, and thirdly because the genome of a sea 
urchin, the purple sea urchin Strongylocentrotus purpuratus (Stimpson, 
1857) has been sequenced (Sodergren et al., 2006). Only one family of 
neuropeptides, the SALMFamides, has previously been characterized in all 
classes of the phylum Echinodermata. 
The thesis reports the identification of putative neuropeptide GPCRs and at 
least seven novel sea urchin neuropeptide genes using genomic and 
Expressed Sequence Tag (EST) analysis. The novel sea urchin 
neuropeptides identified include putative homologues of vasotocin, the sea 
cucumber neuropeptide NGIWYamide, thyrotropin-releasing hormone, 
gonadotropin-releasing hormone, and calcitonin. A further three peptide 
precursor genes encoding peptides lacking strong homology to any known 
peptides were also identified and the peptides have been named GKamides 
and Pedal Peptide-like Neuropeptides. Two of the peptide precursor genes, 
those encoding peptides homologous to vasotocin and NGIWYamide, also 
each encode neurophysin domains, which have previously only been 
identified in association with vasopressin/oxytocin-like peptides. 
 4 
Biochemical and pharmacological techniques were employed to investigate 
the occurrence and functions of the putative neuropeptides identified. These 
included mass spectroscopy and in vitro bioassays, the former to detect the 
putative novel neuropeptides identified in this study and the latter to 
investigate bioactivity of the peptides in sea urchins. The thesis provides 
evidence of the neural expression and bioactivity of novel sea urchin 
neuropeptides and contributes to our understanding of the role of 
neuropeptides in echinoderm physiology and behaviour. 
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1.1   General introduction 
 
 
The subject of this thesis is the identification and functional 
characterization of sea urchin neuropeptides. Neuropeptides are important 
mediators of neural signalling in all known animals with a nervous system, 
including all bilaterians, ctenophorans, and cnidarians. Sea urchin 
neuropeptides are of particular contemporary interest for three significant 
reasons; echinoderms have a radically different secondarily-derived 
pentaradial body structure, sea urchins have served as model organisms for 
research into embryonic development and gene regulatory networks, and 
thirdly because the genome of a sea urchin, the purple sea urchin 
Strongylocentrotus purpuratus (Class Echinoidea; Family 
Strongylocentrotidae) (Stimpson, 1857) was recently sequenced (Sodergren 
et al., 2006). 
 
One goal of the thesis has been to utilize the genome to rejuvenate 
echinoderm neural signalling research. This part of my thesis was 
completed in collaboration with other researchers with the objective of 
characterizing the echinoderm nervous system through genomic analysis. 
The results of the collaboration have been published (Burke et al., 2006). 
To validate the results of my investigation of sea urchin neuropeptides, 
further biochemical and pharmacological techniques were employed. These 
included mass spectrometry and in vitro bioassays, the former to detect 
putative novel neuropeptides identified in this study and the latter to 
investigate the bioactivity of the peptides in sea urchins.  
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1.2   Neuropeptides as neural signalling molecules: structural and 
functional diversity 
 
 
 
Neuropeptides are short peptides secreted by nerve cells that have diverse 
cellular functions in neural signalling. A particular neuropeptide may fulfil 
roles as a neurotransmitter, a neuromodulator or a neurohormone at 
different loci throughout an organism. Neurohormones are neurally 
secreted and transported by the circulatory system to their site of action. 
Neuromodulators act at the synapse by altering the electrochemical 
properties of the postsynaptic or presynaptic cell, whereas 
neurotransmitters are defined as molecules essential for the propagation of 
a neural signal at synapses (Strand, 1999). 
 
Traditionally endocrinology involved the physiological investigation of 
hormones secreted systemically into an organism’s circulation and acting at 
sites distant from their site of synthesis and secretion. Neurohormones are 
similarly secreted, but the same hormones may act as neuromodulators in 
the extracellular plasma or as neurotransmitters pre or post-synaptically. 
Neuroendocrine research in vertebrates began with the isolation of 
gonadotropin-releasing hormone (GnRH) and thyrotropin-releasing 
hormone (TRH) as hormone releasing factors secreted by neurons 
originating in the hypothalamus and targeting the anterior pituitary (Boler 
et al., 1969). Subsequently, invertebrate neuroendocrine pathways were 
investigated  resulting in identification of the arthropod neuropeptide 
proctolin (Starratt and Brown, 1975) and the molluscan cardioexcitatory 
peptide, FMRFamide, from bivalve ganglia in 1977 (Price and Greenberg, 
1977; Walker, 1986). Subsequent to both important discoveries, 
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neuropeptides have been found to act as important neurotransmitters, 
neuromodulators, and neurohormones throughout the animal kingdom 
(Greenberg and Price, 1983; O'Shea and Schaffer, 1985; De Lange et al., 
1997; Strand, 1999; Nassel, 2002). Neuropeptides are even thought to be 
the primary neurotransmitters in the nervous system of cnidarians, a 
metazoan phylum basal to bilaterians, suggesting an ancient and 
evolutionarily conserved role in the mediation of neural signalling 
(Grimmelikhuijzen et al., 1999; Bosch and Fujisawa, 2001). 
 
The full complement of interneuronal mediators, including 
neuromodulators and neurotransmitters is by no means limited to peptides 
and includes monoamines, ions, amino acids, nucleotides, acetylcholine, 
and γ-amino butyric acid (GABA). These molecular mediators 
communicate by altering the electrochemical properties of their target cell. 
The membrane potential of a cell may be indirectly altered via activation of 
metabotropic G Protein-Coupled Receptors (GPCRs) or directly via 
activation of ionotropic ligand-gated ion channels. Furthermore, Voltage-
Gated Ion Channels (VGICs), stimulated by a change in electrochemical 
potential, and stretch-activated ion channels, stimulated by a change in the 
mechanical state of the cell membrane, are also important components to 
neural signalling, allowing the gated movement of anions and cations, 
thereby altering the distribution of charge across a neuronal cell membrane. 
 
Because neuropeptides are modified amino acid polymers they are highly 
diverse in structure. Furthermore, the evolution and functional divergence 
of a family of neuropeptides is reflected in the substitution and mutation of 
 21 
peptide sequence structure. Two mammalian neuropeptides, oxytocin 
(CYIQNCPLG-NH2) and vasopressin (CYFQNCPRG-NH2), arose through 
gene duplication of an ancestral neuropeptide precursor gene similar to the 
precursor encoding Arg-vasotocin (CYIQNCPRG-NH2) (Ruppert et al., 
1984). Both mammalian neuropeptides have acquired additional roles as 
neurotransmitters and neuromodulators in the central nervous system 
alongside their role as neurohormones secreted from cells of the supraoptic 
nucleus (SON) and the paraventricular nucleus (PVN) of the hypothalamus. 
Vasopressin has a number of diverse roles including an involvement in 
water balance via renal tubule receptors (Dibas et al., 1998), ion transport at 
the blood-brain barrier (Jojart et al., 1984; O'Donnell et al., 2005), and 
anxiety and aggression in rodents (Bielsky et al., 2004; Blanchard et al., 
2005). In the central nervous system vasopressin has been found to 
potentiate noradrenaline signalling by membrane depolarization and to 
modulate glutamate excitation and release (Disturnal et al., 1987; Brinton 
and McEwen, 1989; Syed et al., 2007). Van den Hooff et al. (1989) found 
vasopressin to be necessary for maintaining Long-Term Potentiation (LTP) 
between cells of the fibria fornix and the lateral septum.  
 
Oxytocin has roles as both a myoactive neurohormone important for 
lactation and parturition in mammals and in the regulation of behaviour 
associated with trust and pair bonding (Kosfeld et al., 2005). Like 
vasopressin the neurohormone is expressed in cells originating in the PVN 
and SON and secreted from the pituitary gland. It is involved in the 
induction of lactation and uterine contraction, targeting oxytocin GPCRs 
typically coupled to a phospholipase C-mediated transduction pathway 
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(Gimpl and Fahrenholz, 2001). However, the peptide is also expressed in 
the central nervous system. For example the peptide targets vagal 
motorneurons as an excitatory neuromodulator through the generation of 
inward sodium currents (Dreifuss et al., 1992).  
 
Unlike hormones derived from lipids and amino acids, neuropeptides are 
processed in the rough endoplasmic reticulum and packaged and modified 
in the Golgi apparatus, before transportation in vesicles to the site of Ca
2+
-
dependent exocytosis (Thorndyke and Goldsworthy, 1988; Strand, 1999; 
Hartenstein, 2006). The translated preprohormone is processed into a 
prohormone sequence in the rough endoplasmic reticulum by cleavage of 
the N-terminal signal sequence. The peptide precursors are packaged into 
100-300 nm sized vesicles during transportation from the cis face to the 
trans face of the Golgi apparatus. The vesicles are several times larger than 
the vesicles typically used for storing and transporting classical 
neurotransmitters, such as acetylcholine. The precursors are then processed 
by prohormone convertases into short peptides, before enzymatic 
modification which may include pyroglutamate formation and amidation. 
C-terminal α-amidation, which requires a terminal glycine residue, protects 
the peptide from degradation. The inactivation of secreted peptides by 
peptidases occurs in the plasma. 
 
Neuropeptides may be secreted by non-neuronal cell types: for example, 
somatostatin is also secreted by the gut in mammals (Pradayrol et al., 
1978). Many other neuropeptides are also secreted by gut tissue, including 
galanin, calcitonin gene-related peptide, gastrin-cholecystokinin, 
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somatostatin, and the tachykinins (Walsh and Dockray, 1994). Although 
somatostatin is widely expressed in the central nervous system, its name 
derives from its inhibitory role in the regulation of growth hormone (GH) 
secreted by the anterior pituitary. Like both vasopressin and oxytocin, 
somatostatin is also secreted by cells of the PVN and released from the 
median eminence. The peptide has an atypical precursor structure from 
which the peptide sequence is differentially processed into two different 
forms, as opposed to peptide sequence variation in tandem; one of 14 
residues and the other of 28, which may either bind the same receptor, 
albeit with different affinities and activities, or may bind alternate 
somatostatin receptor subtypes (Epelbaum et al., 1994; Patel, 1999).  
 
Neuropeptide precursors often encode a tandem series of structurally 
similar peptides with different potencies and functional properties. Insect 
allatotropin and allatostatin peptides, functional homologues to 
somatostatin in mammals, respectively stimulate and inhibit the corpora 
allata, regulating the release of juvenile hormone (JH). Insect allatostatin 
precursors often encode several peptides of variable myotropic potency 
(Bendena et al., 1999; Nichols et al., 2002; Taghert and Veenstra, 2003; 
Veenstra, 2009). The Allatostatin-A precursor encodes as many as 14 
peptides, defined by the C-terminal sequence YXFGLamide, in the form of 
multiple tandem repeats (East et al., 1996; Vanden Broeck et al., 1996; 
Belles et al., 1999; Stay and Tobe, 2007). 
 
 
Neuropeptides are likely to have acquired diversity through the processes 
that drive gene evolution, including gene duplication, whole-genome 
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duplication events, and random mutation. Although the full sequence of a 
neuropeptide precursor gene may show extensive sequence variation, the 
amino acid structures of neuropeptides themselves are well-conserved and 
the small but significant variations in amino acid sequence have often been 
shown to coincide with novel functional variation and expansion within a 
taxon. Furthermore, conservation of neuropeptide structure across several 
taxa may also be correlated with conservation of function.  
 
1.3   Neuropeptide evolution: the FMRFamide-related Peptide family 
 
The identification of molluscan FMRFamide, and the subsequent 
identification of structurally related peptides in other invertebrates, has led 
to the classification of a family of peptides defined by a C-terminal 
amidated Arginine-Phenylalanine (RF) sequence, the FaRP (FMRFamide-
related peptide) family (Dockray, 2004). An endogenous opioid encoded by 
the Proenkephalin A precursor, [Met
5
]enkephalin-Arg
6
-Phe
7
, also possesses 
an amidated Arg-Phe C-terminus, which may be indicative of an  
evolutionary relationship between RFamide peptides and enkephalins or 
may reflect convergent molecular evolution (Greenberg et al., 1983). 
Opioid peptide homologues have not yet been identified in invertebrates. 
Their absence, and the presence of highly diversified vertebrate FaRP gene 
family members, suggests the opioid peptides arose late in evolutionary 
history. 
 
The vertebrate endogenous opioids include endorphins (e.g. β-endorphin, 
31 residues), enkephalins (e.g. Met and Leu-enkephalin, 5 residues each), 
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and dynorphins (C-terminal extensions of Leu-enkephalin) derived from 
three different precursor genes in the human genome, respectively 
proopiomelanocortin (POMC), proenkephalin, and prodynorphin (Strand, 
1999). Endogenous opioids act presynaptically by inhibiting or 
disinhibiting synaptic output and neurotransmitter release, postsynaptically 
as a neurotransmitter, and interestingly as a co-transmitter in glutamatergic 
hippocampal pathways activated by high frequency impulses (Morris and 
Johnston, 1995; Olson et al., 1995).  
 
 
Unlike endogenous opioids, the RFamide family of peptides have been 
identified in a number of diverse bilaterian phyla, including cnidarians 
(Darmer et al., 1991), nematodes (Li et al., 1999a), arthropods (Vanden 
Broeck, 2001b; Mousley et al., 2004), platyhelminths (Mousley et al., 
2004) and vertebrates (Thorndyke and Goldsworthy, 1988; Strand, 1999; 
Dockray, 2004; Chartrel et al., 2005). The seven human RFamides include 
neuropeptide AF/FF, prolactin-releasing peptide, neuropeptide SF/VF, 
kisspeptin, and 26RFamide, and are encoded by five FaRP precursor genes 
farp1-5. They form a small disparate group for which roles in nociception, 
vascular regulation, hormone secretion, appetite and feeding behaviour 
have been identified (Allard et al., 1995; Panula et al., 1999; Samson et al., 
2003; Dockray, 2004; Takayasu et al., 2006).  A role for RFamide peptides 
in feeding behaviour is not limited to vertebrates. In an example of 
functional homology and structural modification accompanied by variation 
in response, a study of nematode behaviour by de Bono and Bargmann 
(1998) demonstrated that a single amino acid variation in a C. elegans 
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RFamide receptor produces two behavioural phenotypes distinguishable by 
social and asocial feeding. 
 
RFamide peptides have been localized in sensory neurons in both 
invertebrate and vertebrate organisms, including cnidarians (Martin, 1992; 
Mackie et al., 2003), the nematode C. elegans (Troemel et al., 1995; Rogers 
et al., 2003), the annelid Platynereis (Tessmar-Raible et al., 2007), the 
mollusc Ischnochiton (Voronezhskaya et al., 2002) and the zebrafish Danio 
(Pinelli et al., 2000). The RFamidergic sensory neurons are localized in 
morphologically homologous neurosecretory systems in both vertebrates 
and invertebrates, suggesting that the peptides have a cross-phyletically 
conserved role in the integration of sensory information and the regulation 
of behaviour (Hartenstein, 2006; Tessmar-Raible et al., 2007).  
 
1.4   Neuropeptides and echinoderm neurobiology and physiology 
 
The phylum Echinodermata (~7,000 species) originated from a 
Precambrian epibenthic ancestor, attained maximal class diversity during 
the mid-Palaeozoic era and now encompasses five modern classes, 
including, in order of species diversity: brittle stars and basket stars (Class 
Ophiuroidea), starfish (Class Asteroidea), sea cucumbers (Class 
Holothuroidea), sea urchins (Class Echinoidea), and sea lillies or feather-
stars (Class Crinoidea) (Brusca and Brusca, 2003; Southward and 
Campbell, 2006).  
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Defining echinoderm characteristics include the absence of cephalization, 
the adaptation of radial symmetry upon metamorphosis from bilaterally 
symmetrical larvae, a unique water vascular system, and an endoskeleton 
composed of calcareous ossicles, which in some classes is fused to form a 
test. The sessile crinoids diverged earliest from the other echinoderm 
classes and they are identified by the primitive sessile characteristic of an 
aboral stalk attached to the substrate. The remaining classes are thought to 
have derived from a common motile ancestor. Sea urchins, sea cucumbers, 
and brittle stars are commonly grouped together on the basis of closed 
interambulacral grooves in opposition to the supposed ancestral 
characteristics of open grooves retained in extant starfish species (Brusca 
and Brusca, 2003). 
 
 
Notwithstanding the absence of a truly closed circulatory system as 
exemplified in vertebrates, echinoderm neuropeptides acting as 
neurotransmitters, neuromodulators, and neurohormones are likely to have 
important roles in the regulation of echinoderm behaviour and physiology. 
Because of a highly diversified morphology and physiology, the actions 
and functions of homologous and novel echinoderm neuropeptides will be 
an important area of investigation for future animal physiologists, marine 
biologists, and comparative neurobiologists. Moreover, there are a number 
of reasons why echinoderms are of particular interest for neuropeptide 
research.  
 
Firstly, adult echinoderms are unique in the animal kingdom in having a 
pentaradial morphological organization, or bauplan, which is both 
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evolutionarily and developmentally derived from bilateral symmetry 
(Burke et al., 2006). As mediators of neural signalling, neuropeptides may 
be involved in the regulation of behavioural and physiological coordination 
in the context of a pentaradial nervous system, including a novel system of 
motor coordination that is necessary for a foraging organism lacking 
cephalization. A peptidergic nervous system is also present in bilaterally 
organized echinoderm larvae and may be involved in the regulation of 
behaviour before metamorphosis (Byrne and Cisternas, 2002). Hence 
localization of neuropeptide expression in echinoderm larvae will be useful 
in the investigation of neurochemical signalling prior to the morphological 
transition from bilateral to pentaradial symmetry. 
 
 
Secondly, echinoderms and vertebrates have been found to possess 
synapomorphies previously thought to be unique to vertebrates. Together 
with the phyla Hemichordata and Xenoturbellida, the phylum 
Echinodermata forms a sister clade to the craniates, urochordates, and 
cephalochordates (Bromham and Degnan, 1999; Bourlat et al., 2006; Dunn 
et al., 2008). These taxa comprise all known extant deuterostomes. The 
genomes of non-vertebrate chordates, including urochodate (Ciona 
intestinalis) and cephalochordate (Branchiostoma floridae) representative 
species, have also been recently sequenced, providing genomic data for 
organisms that evolved before the evolutionary transition to taxa defined by 
a vertebral column and a cranium (Delsuc et al., 2006). Due to the 
proximity of the phylum to chordates, and a shared mode of deuterostomian 
embryonic development, sea urchins have historically become a valuable 
model organism for research into developmental biology. Therefore, 
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comparative analysis of echinoderms and chordates provides a basis for 
identifying shared deuterostomian traits as well as novel characteristics that 
define echinoderm evolution, including neuropeptide signalling pathways 
and their receptors.  
 
 
Thirdly, neuropeptides may be involved in the remarkable processes of 
autotomy and regeneration demonstrated by echinoderms (Moss et al., 
1994; Thorndyke et al., 2001). Peptides have been found to induce the 
softening of connective tissue which accompanies evisceration and 
autotomy in starfish and sea cucumbers prior to tissue regeneration (Smith 
and Greenberg, 1973; Mladenov et al., 1989; Birenheide et al., 1998; Koob 
et al., 1999; Byrne, 2001; Thorndyke et al., 2001; Wilkie, 2001). 
Pedicellariae attached to the test in sea urchins, appendages of the water 
vascular system including tube feet, and even entire starfish arms are 
capable of complete regeneration. Even more remarkably, species from the 
asteroid genus Linckia are capable of complete regeneration of the 
organism from a single limb (Edmondson, 1935).  
 
Fourthly, echinoderms possess a body wall or test which is unique in being 
capable of rapidly and reversibly changing its mechanical properties 
(Wilkie, 2005). The mutable properties of the body wall and its associated 
appendages have been investigated in detail and neuropeptides, including 
stichopin identified in the holothurian Apostichopus japonicas, are thought 
to play a role as regulators of the unusual and unique rapid transitions in 
mechanical state of the dermis (Birenheide et al., 1998; Tamori et al., 
2007). 
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Lastly, neural signalling molecules, including the putative neuropeptides 
identified in this study, may have a role in synchronization and integration 
of echinoderm sensory and motor pathways. Although the nervous system 
is decentralized, dispersed, and segregated, echinoderms are capable of 
coordinated behavioural and sensory integration (Smith, 1945; Kerkut, 
1954; Smith, 1965; Reese, 1966; Dale, 1999). There are three principal 
nervous systems in the echinoderm; the ectoneural, including both sensory 
and motor neurons; the hyponeural, which typically runs parallel to the 
ectoneural system and which may exclusively contain efferent motor 
neurons; and the typically aboral entoneural system, which is confined to 
asteroids (starfish) and crinoids (featherstars). A fourth is considered to 
innervate the enteric system (García-Arrarás et al., 2001).  
 
Studies of echinoderm behaviour have demonstrated coordination of object 
avoidance and locomotion through tube foot activity (Migita et al., 2005), 
of escape and directional manoeuvring (Dale, 1999), of spine and 
pedicellariae activity on the test (Smith, 1965; Peters, 1981; Campbell, 
1983) and rhythmic coordination and circadian control of reproductive 
behaviour (Okada et al., 1984; Coppard and Campbell, 2005). Some studies 
have provided evidence of echinoderms demonstrating more than just 
innate behaviour (Valentinčič, 1983; Shul'gina, 2006). In Shul'gina's study 
starfish demonstrated long-term inhibition of movement in response to a 
negative stimulus, an adaptation which interestingly disappeared after 
severance of the nerve ring and two ambulacra, or rows of tube feet, across 
the madreporite interambulacrum. Further to the observation of an ability to 
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alter innate behaviour, which in itself implicates a broader concept of 
behavioural evolution through the adaptation of inhibition, the concept of 
self-organization has been suggested to explain the flexibility of innate 
motor behaviour in invertebrates lacking a central organizing locus or 
"brain" (Haken, 1983; Kelso, 1995). Coordinated movement may be reliant 
on processes of self-organization, as suggested in a study of stable phases 
of starfish tube foot and arm locomotion and obstacle avoidance by Migita 
et al (2005). An alternate explanation for locomotory coordination, 
observed at the level of both the tube foot and whole organism, may be the 
presence of rhythm generators sited at the gonopore leading to the gonad 
which regulate synchronization of gonadal contraction, as suggested in a 
study by Okada et al. (1984). 
 
1.5   The biochemical identification and characterization of 
echinoderm neuropeptides 
 
The first echinoderm peptide hormone to be identified was gonad-
stimulating substance (GSS), identified in radial nerve extracts of the 
starfish Asterias forbesi (Class Asteroidea, Family Asteriidae) (Chaet and 
McConnaughy, 1959; Kanatani et al., 1971). Gonad-stimulating substance 
was found to indirectly induce spawning and oocyte maturation by 
targeting follicle cells and was the first invertebrate gonadotropin identified 
(Kanatani et al., 1971; Shirai et al., 1972; Kanatani, 1979; Kanatani, 1983; 
Shirai, 1986). The structure of gonad-stimulating substance, a peptide 
heterodimer of approximately 47 residues, has recently been determined 
following purification from the radial nerve cords of the starfish Asterina 
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pectinifera (Class Asteroidea, Family Asterinidae) and comprises two 
peptide chains of 24 and 19 residues each, potentially separated by three 
disulfide bonds and referred to as GSS chains A and B, respectively (Shirai 
et al., 1987; Kato et al., 2009; Mita et al., 2009) (Table 1). 
 
However, the first echinoderm neuropeptides to be fully sequenced were 
detected in the starfish Asterias rubens and Asterias forbesi using antisera 
raised against molluscan FaRP cardioexcitatory peptide pQDPFLRFamide 
(Elphick et al., 1991a; Elphick et al., 1991b). The starfish neuropeptides, 
GFNSALMFamide (S1) and SGPYSFNSGLTFamide (S2), were both 
denominated SALMFamides after the C terminal motif of S1 
(SALMFamide 1) (Table 1). Subsequently two more SALMFamides, 
GFSKLYFamide and SGYSVLYFamide, were purified from intestinal 
extracts of the sea cucumber Holothuria glaberrima (Class Holothuria) and 
localized in the intestine using an antiserum raised against the same 
molluscan FaRP-related peptide (Díaz-Miranda et al., 1992) (Table 2). The 
peptides identified were subsequently united and defined by the presence of 
a C-terminal motif, Sx(L/F)xFamide (where x is variable). 
 
 
The SALMFamide neuropeptides were found to have significant roles in 
muscle relaxation alongside nitric oxide, a well-documented muscle 
relaxant and neurotransmitter in vertebrates and invertebrates (Palmer et al., 
1987; Elphick et al., 1993; Díaz-Miranda and García-Arrarás, 1995; 
Elphick et al., 1995; Boeckxstaens and Pelckmans, 1997; Melarange et al., 
1999; Elphick and Melarange, 2001; Melarange and Elphick, 2003). The 
SALMFamide neuropeptides were localized to the radial nerve cord and 
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tube foot ectoneural nerve plexus of A. rubens using monoclonal and 
polyclonal antibodies (Newman et al., 1995), and an S2-specific antiserum 
CLII (Elphick et al., 1995). Pharmacological investigation of the action of 
the peptides on starfish muscle preparations found S2 to be as much as ten 
times more potent than S1 at inducing relaxation of the starfish cardiac 
stomach (Elphick et al., 1995). 
 
 
A different strategy for the isolation and identification of echinoderm 
neuropeptides was adopted by Iwakoshi et al. (1995). Radial longitudinal 
muscle and intestinal preparations from the Japanese sea cucumber 
Apostichopus japonicus (Class Holothuroidea, Family Stichopodidae) were 
used to test for the presence of myoactive peptides in body wall extracts of 
the same species (Iwakoshi et al., 1995; Ohtani et al., 1999). Amongst the 
fourteen peptides identified were a further two members of the 
SALMFamide neuropeptide family, GYSPFMFamide and 
FKSPFMFamide, and both peptides caused relaxation of sea cucumber 
muscle preparations consistent with the pharmacological activity of 
SALMFamides S1 and S2 in the starfish  (Ohtani et al., 1999) (Table 2). 
 
 
Additionally, SALMFamides have been shown to be involved in more 
diverse roles including the modulation of luminescence in the brittle star 
Amphipholis squamata (Class Ophiuroidea, Family Amphiuridae) and the 
regulation of GSS secretion in the starfish Asterina pectinifera (Bremaeker 
et al., 1999; Mita et al., 2004). 
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Several other neuropeptides were identified by Iwakoshi et al. (1995), all of 
which appear to be unique to the echinoderm phylum in sequence and 
structure (Table 2). Many of the peptides identified by Iwakoshi et al. 
(1995) had indirect effects on muscle contractility, either potentiating or 
inhibiting electrically-evoked contraction of sea cucumber muscle 
preparations (Iwakoshi et al., 1995; Ohtani et al., 1999).  One of the 
peptides identified, NGIWYamide, was found to cause contraction of sea 
cucumber longitudinal body wall muscle, tentacles, and intestine (Iwakoshi 
et al., 1995; Inoue et al., 1999; Ohtani et al., 1999). NGIWYamide 
immunoreactivity was observed in the body wall dermis, intestine, 
tentacles, and tube feet, loci supporting pharmacological evidence of the 
effects of NGIWYamide on contraction of the same tissues (Inoue et al., 
1999). Saha et al (2006) investigated the expression and function of 
NGIWYamide-like peptides in the starfish Asterina pectinifera. Similar to 
the effects observed with sea cucumber preparations, NGIWYamide caused 
contraction of starfish tube foot preparations. Furthermore, NGIWYamide-
like immunoreactivity was found in the starfish radial nerve cords and tube 
foot nerve plexus (Saha et al., 2006). These combined studies of 
NGIWYamide neuropeptide function and expression suggest a role for the 
neuropeptide family in regulating muscle contraction. 
 
More recently NGIWYamide was identified as one of two peptides, the 
other being QGLFSGVamide, purified from buccal nerve ring and 
longitudinal radial nerve from the sea cucumber Apostichopus japonicus 
(Kato et al., 2009). The two peptides were isolated on account of their 
ability to induce oocyte maturation and spawning. Surprisingly, a synthetic 
 35 
peptide with the sequence NGLWYamide (ie. with the isoleucine residue 
replaced with a leucine residue) was found to be ten to one hundred times 
more potent than the endogenous peptide, NGIWYamide (Kato et al., 
2009). 
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Table 1: Asteroid (starfish) neuropeptides. 
 
______________________________________________________________________________________________________________________________________________________ 
Name     Sequence 
______________________________________________________________________________________________________________________________________________________ 
 
GSS
1
: 
A Chain    SEYSGIASYCCLHGCTPSELSVVC 
B Chain    EKYCDDDFHMAVFRTCAVS                      
______________________________________________________________________________________________________________________________________________________ 
 
S1
2
             GFNSALMF-NH2 
S2
2
      SGPYSFNSGLTF-NH2 
______________________________________________________________________________________________________________________________________________________ 
 
1 
Asterina pectinifera (Mita et al., 2009); 
2 
Asterias rubens
 
(Elphick et al., 1991a). 
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Table 2: Holothuroid (sea cucumber) neuropeptides.  
 
 
______________________________________________________________________________________________________________________________________________________ 
Name     Sequence 
______________________________________________________________________________________________________________________________________________________ 
 
SWYG-1
1
    SWYGSLG 
SWYG-2
1
    SWYGTLG 
SWYG-3
1
     SWYGSLA 
Holokinin-1
1
   PLGYMFR 
Holokinin-2
1
   PLGM(O)FR 
Holokinin-3
1
   PLGY(Br)M(O)FR 
Holokinin-1(3-7)
1
   GYMFR 
NGIWYamide
1
   NGIWY-NH2 
Stichopin
1
   DRQGWPACYDSKGNYKC 
Sticho-MFamide-1
1
  GYSPFMF-NH2 
Sticho-MFamide-2
1
  FKSPFMF-NH2 
KIamide-9
1
   KHKTAYTGI-NH2 
GLRFA
1
     GLRFA 
GN-19
1
     GGRLPNYAGPPRMPWLIHN 
______________________________________________________________________________________________________________________________________________________ 
 
-    GYI
2
 
-    MPMNPADYFSRGTVYIPTRDS
2
 
-    FDWHALLH
2
 
-     GPSANSFTYGRCADDRC
2
 
-    KGKQKGAGRGKGN
2
 
-    APHAIRPPSG
2
 
______________________________________________________________________________________________________________________________________________________ 
 
QGLFSGVamide
3
   QGLFSGV-NH2 
______________________________________________________________________________________________________________________________________________________ 
 
GFSKLYFamide
4
   GFSKLYF-NH2 
SGYSVLYFamide
4
   SGYSVLYF-NH2 
______________________________________________________________________________________________________________________________________________________ 
 
1
Apostichopus japonicus (Iwakoshi et al., 1995); 
2
(Ohtani et al., 1999); 
3
(Kato et 
al., 2009); 
4
Holothuria glaberrima (Díaz-Miranda et al., 1995). 
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1.6   The sea urchin genome project: an investigation of sea urchin 
neural genes 
 
New opportunities to identify and characterize echinoderm neuropeptides 
have emerged recently with the sequencing of an echinoderm genome from 
sperm from a single male specimen of the north-east Pacific sea urchin 
Strongylocentrotus purpuratus (Stimpson, 1857) (Order Echinoida; Family 
Strongylocentrotidae) (Sodergren et al., 2006). S. purpuratus is the first 
representative echinoderm to have its whole genome sequenced. The sea 
urchin was chosen for sequencing because of its established role as a model 
organism for research on embryological development (Briggs and Wessel, 
2006). The genome was sequenced using Clone-Array Pooled Shotgun 
Sequencing (CAPSS) (Cai et al., 2001), a development of the whole-
genome shotgun (WGS) sequencing strategy (Weber and Myers, 1997; 
Green, 2001), using bacterial artificial chromosomes (BACs) as cloning 
vectors (Sodergren et al., 2006). 
 
 
Approximately 28,000 genes were identified and assembled into an official 
gene set from the genomic data using the Glean3 gene prediction algorithm 
(Sodergren et al., 2006; Elsik et al., 2007). The Glean3 gene predictions 
have subsequently been labelled using the epithet 'SPU' and are publicly 
accessible online (http://annotation.hgsc.bcm.tmc.edu/Urchin/cgi-
bin/pubLogin.cgi). The annotated genome can be accessed via NCBI, the 
Sea Urchin Genome Project at the Baylor College of Medicine website 
(http://www.hgsc.bcm.tmc.edu/project-species-o-
Strongylocentrotus%20purpuratus.hgsc?pageLocation=Strongylocentrotus
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%20purpuratus), or SpBase (http://www.spbase.org/SpBase/) (Cameron et 
al., 2009). 
 
 
The genome was analysed for genes important for neural growth and 
signalling in both the adult and embryo (Burke et al., 2006), providing data 
with which to supplement earlier physiological and anatomical studies of 
the echinoderm nervous system (Hyman, 1955; Bullock and Horridge, 
1965; Smith, 1965).  
 
As part of the bioinformatic analysis of the sea urchin nervous system, an 
investigation was made into the identification of sea urchin voltage-gated 
ion channels (VGICs), a group of membrane-bound receptors important for 
neural electrical signalling. Like GPCRs, VGICs have an ancient common 
ancestor and members have even been identified in prokaryotes (Hille, 
2001; Gutman et al., 2005). BLAST searching the sea urchin genome using 
vertebrate VGIC sequences as query entries resulted in the identification of 
eleven K
+
 channels, four Ca
2+
 channels and one Na
+
 channel (Appendix B) 
(Burke et al., 2006). Sodium VGICs are present in both protostomes and 
deuterostomes, although they are thought to have arisen from T-type 
calcium VGICs (Burke et al., 2006). However, action potentials in the sea 
urchin nervous system may be calcium-based (Cobb and Moore, 1989) and 
ion specificity is determined by small but significant modifications of 
residue structure in the ion pore. Thus, verification of ion specificity 
requires further bioinformatic analysis accompanied by physiological 
investigation. 
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Although echinoderm morphological studies have shown a lack of synaptic 
structure in which pre-synaptic terminals are rarely seen in contact with 
post-synaptic terminals (Cobb and Laverack, 1967), the process of synaptic 
formation, and its associated genes, is a characteristic of eumetazoans and a 
defining feature of the nervous system.  A study by Sakarya et al. (2007) 
reported the conservation of synaptic protein scaffold structure in the 
genome of the poriferan demosponge Amphimedon queenslandia, an 
animal phylum basal to the eumetazoans and characterized by the absence 
of a nervous system. Investigation of the sea urchin genome also found an 
absence of ionotropic glutamate receptor subunit genes, important to long 
term potentiation and synaptic plasticity in vertebrates. In contrast to 
vertebrate genomes, the sea urchin genome also lacked genes encoding gap 
junction proteins and receptors for cannabinoid and lysophospholipid 
neuromodulators, suggesting a predominance of signalling through 
chemical synapses (Burke et al., 2006).  
 
Previous studies have shown that echinoderm neuromuscular signalling 
appears to be mediated in part by biogenic amines, acetylcholine, nitric 
oxide, and GABA (Florey et al., 1975; Elphick and Melarange, 2001), and 
putative genes encoding proteins homologous to nitric oxide synthase  and 
monoamine neurotransmitter receptors were identified in the genome 
(Burke et al., 2006).  
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1.7   The identification of a novel SALMFamide neuropeptide 
precursor gene in the sea urchin genome 
 
Prior to recent genome sequencing and annotation projects, invertebrate 
neuropeptides were most commonly identified using more time-consuming 
biochemical techniques including immunolocalization, mass spectrometry, 
and chromatography. In the post-genomic era high-throughput 
bioinformatic techniques offer an alternative approach to the identification 
of novel and homologous neuropeptides in sequenced genomes. 
 
The first neuropeptide precursor gene to be identified in the sea urchin 
genome was a gene encoding members of the SALMFamide family of 
neuropeptides (Elphick and Thorndyke, 2005). The gene was identified by 
BLAST searching the genome using a search query consisting of the 
repeated starfish S1 SALMFamide sequence interrupted by basic residues.  
For example: 
 
...GFNSALMFGKRGFNSALMFGKRGFNSALMFGKRGFNSALMFGKR... 
 
Thus, the query successfully identified the precursor gene by constructing a 
sequence emulating the structure of a putative precursor coding region. The 
gene identified encoded a total of seven SALMFamide family peptides, 
evidence of intragenic duplication, and the peptides were denominated 
SpurS1 to SpurS7 (Table 3).  
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1.8   Aims 
 
Building on the strategy employed by Elphick and Thorndyke (2005), the 
primary aim of this project was to systematically search the sea urchin 
genome for neuropeptide precursor genes encoding peptides homologous to 
the widely diverse neuropeptides previously identified and sequenced from 
both vertebrates and invertebrates, as well as to identify putative sea urchin  
neuropeptide receptors. The project also aimed to detect the putative 
peptides identified in S. purpuratus tissue extracts using mass spectrometry, 
and to investigate the myoactive properties of the putative peptides when 
tested on sea urchin muscle preparations.  
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Table 3: Echinoid (sea urchin) neuropeptides. All putative peptides 
identified from the genome of the sea urchin Strongylocentrotus 
purpuratus (Elphick and Thorndyke, 2005). 
______________________________________________________________________________________________________________________________________________________ 
Name     Sequence 
______________________________________________________________________________________________________________________________________________________ 
 
SpurS1     PPVTTRSKFTF-NH2 
SpurS2        DAYSAFSF-NH2 
SpurS3                  GMSAFSF-NH2 
SpurS4                  AQPSFAF-NH2 
SpurS5                 GLMPSFAF-NH2 
SpurS6                PHGGSAFVF-NH2 
SpurS7                  GDLAFAF-NH2 
 
______________________________________________________________________________________________________________________________________________________ 
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2.1   Introduction: Neuropeptide GPCR structure and diversity 
 
This chapter reports the identification of putative S. purpuratus 
neuropeptide G-protein coupled receptor (GPCR) genes. A bioinformatic 
investigation of the number of putative sea urchin neuropeptide receptors 
can be used as an approximate estimate of the number of expressed sea 
urchin neuropeptide ligands. The structure of the receptor and its homology 
to sequenced vertebrate receptors can also assist in predicting the structure 
and identity of a receptor's ligand. This chapter aims to comprehensively 
identify putative neuropeptide receptors in the sea urchin genome and to 
correlate their phylogenetic position and molecular structure to putative 
neuropeptide ligands.  
 
GPCRs are the most common neuropeptide receptors across the animal 
kingdom. The super-family of receptors are characterized by activating 
cytoplasmic G proteins upon binding a diverse range of ligands, including 
peptides, biogenic amines, chemokines, photons, lipids and organic 
odorants (Lichtarge et al., 1996; Fredriksson et al., 2003; Kamesh et al., 
2008). There are many human orphan GPCRs without functional 
characterisation and for which endogenous ligands and pharmacological 
agents are yet to be identified. GPCRs are highly important as receptors for 
pharmacological agents, contributing to up to 50% of the targets for drug 
design (Gudermann et al., 1997; Flower, 1999; Wilson and Bergsma, 
2000).  
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Due to evolutionarily conserved similarities in sequence structure, 
phylogenetic tree-building can provide a framework for structural and 
functional comparison of invertebrate and vertebrate receptors. GPCRs are 
characterized by seven transmembrane (7TM) domains of 25 to 35 residues 
that cross the cell membrane seven times (Gudermann et al., 1997). The 
polypeptide has an extracellular N-terminal and an intracellular C-terminal. 
Ligand specificity is conferred by sequence variation in the TM domains 
and/or extracellular inter-domain loops.  
 
Thus, conserved 7TM domain structure and variable inter-domain loop 
regions enable the construction of receptor phylogenies suggesting 
divergence from a common ancestral gene (Fredriksson et al., 2003). 
Smaller genome and organism specific sub-families of receptors can also 
be identified, which indicate gene duplication and expansion. Therefore, 
GPCR abundance has previously been used as an estimate of neuropeptide 
precursor expansion and diversification (Bargmann, 1998; Hewes and 
Taghert, 2001).  
 
There are more than 800 human GPCRs, including about 342 of which are 
non-olfactory, making them one of the largest protein families expressed in 
metazoans, including humans (Fredriksson et al., 2003), insects (Brody and 
Cravchik, 2000; Hewes and Taghert, 2001; Vanden Broeck, 2001a), 
cephalochordates (Nordström et al., 2008), and urochordates (Kamesh et 
al., 2008). Frederiksson's analysis of the complement of human GPCRs 
(2003) described a GRAFS system of five GPCR families based on 
phylogenetic analysis; Glutamate, Rhodopsin, Adhesion, Frizzled and 
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Secretin. Previous methods of GPCR classification involved use of an 
interphyletic alphabetical/numerical clan system (A-F) (Kolakowski, 1994). 
In this system clan C corresponds to the glutamate (G) family of receptors, 
clan A corresponds to rhodopsin (R) family GPCRs, and clan B 
corresponds to the secretin (S) family GPCRs. Fredriksson (2003) 
identified two families of GPCRs independent of the former system, 
adhesion (A) and frizzled (F). Clans D and E exclusively represented 
fungal pheromone receptors and cAMP receptors and clan F contained 
archaebacterial opsins. The GRAFS system has subsequently been used to 
classify GPCRs from 13 sequenced protostome and deuterostome 
organisms (Kamesh et al., 2008). Therefore, phylogenetic analysis using 
the receptor amino acid sequences allows for comparative bioinformatic 
studies of receptors from other phyla (Vanden Broeck, 2001a; Fredriksson 
et al., 2003; Nordström et al., 2008). 
 
Most neuropeptide receptors are found in the rhodopsin family of GPCRs. 
The rhodopsin family is the largest of the GPCR families and has been 
subdivided into four groups (α, β, γ, δ) with 13 main branches (Fredriksson 
et al., 2003). Neuropeptides are primarily found in the alpha, beta and 
gamma groups. There are five main branches of vertebrate α subgroup 
rhodopsin family receptors, including a prostaglandin clade, an amine 
receptor clade, an opsin receptor clade, a melatonin receptor clade, and a 
MECA receptor clade, including receptors to melanocortin (Fredriksson et 
al., 2003). The ligands for beta (β) group rhodopsin receptors are 
exclusively peptides and the gamma (γ) group includes receptors for 
chemokines. The delta group of rhodopsin GPCRs includes receptors that 
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bind neurally secreted glycoproteins. The family of receptors are defined by 
characteristics including an NSxxNPxxY motif in transmembrane domain 
VII and a D(E)-R-Y(F) motif at the border of transmembrane domain III 
(Fredriksson et al., 2003).  
 
The receptors in the glutamate family of GPCRs, corresponding to clan C, 
include glutamate receptors, GABA receptors, and taste receptors. There 
are, however, no known vertebrate neuropeptide receptors in this family. 
The adhesion family of GPCRs is defined by the presence of a GPS domain 
(Nordström et al., 2008). There are 33 human adhesion-family GPCRs and 
37 amphioxus adhesion-family GPCRs. The frizzled family of GPCRs 
contains two groups: frizzled receptors and taste receptors. The taste 
receptors are thought to be expressed in the tongue and palate epithelium 
(Fredriksson et al., 2003). The frizzled receptors bind glycoproteins and are 
involved in the regulation of cell growth (Fredriksson et al., 2003). There 
are also no known vertebrate neuropeptide receptors within either of these 
families. 
 
In this bioinformatic investigation of sea urchin neuropeptide receptors, 
vertebrate neuropeptide receptor sequences, which are members of the 
families and groups of neuropeptide receptors defined by Fredriksson 
(2003), were used to identify homologous putative sea urchin GPCR genes. 
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2.2   Methods: Bioinformatic identification of putative receptors 
 
As part of the sea urchin genome annotation project, sea urchin GPCRs had 
been identified using Pfam domain analysis and compiled into secretin and 
rhodopsin families according to Fredriksson's system of classification 
(Bateman et al., 2000). The complement of S. purpuratus GPCRs 
corresponding to each sub-family of vertebrate neuropeptide receptors was 
identified using the full amino acid sequence of known human 
neuropeptide GPCR sequences as BLAST query entries against the set of 
Glean3 gene predictions assembled from the sequenced sea urchin genome 
(http://www.spbase.org/SpBase/wwwblast/blast.php). Putative receptors 
were identified on the basis of strong homology to vertebrate neuropeptide 
GPCRs. For example, a putative sea urchin neuropeptide CCK-like receptor 
(Sp_115741932) was 33% homologous to the Ciona CCK-like receptor 
(GI:74136025) and 36% homologous to human CCK B receptor 
(GI:119589141).  
 
Human neuropeptide GPCRs were also used to identify homologous 
GPCRs in six other organisms using BLAST searches of the NCBI protein 
database and phylogenetic analysis using ClustalX and NJ Plot (European 
Bioinformatics Institute) (Higgins and Sharp, 1988; Thompson et al., 
1997). The representative organisms from which GPCR gene sequences 
were collated included Homo sapiens (Phylum Chordata, Subphylum 
Vertebrata), the lancelet Branchiostoma floridae (Phylum Chordata, 
Subphylum Cephalochordata), the sea squirt Ciona intestinalis (Phylum 
Chordata, Subphylum Urochordata), the roundworm Caenorhabditis 
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elegans (Phylum Nematoda), the opisthobranch mollusc Aplysia californica 
(Phylum Mollusca), the fruitfly Drosophila melanogaster (Phylum 
Arthropoda), and the sea anemone Nematostella vectensis (Phylum 
Cnidaria). Phylogenetic trees were rooted using closely-related but 
phylogenetically separate GPCRs supported using bootstrap analysis and 
described in the study by Fredriksson et al (2003). 
 
The same strategy of using vertebrate GPCR sequences as BLAST search 
queries was used to identify GPCRs in an EST database derived from 
embryonic and larval stages, and adult tube foot and radial nerve tissues to 
refine the set to genes expressed within those tissues 
(http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=7
668).  
 
2.3   Results 
 
The majority of sea urchin GPCRs identified by the presence of a 7TM are 
putative orphan receptors without strong homology to known vertebrate or 
invertebrate neuropeptide receptors. Ascribing a putative ligand for orphan 
sea urchin GPCRs is unachievable via bioinformatic analysis alone. 
However the genome contains at least 38 putative neuropeptide GPCRs 
identified on the basis of strong homology and sequence alignment to 
vertebrate rhodopsin family beta group GPCRs (Table 4). These results 
were summarized and included as part of a published bioinformatic 
analysis of the sea urchin nervous system (Burke et al., 2006). The results 
presented in this chapter are discussed according to GPCR group as defined 
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by the GRAFS system of classification, including putative sea urchin 
neuropeptide receptors of the rhodopsin and secretin family GPCRs. 
 
2.3.1   Putative sea urchin neuropeptide GPCRs 
 
There are 874 putative sea urchin rhodopsin-family GPCRs predicted by 
Pfam protein domain analysis. A total of fifty-four putative sea urchin 
neuropeptide GPCRs were identified. Thirty-eight putative sea urchin 
neuropeptide receptors showed homology to GPCRs of the beta (β) group 
of Rhodopsin GPCRs defined by Fredriksson (2003) (Figures 1-9). Putative 
neuropeptide receptors were also identified showing homology to 
vertebrate neuropeptide receptors within the secretin GPCR family and the 
gamma (γ) and delta (δ) groups of rhodopsin GPCR family. The 
melanocortin receptors, belonging to the 'α' subfamily MECA receptor 
clade, as well as the cluster of human GPCRs containing GPR3, GPR6, and 
GPR12, appear not to have homologous invertebrate receptors. 
 
The complement of sea urchin beta group rhodopsin receptors is illustrated 
in comparison to 32 human beta (β) rhodopsin family receptors (Figures 1-
4). Putative sea urchin receptor-encoding genes showing sequence 
homology accompanied by strong bootstrap support include two 
tachykinin-like receptors (Figures 1 & 5), two vasotocin-like receptors 
(Figures 4 & 6), three gonadotropin-releasing hormone receptors (Figures 4 
& 6), one cholecystokinin-like receptor (Figures 1 & 7), two 
bombesin/neuromedin B-like receptors (Figure 3 & 8), and two 
orexin/hypocretin-like receptors (Figures 1 & 9). Twenty-six other putative 
 52 
rhodopsin beta group receptors were identified, three of which grouped 
with a clade of vertebrate receptors including neuromedin U (Figure 3).  
 
Fredricksson (2003) distinguished two separate subgroups within the 
gamma (γ) group: the SOG subgroup, which includes receptors for galanin-
like peptides, the RFamide receptor GPR54, somatostatin receptors and 
opioid receptors, and the MCH (melanin-concentrating hormone) subgroup. 
The sea urchin GPCRs identified included homologues to vertebrate 
receptors in both of these sub-clades, including a cluster of six GPR54-like 
receptors (Figure 10), a galanin-like receptor (Figure 11), two receptors 
grouped with the orphan vertebrate receptors GPR7 and GPR8 (Figure 12), 
and a melanin-concentrating hormone-like receptor (Figure 13).  
 
 
The delta (δ) group of rhodopsin receptors includes receptors for the 
vertebrate glycoproteins luteinizing hormone, follicle-stimulating hormone, 
and thyroid stimulating hormone (Hsu et al., 2002; Fredriksson et al., 
2003). One putative sea urchin GPCR was found to show homology to 
glycoprotein hormone receptors and two putative sea urchin GPCRs were 
found to show homology to relaxin-like receptors LGR7 and LGR8 (Figure 
14). 
 
From the secretin family of GPCRs two putative sea urchin neuropeptide 
receptor homologues were identified; these showed homology to 
corticotropin-releasing hormone receptor and calcitonin receptor (Figure 
14). 
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2.3.2   Putative sea urchin neuropeptide GPCRs identified in EST 
libraries 
 
Seventy-four GPCRs were identified in EST libraries derived from 
embryonic and adult tissues (Table 5). The majority were found in EST 
libraries produced from echinoderm larvae at early developmental stages, 
however the number identified is reflective of the size of the EST dataset. 
Three ESTs encoding putative neuropeptide GPCRs were identified. The 
putative cholecystokinin-like receptor (SPU_026458 or Sp_115741932) 
was found in the cDNA library assembled from adult radial nerve tissue 
(Table 5). Two other putative neuropeptide receptors are also found in the 
radial nerve tissue cDNA library (SPU_012974 and SPU_026973), which 
both have reciprocal BLAST matches to the human galanin receptor. 
Putative non-peptidergic receptors identified in the EST libraries included 
an α-1 adrenergic-like receptor (SPU_001020), two muscarinic cholinergic-
like receptors (SPU_011401 and SPU_021092), and a histamine H1-like 
receptor (SPU_022857).  A putative receptor homologue of Drosophila 
ecdysis-triggering hormone receptor was also identified in a sea urchin 
testis cDNA library (SPU_027212). 
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Table 4: Putative neuropeptide G-protein coupled receptors in S. purpuratus and their vertebrate homologues, identified by BLAST search, sequence 
alignment, and bootstrap analysis. The twenty-eight were identified on the basis of strong sequence homology. 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
 Rhodopsin Family Beta Group-like Receptors  
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Tachykinin-like     Sp_115665194, SPU_011338 
Vasotocin-like      SPU_021291, Sp_115899360 
Gonadotropin-releasing hormone-like  Sp_185134947, Sp_185134985, Sp_185134933 
 Cholecystokinin-like    Sp_115741932 
Bombesin/neuromedin B-like    Sp_72172891, Sp_115928214 
Orexin-like     SPU_023223, Sp_72146578 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Rhodopsin Family Gamma Group-like Receptors 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
GPR54-like      SPU_021291, SPU_012318, SPU_007422, SPU_025226, SPU_022468, SPU_022376,   
      SPU_015139 
Galanin-like       Sp_115841642 
Neuropeptide W      Sp_115923312, SPU_026626 
Melanin-concentrating hormone-like   Sp_72011294 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Rhodopsin Family Delta Group-like Receptors 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Gonadotropin-like     Sp_115678957 
 Relaxin/insulin-like     SPU_015740, SPU_003527 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
 Secretin Family Neuropeptide Receptors 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
 Corticotropin-releasing hormone-like  Sp_115720160 
 Calcitonin/CGRP-like    SPU_018314 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
The genes labelled by four digits preceded by zero (SPU_0XXXX) are identical to the four number Glean3 gene predictions (XXXX) assigned as part of 
the sea urchin genome annotation project. Where available the identifier has been with the gene index number (Sp_X). 
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Table 5: Putative S. purpuratus neurotransmitter and neuropeptide receptors identified in EST libraries assembled from larval 
and adult sea urchin tissues.  
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
EST Library   GPCR gene prediction (SPU_0XXXXX) 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Blastula-stage   000498, 000703, 002312, 003105, 003365, 004925, 005097, 005162, 005239, 008205, 011108, 012382, 012383,  
   013918, 015161, 015968, 018339, 021363, 021507, 021683, 022683, 023047, 024079, 024655, 024811, 025314,  
   025436, 025453, 025821, 027584, 027884, 028801, 028801, 006250 
Mesenchyme   000703, 003101, 004805, 004925, 007574, 008205, 012382, 012610, 014765, 014768, 015263, 019158, 020348,  
   020361, 022219, 022220, 023251, 006919, 006920 
7 hour embryo  000703, 004925, 023253 
 20 hour embryo  002875, 002876, 009880, 011953, 013248, 027884, 028801 
 40 hour embryo  002876, 011953, 013248 
 Larval    002875, 002876, 003698, 010167, 011320, 011953, 012979, 013248, 013760, 014448, 015217, 015263, 016400, 017624, 
    021176, 021683, 024079, 028056 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
 Coelomocyte   001020 (alpha-1 adrenergic receptor), 013595, 015593, 028824 
 Radial nerve   002312, 012974, 021092 (cholinergic muscarinic 3-like receptor), 022857 (histamine H1-like receptor), 026458 (CCK-like  
    receptor), 026973 
 Lantern   011401 (cholinergic muscarinic 1-like receptor) 
 Testis    027212 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
The genes labelled by four digits preceded by zero (SPU_0XXXX) are identical to the four number Glean3 gene predictions (XXXX) assigned as part of 
the sea urchin genome annotation project. 
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Figure 1. Human rhodopsin family beta group receptors and 
putative sea urchin homologues. The key above the phylogeny 
illustrates the position of the subclade within a clade of rhodopsin 
family-like GPCRs assembled from sea urchin and human GPCRs 
using ClustalX and NJPlot. Calcitonin receptors, which belong to the 
secretin family of human GPCRs, were used as an outgroup to the 
rhodopsin family-like GPCR clade. Bootstrap values are shown 
adjacent to tree branches. Putative sea urchin genes Sp_X are 
labelled by gene index number and putative sea urchin genes 
SPU_X are labelled according to the Glean3 gene prediction 
numbers assembled as part of the sea urchin genome annotation 
project. Hs = Homo sapiens. Sp = Strongylocentrotus purpuratus.   
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Figure 2. Putative sea urchin peptide receptors homologous to 
human rhodopsin family beta group receptors. The key above the 
phylogeny illustrates the position of the subclade within a clade of 
rhodopsin family-like GPCRs assembled from sea urchin and human 
GPCRs using ClustalX and NJPlot. Calcitonin receptors, which 
belong to the secretin family of human GPCRs, were used as an 
outgroup to the rhodopsin family-like GPCR clade. Bootstrap values 
are shown adjacent to tree branches. Putative sea urchin genes 
Sp_X are labelled by gene index number. Hs = Homo sapiens. Sp = 
Strongylocentrotus purpuratus.   
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Figure 3. Human and putative sea urchin neuromedin B/bombesin, 
neuromedin U, neurotensin, and growth hormone secretagogue-like 
receptors. The key above the phylogeny illustrates the position of 
the subclade within a clade of rhodopsin family-like GPCRs 
assembled from sea urchin and human GPCRs using ClustalX and 
NJPlot. Calcitonin receptors, which belong to the secretin family of 
human GPCRs, were used as an outgroup to the rhodopsin family-
like GPCR clade. Bootstrap values are shown adjacent to tree 
branches. Putative sea urchin genes Sp_X are labelled by gene 
index number. Hs = Homo sapiens. Sp = Strongylocentrotus 
purpuratus.   
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Figure 4. Human and putative sea urchin AVP and GnRH-like 
receptors. The key above the phylogeny illustrates the position of 
the subclade within a clade of rhodopsin family-like GPCRs 
assembled from sea urchin and human GPCRs using ClustalX and 
NJPlot. Calcitonin receptors, which belong to the secretin family of 
human GPCRs, were used as an outgroup to the rhodopsin family-
like GPCR clade. Bootstrap values are shown adjacent to tree 
branches. Putative sea urchin genes Sp_X are labelled by gene 
index number and putative sea urchin genes SPU_X are labelled 
according to the Glean3 gene prediction numbers assembled as part 
of the sea urchin genome annotation project. Hs = Homo sapiens. 
Sp = Strongylocentrotus purpuratus.   
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Figure 5. Human and putative non-vertebrate tachykinin-like 
receptors. Dm_SIFamide_R (Drosophila SIFamide receptor) and 
Dm_157997 (Drosophila receptor GI:157997) were used as 
outgroups. Putative sea urchin genes are labelled by gene index 
number (Sp_X). Sp = Strongylocentrotus purpuratus. Dm = 
Drosophila melanogaster. Bf = Branchiostoma floridae. Ce = 
Caenorhabditis elegans. 
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Figure 6. Human and putative non-vertebrate gonadotropin-
releasing hormone and vasotocin-like receptors. Human neuromedin 
B and bombesin-like receptors were used as outgroups. Putative 
sea urchin genes are either labelled by gene index number (Sp_X) 
or sea urchin genome annotation index number (SPU_X). Sp = 
Strongylocentrotus purpuratus. Dm = Drosophila melanogaster. Bf = 
Branchiostoma floridae. Ce = Caenorhabditis elegans. 
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 Figure 7. Human and putative non-vertebrate cholecystokinin-like 
 receptors. Two putative Drosophila neuropeptide receptors (gene 
index  numbers 45553225 and 62472541) were used as outgroups. 
Putative sea urchin genes are labelled by gene index number 
(Sp_X). Sp =  Strongylocentrotus purpuratus. Dm = Drosophila 
melanogaster. Bf =  Branchiostoma floridae. Ce = Caenorhabditis 
elegans. Ci = Ciona  intestinalis. 
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Figure 8. Human and putative non-vertebrate bombesin and 
neuromedin B-like receptors. Human GPR37 and GPR37-like 
receptors were used as outgroups. Putative sea urchin genes are 
labelled by gene index number (Sp_X). Sp = Strongylocentrotus 
purpuratus. Dm = Drosophila melanogaster. Bf = Branchiostoma 
floridae.
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Figure 9. Human and putative non-vertebrate orexin/hypocretin-like 
receptors. Putative sea urchin genes are either labelled by gene 
index number (Sp_X) or sea urchin genome annotation index 
number (SPU_X). Human neuropeptide FF receptors were used as 
a outgroups. Sp = Strongylocentrotus purpuratus. Ci = Ciona 
intestinalis.  
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Figure 10. Human and putative non-vertebrate GPR54-like 
receptors. Human galanin receptors were used as outgroups. 
Putative sea urchin genes are labelled by sea urchin genome 
annotation index number (SPU_X). Sp = Strongylocentrotus 
purpuratus. Dm = Drosophila melanogaster. Bf = Branchiostoma 
floridae. Ci = Ciona intestinalis. 
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Figure 11. Human and putative non-vertebrate galanin-like 
receptors. Kisspeptin receptor GPR 54 and a putative GPR 54-like 
Branchiostoma receptor were used as outgroups. Putative sea 
urchin genes are labelled by gene index number (Sp_X). Sp = 
Strongylocentrotus purpuratus. Dm = Drosophila melanogaster. Bf = 
Branchiostoma floridae. Ci = Ciona intestinalis. 
 
 
 67 
 
 
SSTR1
SSTR2
SPU_026626
Sp_115923312
Ce_MGLR-3
GPR_7
GPR_8
Bf_219461369
1000
Bf_219412190
809
1000
1000
892
1000
0.05
  
Figure 12. Human and putative non-vertebrate GPR7 and GPR8-
like receptors. Human somatostatin receptors were used as 
outgroups. Putative sea urchin genes are either labelled by gene 
index number (Sp_X) or sea urchin genome annotation index 
number (SPU_X). Sp = Strongylocentrotus purpuratus. Dm = 
Drosophila melanogaster. Bf = Branchiostoma floridae.
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Figure 13. Human and putative non-vertebrate melanin-
concentrating hormone (MCH)-like receptors. Human galanin 
receptors and GPCR 54 were used as outgroups. Putative sea 
urchin genes are either labelled by gene index number (Sp_X). Sp = 
Strongylocentrotus purpuratus. Dm = Drosophila melanogaster. Bf = 
Branchiostoma floridae.
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Figure 14. Human and putative non-vertebrate gonadotropin and 
relaxin-like receptors. Human MAS1 oncogene-like receptors were 
used as outgroups. Putative sea urchin genes are either labelled by 
gene index number (Sp_X) or sea urchin genome annotation index 
number (SPU_X). Sp = Strongylocentrotus purpuratus. Dm = 
Drosophila melanogaster. Bf = Branchiostoma floridae. Nv = 
Nematostella vectensis. 
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Figure 15.  Human and putative non-vertebrate corticotropin-
releasing hormone (CRH)-like and calcitonin/CGRP-like receptors. 
Human parathyroid hormone receptors were used as outgroups. 
Putative sea urchin genes are either labelled by gene index number 
(Sp_X) or sea urchin genome annotation index number (SPU_X). Sp 
= Strongylocentrotus purpuratus. Dm = Drosophila melanogaster. Bf 
= Branchiostoma floridae. Ci = Ciona intestinalis.
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2.4   Discussion 
 
 
 
The number of putative neuropeptide GPCRs identified (54, including 38 
putative rhodopsin family beta subfamily neuropeptide GPCRs) is 
comparable to the thirty-two putative GPCRs found in a similar analysis of 
the Drosophila melanogaster genome (Cazzamali and Grimmelikhuijzen, 
2002). It can be suggested that a similar number of neuropeptide ligands 
may be expressed in the sea urchin. Structurally homologous peptides 
encoded by the same precursor may bind a single target with variable 
affinities and efficacies, and, conversely, homologous peptides may bind 
more than receptor. Thus, a strict 1:1 peptide precursor to receptor ratio 
cannot be assumed. 
 
Putative urchin neuropeptide receptors were homologous to receptors in 
both of the neuropeptide receptor-containing families described by 
Frederiksson (2003), the rhodopsin and secretin families. There were no 
putative receptors homologous to neuropeptide receptors in the alpha group 
of rhodopsin receptors, however there were 39 putative sea urchin receptors 
homologous to human receptors in the beta group of rhodopsin family 
receptors. Twelve of these were highly homologous to receptors for human 
neuropeptides, including tachykinin, arginine vasopressin/oxytocin, 
gonadotropin-releasing hormone, cholecystokinin, and orexin/hypocretin 
(Table 4).  
 
Human tachykinins include substance P and neurokinin A, encoded by 
preprotachykinin A, and neurokinin B. Each of the tachykinins binds 
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selectively to one of the human tachykinin receptors. The putative sea 
urchin tachykinin-like receptors are basal to the vertebrate receptors, 
alongside the two Drosophila tachykinin-like receptors identified by Poels 
et al (2009). Drosophila tachykinin-like neuropeptides, referred to as 
drosotachykinins, have also been identified from a precursor bearing 
similarity to human preprotachykinin A (Siviter et al., 2000). Therefore, 
there may be one or more similar neuropeptide precursors in the sea urchin 
genome.  
 
The single vasotocin-like receptor identified (Sp_115899360) may bind a 
vasotocin-like peptide and the identification of a single receptor is 
consistent with the hypothesis that oxytocin and vasopressin originated by 
gene duplication of a common ancestral precursor encoding a vasotocin-
like neuropeptide during early chordate evolution (Hoyle, 1999). 
Vasotocin-like peptides have been identified in both protostome and 
deuterostome phyla and the phylogeny illustrated includes the receptor for 
the Drosophila crustacean cardioactive peptide neuropeptide 
(Dm_CCAP_R; Figure 6), which also bears sequence similarity to 
vasotocin-like peptides in having a structure incorporating an amidated C-
terminal and a disulfide bridge between two cysteines (PFCNAFTGC-
NH2). Three putative sea urchin GnRH-like receptors have been identified 
compared to the single human GnRH receptor expressed in the human 
pituitary gland, which when activated by GnRH induces the release of 
gonadotropins.  
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The single putative CCK-like receptor was also identified in the limited 
cDNA library of adult sea urchin radial nerve tissue, suggesting that the 
receptor is highly expressed in the sea urchin nervous system and that a 
hypothetical sea urchin CCK-like peptide may act as either a 
neurotransmitter or neuromodulator. However, the receptor is basal to 
protostome CCK-like receptors, which bind protostome CCK-like 
neuropeptides, suggesting significant structural divergence or a structurally 
unrelated ligand.  
 
The two orexin/hypocretin receptors bind the two orexin/hypocretin 
neuropeptides expressed in the vertebrate brain and which are encoded by a 
single neuropeptide precursor (De Lecea et al., 1998; Sakurai et al., 1998). 
Furthermore, the identification of an orexin/hypocretin-like receptor in the 
sea squirt Ciona intestinalis genome suggests orexin/hypocretin-like 
peptides may be expressed in a non-vertebrate deuterostome.   
 
Other putative sea urchin receptors were homologous to rhodopsin family 
gamma group receptors for human neuropeptides, including kisspeptin, 
galanin, neuropeptide W, and melanin-concentrating hormone (Table 4).  
Although GPCRs 7 and 8 are about 33% similar in sequence to human 
opioid receptors (Fredriksson et al., 2003), homologs of which may be 
absent from non-vertebrate genomes, both receptors bind neuropeptide W 
and neuropeptide B and are expressed in the vertebrate central nervous 
system (Singh and Davenport, 2006). Interestingly, a GPR7/8-like receptor 
was also identified in the genome of the nematode C. elegans, although a 
peptide ligand has yet to be identified.  
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Vertebrate RFamide receptors are distributed across several GPCR 
families. Seven sea urchin neuropeptide receptors were found to show 
homology to vertebrate rhodopsin family gamma group receptor GPR 54, 
which binds the vertebrate RFamide kisspeptin/metastin, originally named 
for its action as a metastasis suppressor. The other vertebrate RFamide 
receptors, for which homologous putative sea urchin receptors were not 
identified, are found in the beta group (neuropeptide FF and prolactin-
releasing peptide receptors) and the delta group (26 RFamide receptor). 
 
One putative sea urchin neuropeptide receptor (Sp_115678957) was 
homologous to the receptors for human gonadotropin glycoprotein 
neuropeptides follicle-stimulating hormone (FSH), thyroid-stimulating 
hormone (TSH), and luteinizing hormone (LH). Insect gonadotropins are 
more diverse and unrelated (Kuczer et al., 2007), however a putative 
Drosophila peptide receptor with sequence homology to human 
gonadotropins was identified in this study and two putative insect 
gonadotropin receptors have previously been identified by De Loof et al 
(2001). 
 
Lastly, two putative sea urchin receptors were found to be homologous to 
corticotropin-releasing hormone and calcitonin receptors. Human 
corticotropin-releasing hormone is a 41 amino acid peptide releasing factor 
and neurotransmitter which induces the release of corticotropin from the 
anterior pituitary. Although two CRH-like receptors are expressed in both 
the human and cephalochordate genomes, a single putative CRH-like 
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receptor was identified using phylogenetic analysis and bootstrap values 
support a hypothesis of independent duplication in each deuterostome 
lineage.  
 
The phylogenetic trees illustrated conform to accepted models of animal 
evolution. The results of phylogenetic analysis place many of the vertebrate 
GPCRs and putative sea urchin GPCRs into a model which conforms to 
current understanding of deuterostomian evolution (Figures 1-15). The 
results of sequence alignment and bootstrap analysis support the hypothesis 
of a super-family of GPCRs arising from a eukaryote ancestor. Putative 
cnidarian GPCRs are located at basal branches of clades representing 
structurally distinct sub-families of human GPCRs (e.g. Figure 13).  
 
Evidence of monophyletic vertebrate receptors in paraphyletic relationship 
to putative sea urchin neuropeptide receptors may correlate with the 
emergence of vertebrate paralogs accompanying whole genome duplication 
events in early chordate evolution (Lundin, 1993; Holland et al., 1994; 
Panopoulou et al., 2003). Particular receptors may only be expressed within 
the chordate phylum (e.g. endogenous opiate receptors), the deuterostomes 
(e.g. hypocretin and melanin-concentrating hormone receptors), or may be 
expressed across a broad range of bilaterian phyla (e.g. receptors for 
calcitonin, tachykinin, gonadotropin-releasing hormone, cholecystokinin, 
vasotocin-like peptides, and FaRPs).  
 
 
There were 161 sea urchin secretin-family GPCRs predicted by Pfam 
genomic analysis, representing a large expansion in comparison to the 15 
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secretin-family receptors in the human genome (Fredriksson et al., 2003) 
and the 16 secretin-family receptors identified in the cephalochordate 
genome (Nordström et al., 2008). Twenty-eight of these are predicted to be 
metabotropic glutamate receptors.  
 
In conclusion, the identification of putative sea urchin neuropeptide 
receptors reported here will assist in future studies of neuropeptide function 
in echinoderm larval development and adult physiology and behaviour. 
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3.1   Introduction: Identification of putative neuropeptide precursor 
genes in Strongylocentrotus 
 
In the studies reported in this chapter bioinformatic methods were used to 
identify genes encoding the precursors of two putative sea urchin 
neuropeptides, NGFFFamide and echinotocin. The precursors were 
identified by BLAST homology searching using deuterostome neuropeptide 
and neuropeptide precursor sequences as queries. Biochemical methods, 
including mass spectrometry and immunohistochemistry, were also used to 
detect the two peptides and to localize echinotocin expression. 
Pharmacological methods, specifically in vitro bioassays of echinoderm 
tissue, were used to test the myoactivities of the identified putative 
neuropeptides on sea urchin tissue preparations as an indication of peptide 
bioactivity.  
 
In the post-genomic era there has been an increase in the number of studies 
using bioinformatic methods to identify invertebrate neuropeptides (Liu et 
al., 2006; Husson et al., 2007). However there is no current high-
throughput method for the identification of neuropeptide genes in newly 
sequenced genomes. One reason for the difficulty involved in identifying 
echinoderm neuropeptides through conventional BLAST homology 
searching is neuropeptide sequence divergence, which accompanies 
functional diversification, and the consequent lack of sequence homology 
with neuropeptides identified in other phyla.  
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Despite having acquired significant structural variation, neuropeptides 
derived from the same ancestral preprohormone gene may have retained 
many of the ancestral protein's functional characteristics, including its 
expression patterns, receptor specificity, signal transduction pathway and 
even physiological role. However, non-coding residues in the preproprotein 
sequence are unlikely to be conserved and neuropeptide coding regions are 
characteristically short, sometimes as few as three residues (for example the 
vertebrate neuropeptide thyrotropin-releasing hormone with the sequence 
pyroGlu-His-Pro-NH2). Because of the short length of most neuropeptides, 
BLAST search queries of translated genomic data using known 
neuropeptide sequences can generate an unmanageable number of search 
results (Liu et al., 2006). 
 
Bioinformatic techniques for the identification of novel and homologous 
neuropeptides have previously included the use of consensus patterns from 
other neuropeptides for BLAST algorithm searching (Riehle et al., 2002; 
Hummon et al., 2006; Liu et al., 2006). Pattern searching for neuropeptides 
within a sequenced genome relies on the repetition of peptide coding 
sequences, a structural characteristic of neuropeptide precursor sequences. 
A sea urchin gene encoding seven SALMFamide neuropeptide family 
members has already been identified in the genome using this method of 
BLAST homology searching (Elphick and Thorndyke, 2005) (see Chapter 
One). 
 
The identification of putative novel neuropeptide genes in the sea urchin 
genome does not in itself provide evidence of cellular expression or 
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bioactivity. For this reason sea urchin body wall and visceral tissue extracts 
were analysed using High Performance Liquid Chromatography Mass 
Spectrometry (HPLC-MS) for the purpose of detecting the expression of 
the identified neuropeptides. 
 
Mass spectrometry has been an essential biochemical technique for the 
identification of peptides and proteins. Before the current 'post-genomic' 
era the technique was often used to determine the sequences of novel 
peptides from bioactive or immunoreactive fractions. Mass spectrometry 
continues to be used for the identification of novel neuropeptides from 
either solution (e.g. LC-MS) or matrix (e.g. Matrix-assisted Laser 
Desorption/Ionization Time of Flight Mass Spectrometry or MALDI-TOF 
MS) incorporating sequencing techniques using tandem MS and peptide 
fragmentation (Nachman et al., 2002; Husson et al., 2005; Husson et al., 
2007).  
 
Pharmacological bioassays for the investigation of bioactivity and 
immunohistochemical investigations for the purpose of localizing 
echinotocin were made possible for two reasons. Firstly, specimens of 
Echinus esculentus (Class Echinoidea, Family Echinidae) were readily 
available for pharmacological in vitro bioassays and for tissue sectioning 
from a source in Scotland.  
 
Secondly, immunohistochemical investigation of echinotocin expression 
was feasible due to the commercial availability of antibodies prepared 
against vasopressin. Vasopressin (CYFQNCPRG-NH2) shares sequence 
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similarity to the putative S. purpuratus echinotocin neuropeptide 
(CFISNCPKG-NH2), and is likely to be structurally homologous to 
unidentified echinotocin-like peptides expressed in other echinoderm 
species. The two peptides are structurally differentiated by a Phe
3
 residue in 
vasopressin compared to an Ile
3
 in echinotocin. Although a hydrophobic 
residue in the third position (Ile
3
) is typically associated with oxytocin-like 
peptides, echinotocin structurally resembles vasopressin-like peptides in 
sharing a basic residue in the eighth position (Lys
8
). Furthermore, a polar 
Ser
4
 residue in echinotocin takes the place of a polar Gln
4
 in vasopressin. 
Overall, echinotocin and vasopressin share about 56% sequence identity. 
Therefore, anti-vasopressin antibodies may cross-react with echinotocin 
and could potentially be used for the localization of echinotocin-like 
peptides in Echinus esculentus tissue sections. 
 
3.2   Methods 
 
3.2.1   Bioinformatics: Identification of putative sea urchin 
neuropeptide genes through BLAST homology searching 
 
The search for genes encoding homologues of known neuropeptides in the 
sea urchin genome was initiated using the Basic Local Alignment Search 
Tool (BLAST) facility available on the Baylor College of Medicine Human 
Genome Sequencing Center website 
(http://www.hgsc.bcm.tmc.edu/projects/seaurchin). Neuropeptide 
consensus sequences and vertebrate and invertebrate neuropeptide 
sequences were used to search for homologues encoded in the sea urchin 
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genome (see Appendix C for vertebrate neuropeptide sequences). The 
strategy used was similar to that used to identify the novel SALMFamide-
encoding neuropeptide precursor, whereby the BLAST query consisted of 
an artificial sequence of tandem peptide repeats (Elphick and Thorndyke, 
2005). When the neuropeptide sequence was long enough to generate 
manageable number of BLAST search results the full sequence was entered 
as a direct search query. Thus, the query sequence, submitted as a 
tBLASTn search (a protein query against the six nucleotide reading frames 
of the genomic data), comprised multiple copies of the neuropeptide 
sequence separated by the residues GKR. A glycine (G) terminal residue 
often provides a substrate for neuropeptide C-terminal amidation and the 
lysine-arginine (KR) dipeptide sequence is a dibasic cleavage site for 
endopeptidases. The search query used to identify NGFFFamide used the 
three repeats of the sea cucumber NGIWYamide sequence, originally 
isolated by Iwakoshi et al (1995). For example, 
 
...NGIWYGKRNGIWYGKRNGIWYG... 
 
The presence and location of an N-terminal signal peptide, essential for 
directing the transport of a neuropeptide prohormone through the 
endoplasmic reticulum, was predicted using the online program Signal P 
(www.cbs.dtu.dk/services/SignalP) (Emanuelsson et al., 2007). Two sets of 
genes predicted by the gene prediction programs Gnomon, developed by 
Souvorov (unpublished), and the Glean3 algorithm, as well as GenScan 
(http://genes.mit.edu/GENSCAN.html), developed by MIT (Burge and 
Karlin, 1997), which provides a model of gene intron and exon structures 
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derived from the input of a nucleotide search query, were used to support 
the putative gene structures, including the organization and structure of 
exons and introns. Additionally, the S. purpuratus EST libraries were 
searched, using the putative precursor amino acid sequences as queries, for 
evidence of the expression of the putative precursor gene, as well as for 
evidence of intron and exon expression. Search results were also used as 
query sequences for BLAST searching of the sea urchin genome to identify 
similar genes, including other putative neuropeptide precursors. The 
tBLASTn search algorithm was used for precursor sequence queries and 
the BLASTx was used sea urchin EST queries. Lastly, online homology 
modelling software was used for structural investigation, including 
DeepView Swiss PDB Viewer (http://spdbv.vital-it.ch/index.html) as 
software for protein modelling and SWISS-MODEL 
(http://swissmodel.expasy.org) for the generation of homology models 
based on 3-D protein structural data. 
 
3.2.2   Mass Spectrometry: Development of protocols for the 
identification of starfish SALMFamides 
 
As random mutations may contribute to variation in peptide residue 
identities across species and class, the detection of peptides with masses 
accurately corresponding to the predicted molecular weights of the 
identified peptides would require samples from S. purpuratus specimens, 
which were not readily available. Therefore, the two starfish neuropeptides, 
SALMFamides S1 and S2, respectively an octapeptide and a 
dodecapeptide, originally isolated from the starfish Asterias rubens using 
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HPLC (Elphick et al., 1991a) were used to develop a protocol for mass 
spectrometric analysis of echinoderm tissue samples. The starfish 
SALMFamides were selected for protocol development for two reasons. 
Specimens could be purchased from a commercial fishery at Southend-on-
Sea, operating in the Thames Estuary and North Sea, and secondly because 
both neuropeptides were originally identified and sequenced by Elphick et 
al. (1991a) using an extraction protocol that could be replicated.  
 
However, replicating the acetone extraction procedure as used by Elphick 
et al. (1991a) failed to identify SALMFamide S1 (Gly-Phe-Asn-Ser-Ala-
Leu-Met-Phe-NH2). An alternate extraction protocol derived from a mass 
spectrometric study of nematode neuropeptides by Husson et al. (2005), 
and which used methanol as a solvent for peptide extraction, was trialled 
and proved successful for the detection of both SALMFamide 
neuropeptides, S1 (Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2) and S2 (Ser-
Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2). Furthermore, rather 
than dissecting only Asterias rubens radial nerve cords for peptide 
extraction as in the investigation made by Elphick et al. (1991a) , starfish 
tube feet were also included and encompassed the bulk of the tissue 
dissected for extraction. The extraction medium was a solution of 
methanol, water, and acetic acid (90:9:1) (Husson et al., 2005). To 
delipidate the extract, it was mixed in a 1:1 ratio with ethyl acetate and n-
hexane, before removal of the insoluble suspension by pipette.  
 
The C18 SepPak cartridges were prepared by washing with 40% 
acetonitrile and water, both with 0.1% formic acid, prior to loading 
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approximately 5 ml of extract (0.1% formic acid). The loaded cartridges 
were then washed in water (0.1% formic acid), and the pigment removed 
with 30% acetonitrile (0.1% formic acid). The peptides were eluted with 
80% acetonitrile (ACN). The first nine drops eluted from the cartridge were 
discarded, and the proceeding five to ten drops captured for analysis. After 
evaporation of the organic solvent from the purified extract overnight the 
final volume was approximately 0.5 ml. 
 
The HPLC-MS system used for peptide detection incorporated an Agilent 
1100 Series pumping system, a Vydac C8 chromatography column (Cat # 
208TP54), an Atmospheric Pressure Interface (API) electrospray source, an 
ion trap mass analyzer, and a dynode-based system ion detector (Daly 
detector). Mass spectrometry parameters were set at default values: the 
nebulizer pressure was set to 40 psi, the flow rate was set to 0.5 mL/min, 
and the injection volume was set to 20μL. 
 
After establishing a protocol for the identification of SALMFamide 
peptides, a protocol for the detection of the putative novel sea urchin 
neuropeptides was developed. Echinotocin and NGFFFamide were 
synthesized for use as standards in the development of an identification 
protocol. The peptides were synthesized by the Advanced Biotechnology 
Centre at Imperial College London. Both peptides were synthesized with an 
amidated C-terminal. Echinotocin was constructed with a disulfide bond 
between the first and sixth residues.  
 NGFFFamide (MW=629.7162)  NGFFF-NH2 
 Echinotocin    (MW=965.1654)  CFISNCPKG-NH2 
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Synthetic peptide solutions were firstly subjected to the same extraction 
protocol that proved effective for detection of the SALMFamide 
neuropeptides. Mass spectrometric detection of each of the synthetic 
peptides using HPLC-MC was standardized using a 20 μl injection of a 10 
μM peptide solution and 0.5%, 1%, 1.67%, 2%  and 8.3% per minute 
gradients of organic solvent (see Table 8, Chapter 4). The full gradient for 
the identification of SALMFamide S1 ran at 8.3%/min from 20% to 45%, 
at 2%/min ACN from 45% to 65% in 10 minutes, and at 8.3%/min ACN 
from 65% to 90%. The full gradient for the identification of SALMFamide 
S2 ran at 2%/min from 30% to 90% in 30 minutes. 
 
Capillary, skimmer, octopole, trap drive, and lens voltages, or 'expert 
parameter settings' were optimized for each synthetic peptide by injecting 
the mass spectrometer directly with a 1 μM peptide solution, bypassing 
separation on the HPLC column (Appendix D). These parameters were then 
used to construct segmented gradients for the elution and detection of more 
than one peptide on a single run to minimise the amount of extract 
expended.  
 
Ten specimens of S. purpuratus were dissected into body wall and viscera 
by Robert Burke's laboratory at the University of Victoria, British 
Columbia. The viscera and body wall were separately homogenized in a 
Waring blender, centrifuged (15000 x g for 10 minutes), the supernatant 
decanted and the pellet discarded, lyophilized overnight, and stored at         
-80˚C prior to transport in separate vials on dry ice to Queen Mary, 
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University of London, via Fedex. The vials were combined for each tissue 
type, re-homogenized (Ultra-Turrax T25, max. 24000 rpm) and filtered and 
purified using a C18 SepPak column according to the same procedure used 
for the extraction of SALMFamide neuropeptides from starfish tube foot 
and radial nerve tissue.  
The identification of putative peptides on detection by mass spectrometry 
was guided by correlating the putative peptide's elution point to the elution 
point of the synthetic peptide run on an identical gradient immediately after 
the extract. As a negative control, pure water was run on the same gradient 
immediately prior to the extract. 
 
3.2.3   Methods: Immunohistochemistry protocols for the localization 
of echinotocin 
 
Two different commercially available rabbit anti-vasopressin polyclonal 
antibodies were purchased for the localization and detection of echinotocin: 
one from Millipore (Cat. AB1565), another from Calbiochem (Cat. 
PC234L). The antibodies were stored at -20˚C in 50% glycerol aliquots. 
Synthetic vasopressin, [Arg
8
]-vasopressin, was also purchased for use as a 
positive control (Cat. 2935, Tocris Bioscience). 
 
Firstly, immunoblot assays were used to test the antibody's affinity for the 
peptide on a nitrocellulose membrane. Secondly, frozen tissue sections and 
sections prepared from paraffin-embedded tissues of Echinus esculentus 
tube foot and oesophagus were prepared to test for immunoreactivity with 
anti-vasopressin antibodies. 
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3.2.3.1   Immunoblot Assay Protocol 
 
Immunoblot assays were used to test the immunoreactivity of both 
antibodies against synthetic peptide. The synthetic peptides were blotted 
onto a nitrocellulose membrane, washed in phosphate-buffered saline (PBS; 
pH 7.4) and blocked in 5% w/v Marvel
TM
 milk powder for two hours. 
Unrelated synthetic peptides (Sp-GKamide and Sp-GnRH) were used as 
negative controls. Primary antibody, a dilution of 1:1000, was left to 
incubate overnight at 4˚C in a blocking solution of MPBST (PBS; 1% 
Marvel
TM
, 0.05% Tween 20). The membrane was given three ten minute 
washes in MPBST before incubation with the secondary antibody, alkaline 
phosphatase-labelled goat anti-rabbit immunoglobulin (AP-1000, Vector 
Laboratories), at a concentration of 1:1000 in MPBST (1% Marvel
TM
, 
0.05% Tween 20). The secondary antibody was incubated for two hours at 
room temperature. The membrane was given three ten minute washes in 
PBST (PBS; 0.05% Tween 20) and one ten minute wash in 100 mM Tris 
buffer (pH 9.5). To detect immunoreactivity, the membrane was submerged 
in BCIP/NBT substrate (12761220, Roche), diluted 1:100 in buffer (3.3% 
3M NaCl; 10% 1M Tris pH 9.5). Immediately after staining the membrane 
strips were washed in water and air-dried.  
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3.2.3.2   Immunohistochemistry: Tissue fixation, sectioning and 
immunostaining 
 
Sea urchin (E. esculentus) tube foot, oesophagus, and intestine tissues were 
fixed in water (4% w/v PFA), sea water (4% w/v PFA), and Bouin's 
fixative (saturated picric acid, 24% formalin, 5% acetic acid) and either 
embedded in paraffin or prepared for freezing (see below). The tissues 
fixed in 4% w/v PFA solutions were incubated overnight at 4˚C, while the 
tissues fixed in Bouin's fixative were incubated in the fixative for several 
days at 4˚C. The tissues were rinsed of fixative before stepped dehydration 
in ethanol (EtOH) (50%, 70%, 90%, and 2 x 100%) with gentle shaking for 
one hour per stage at room temperature. The dehydrated tissues were 
submerged twice in xylene, to displace the alcohol, at a maximum duration 
of five minutes each, before embedding in paraffin at 56˚C for six to twelve 
hours depending on the size of the fixed tissue. 
 
Sections of seven to twelve micrometres were prepared from the paraffin-
embedded tissues using a rotary microtome (RM2145, Leica). The sections 
were left to adhere to SuperFrost® slides on a work bench heater set at a 
warm temperature for several hours before storage. Prior to staining, 
sections prepared were treated in xylene (three separate immersions for ten 
minutes each) before stepped rehydration in EtOH (2 x 100%, 90%, 70%, 
50%, water) for ten minutes per step. Before immersion in 90% EtOH, the 
sections were treated with hydrogen peroxide in methanol (1% H2O2) for 
30 minutes to eliminate endogenous peroxidase activity. The sections were 
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washed in normal PBS buffer, then PBS-X (PBS; 0.2% Triton X-100), 
before blocking, incubation with antibody, and staining. 
 
To prepare fixed samples for freezing, the tissues were gradually infused 
with a 30% sucrose solution overnight, embedded in Tissue-Tek O.C.T. 
Compound 4583 tissue-embedding medium and frozen in liquid nitrogen. 
Sections of approximately 20 µm in thickness were prepared using a 
cryostat (Leica CM3050 S) and mounted on gelatin-coated SuperFrost® 
slides. The sections were dried for half an hour before storing at -20˚C for 
no longer than 24 hours prior to three ten minutes washes with PBS, one 
ten minute PBS-X, and staining. 
 
Prior to antibody incubation, slides were blocked in 5% w/v Normal Goat 
Serum (G9023, Sigma) PBS-X at room temperature for two hours. Primary 
antibodies (AB1565, Millipore; PC234L, Calbiochem) were diluted at 
concentrations of 1:500 and 1:1000 in 5% NGS PBS-X blocking buffer, 
and incubated with the prepared sections overnight. After three washes with 
PBS-X (0.05% Triton X-100) for 10 minutes each wash, the sections were 
incubated in secondary antibody, horseradish peroxidase-conjugated goat 
anti-rabbit immunoglobulin (A-0545, Sigma), diluted 1:500 in 1.5% w/v 
NGS PBS-X (0.05% Triton X-100) for four hours at room temperature. The 
sections were washed again in PBST (PBS; 0.05% Tween 20) three times 
before using a 3,3'-diaminobenzidine/nickel staining kit according to the 
manufacturer's instructions (solution ratios: 1 substrate buffer: 2 DAB: 1 
H2O2: 1 Ni) (SK-4100, Vector Laboratories). Tissue section staining was 
carried out in the dark at room temperature for approximately ten minutes. 
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The staining reaction was stopped with PBS buffer before the sections were 
dehydrated in alcohol (10 minute stages of 50%, 70%, 90%, 2 x 100% 
EtOH), treated with twice with xylene (10 min) to remove the alcohol, 
covered with a coverslip mounted on DPX, and viewed under a light 
microscope. 
 
Preabsorption controls, prepared in parallel to primary antibody incubation 
and negative controls without primary antibody, involved incubating the 
primary antibody at a 1:100 dilution in a 20 μM echinotocin PBS buffered 
solution. The vasopressin antibody was incubated with synthetic 
echinotocin for two hours with gentle rocking at room temperature, before 
centrifugation and dilution to 1:1000. Positive controls of mouse brain 
sections containing vasopressinergic neurons, the paraventricular nucleus 
(PVN) and supraoptic nucleus (SON), were used to test the ability of the 
antibodies to recognise vasopressin in fixed tissues.  
 
3.2.4   Methods: Pharmacological investigation of echinotocin and 
NGFFFamide myoactivity 
 
Live specimens of the sea urchin Echinus esculentus Linnaeus (Class 
Echinoidea, Family Echinidae) were maintained in a sea water aquarium at 
approximately 4˚C. Synthetic echinotocin and NGFFFamide were tested for 
myoactivity on E. esculentus oesophagus and tube foot preparations. All 
recordings of E. esculentus oesophagus and tube foot myoactivity were 
made using an isometric force transducer (Harvard Apparatus). When 
relaxed and fully extended, tube feet were severed from approximately 
 92 
halfway along a sea urchin radial canal. The tube foot epithelial layer was 
either sheared using a blunt seeker probe or left intact. Because sea urchin 
tube feet which have been stripped of their epithelial layer are very fragile, 
for some of the preparations only half of the epithelium was removed 
(subsequently referred to in this study as 'semi-stripped' preparations). 
Oesophagi were removed and cut into 1.5 cm long segments. Although tube 
foot and oesophagus tissues were the easiest to dissect, intestine sections 
and muscles involved in lantern movement, including the compass 
depressor muscle and the lantern protractor and retractor muscles, were also 
dissected for investigation. 
 
The preparations were tied using a silk ligature, suspended in an 11°C, 20 
mL bath of aerated sea water supplied from the aquarium, before being 
connected to the force transducer. All tissues were maintained in the bath at 
a constant temperature for several hours until attaining a state of stable 
tension and before applying the synthetic peptide. Peptide solutions were 
freshly prepared at concentrations from 10 nM to 10 µM. The solutions 
were pipetted into the sea water bath at a series of concentration increments 
typically increasing by a factor of ten. The water bath was washed out with 
sea water (11ºC) approximately ten minutes after applying each peptide 
solution. Individual applications of the synthetic peptides at high 
concentrations (3 µM) were recorded on separate tube foot and oesophagus 
preparations to observe the magnitude of responses independent of the 
effects of desensitization. Because individual responses were recorded 
when contraction of the preparation were clearly stronger than background 
variation, single observations of contractile activity were recorded and 
 93 
included the response data. The transducers were calibrated with weights so 
that the force of contraction (mN) could be calculated from the number of 
units displaced on the recorder as a result of contractile activity. As a 
negative control, distilled water was pipetted into the bath to determine 
whether mechanical stimulation also induced contraction. Acetylcholine 
(ACh), which has previously demonstrated myo-excitatory activity on sea 
urchin tissue preparations (Florey and Cahill, 1980), and carbachol, a 
nicotinic and muscarinic cholinergic agonist, were also applied to the 
preparations. Both were used as positive controls and for pharmacological 
comparisons of efficacy, or strength of response for a given contraction, 
and potency, or the concentration of agent which induces 50% of the 
maximal response observed.  
 
3.3   Results 
 
Four neuropeptide homologues were identified by BLAST searching the 
sea urchin genome. The putative neuropeptides identified included 
homologues of vertebrate hormone vasotocin and the sea cucumber 
neuropeptide NGIWYamide. Genes encoding homologues of both the alpha 
and beta chains of the insect cysteine knot cuticle-hardening hormone 
bursicon were also identified in the genome by BLAST homology 
searching (SPU_003984 and SPU_017707) (Figure 16). 
 
3.3.1   Identification of NGFFFamide 
 
Analysis of the S. purpuratus genome using tBLASTn with a query 
constructed from three repeats of the sea cucumber NGIWYamide 
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neuropeptide resulted in the identification of a sequence 
('KRNGFFFGKRNGFFFGKR') encoding two copies of a putative 
NGIWYamide-like peptide, Asn-Gly-Phe-Phe-Phe-NH2 (or NGFFFamide, 
pronounced "Neg-famide"). An N-terminal signal peptide sequence was 
identified in the Gnomon prediction model (hmm5205), upstream of the 
peptide coding region. However, the putative NGFFFamide precursor gene 
was not contained within the set of genes predicted by the Glean3 
algorithm. Therefore, the putative NGFFFamide precursor gene was 
included as one of a number of ‘novel genes’ identified as part of the sea 
urchin genome annotation project (SPU_030074) (Burke et al., 2006; 
Sodergren et al., 2006).  
 
The amino acid sequence of the NGFFFamide precursor was then 
submitted as a tBLASTn query against a database of the adult radial nerve 
EST sequences. Corresponding 5-prime and 3-prime sequences of a cDNA 
clone (RNSP-5L15) from the S. purpuratus radial nerve cord library were 
identified, providing evidence of expression of the putative NGFFFamide 
precursor in neural tissue. A five prime EST corresponding to the three 
prime region of the precursor was also identified in an EST library of S. 
purpuratus 20 hour blastula stage embryos (GI:34799242).  
 
3.3.2   Identification of the neurophysin domain 
 
On submitting the EST nucleotide sequences as a BLASTx query against 
the NCBI protein database the 3-prime EST sequence strongly aligned to 
neurophysin sequences of vasopressin/oxytocin-like neuropeptide 
precursors. The presence of the neurophysin-encoding exon was also 
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supported by the Gnomon gene prediction model (hmm5205). The 
complete NGFFFamide encoding preproprotein was found to contain two 
copies of the putative neuropeptide NGFFFamide and a C-terminal 
neurophysin sequence of up to 108 amino acids (Figure 17).  
 
3.3.3   Identification of echinotocin 
  
A novel neuropeptide also containing a C-terminal neurophysin domain, 
denominated echinotocin (Cys-Phe-Ile-Ser-Asn-Cys-Pro-Lys-NH2), was 
identified by BLAST searching the genome on the basis of sequence 
similarity to the vertebrate vasopressin neuropeptide amino acid sequence 
(Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2). Although the precursor 
gene was not predicted by Gnomon gene prediction heuristics, the 
precursor was predicted by both GenScan and Glean3 gene prediction 
programs and was subsequently annotated in the sea urchin annotation 
database (SPU_006899). However, the echinotocin sequence was not found 
to be amongst the nucleotide sequences represented in adult or embryonic 
EST libraries. The putative echinotocin encoding preproprotein contains 
one copy of the neuropeptide, a neurophysin sequence of up to 95 amino 
acids, and a C-terminal glycoprotein or putative copeptin molecule of 30 
amino acids (Figure 18). 
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Sp_beta  MPEATSNEMSTCRLAKVIILFTPKPPGIWLYTMLLLLVVLLC                     
Dm_beta  ---------------------------MHVQELLFVAAILVP 
Dm_alpha ---------------MLRHLLRHENNKVFVLILLYCVLVSIL 
Sp_alpha -----------------------MATLTTTQSSLLMLALILL 
 
 
Sp_beta  GAGSVSRVSSLADGETCELSHGETTIDVEVVDDNLQRTLRCRK 
Dm_beta  QCLRALRYSQGTGDENCETLKSEIHLIKEEFDELGRMQRTCNA 
Dm_alpha KLCTAQPDSSVAATDN-DITHLGDDCQVTPVIHVLQYPGCVPK 
Sp_alpha SLTTSS--------------LVLADCRKLGLQYKLARPGCRPV 
 
 
 
Sp_beta  RVQVNQCEGKCISQVSPTVLQ-HGFDKKCHCCREHGMVHKKVV 
Dm_beta  DVIVNKCEGLCNSQVQPSVITPTGFLKECYCCRESFLKEKVIT 
Dm_alpha PIPSFACVGRCASYIQVSGSKIWQMERSCMCCQESGEREAAVS 
Sp_alpha TLDSVGCRGTCSGYTRISPNNYLEVERSCTCCQEMGFLERTQR 
 
 
Sp_beta  MTNCYD-HALGITDPDF-THQVTLKQPEACRCQICTF------                                                      
Dm_beta  LTHCYDPDGTRLTSPEMGSMDIRLREPTECKCFKCGDFTR--- 
Dm_alpha LF------CPKVKPGERKFKKVLTKAPLECMCRPCTSIEESGI 
Sp_alpha LQ------CPTLNPPFR---DVTYRIPRRCSCRPCRSVASVSR 
 
 
Sp_beta  ----------------------- 
Dm_beta  ----------------------- 
Dm_alpha PQEIAGYSDEGPLNNHFRRIALQ 
Sp_alpha VQTLEDLRLG------------- 
 
 
Figure 16. ClustalX alignment of two putative alpha and beta sea 
urchin bursicon-like preprohormone sequences with the two 
Drosophila alpha and beta bursicon preprohormone sequences. N-
terminal signal peptide sequences are identified in bold italic and the 
eleven cysteines common to each of the four sequences are 
underlined. 
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Figure 17. NGFFFamide precursor. The putative precursor gene 
contains 1309 nucleotides and the preprohormone sequence 
contains 266 residues. There are four exons separated at splice 
sites indicated in bold underlined font. The signal peptide sequence 
is indicated in blue font, the two peptides in red font, dibasic 
cleavage site ('KR') in green font, and the neurophysin sequence in 
purple. Neurophysin cysteine residues are underlined. The 
translation stop codon is indicated by an asterisk. 
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Figure 18. Echinotocin precursor. The putative precursor gene 
contains 499 nucleotides and the preprohormone sequence contains 
165 residues. There are three exons separated at splice sites 
indicated in bold underlined font. The signal peptide sequence is 
indicated in blue font, echinotocin in red font, a single dibasic 
cleavage site ('KR') in green font, and the neurophysin sequence in 
purple. Neurophysin cysteine residues are underlined. A putative 
copeptin-like sequence is underlined in purple. The translation stop 
codon is indicated by an asterisk. 
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3.3.4   Mass spectrometry: detection of starfish SALMFamides and sea 
urchin NGFFFamide 
 
Both SALMFamide peptides were successfully detected in the 0.1% formic 
acid starfish tube foot and radial nerve extract when injected into the 
HPLC-MS system (Figures 19 & 20). SALMFamide S1 was detected at 
approximately 70% ACN from a gradient of 8.33%/min ACN, 0.1% formic 
acid, at a 0.5 mL/min flow rate (Figure 19). SALMFamide S2 was detected 
at approximately 50-51% ACN from a gradient of 2%/min ACN, 0.1% 
formic acid, at a 0.5 mL/min flow rate (Figure 20). 
 
Synthetic NGFFFamide eluted at between 39% and 46% on a 0.5% 
ACN/min gradient, at between 44% and 46% on a 1% ACN/min gradient, 
and at between 44% and 47% on a 2% ACN/min gradient. Synthetic 
echinotocin eluted at between 32% and 39% on a 1%/min ACN gradient, at 
between 37% and 39% on a 1.67%/min ACN gradient, and at 
approximately 42% on a 2%/min ACN gradient. The peptide masses 
identified by mass spectrometry, in protonated form, are compared to the 
calculated masses in Table 6.  
 
A molecule with a mass corresponding to that of NGFFFamide was 
identified in extracts of S. purpuratus visceral tissue, coinciding with the 
elution point of the synthetic peptide. The molecule (630.3 u) appeared in 
all mass spectrometry traces and was absent from the blank standard 
(water, 0.1% formic acid) run prior to the extract and confirmed on running 
synthetic NGFFFamide on an identical gradient after the extract. On 
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running the body wall extract, a peak corresponding to NGFFFamide was 
identified again, at a stronger intensity than the peak identified from the 
visceral extract (2 x 10
5
 cps) (at 32 to 32.9 min) (Figure 21). There were no 
mass spectrometric peaks corresponding to the mass of echinotocin, 
coincident with the elution point of synthetic echinotocin, detected in either 
the sea urchin body wall or visceral tissue purified extracts. 
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Table 6: Predicated and observed synthetic peptide masses of 
echinotocin and NGFFFamide detected using HPLC-MS. The 
difference observed between observed and calculated mass gave 
There was an error range of 0.082% between the observed and 
calculated masses. 
 
______________________________________________________________________________________________________________________________________________________ 
 
Peptide  Predicted Mass Observed Mass 
 
NGFFFamide 630.7162 (H
+
) 630.3 (H
+
) 
 
Echinotocin 966.1654 (H
+
) 965.4 (H
+
), 
      483.2 (2H
+
) 
 
______________________________________________________________________________________________________________________________________________________ 
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Figure 19. SALMFamide S1 (MW=885.4, predicted MW=885.1) 
detected in Asterias rubens tube foot and radial nerve tissue extract. 
The peptide was eluted at approximately 70% acetonitrile (ACN), 
0.1% formic acid. The smaller peaks (886.4, 887.4) correspond to 
larger masses representing isotopic variation in atomic carbon mass.  
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Figure 20. SALMFamide S2 (MW=1275.5, predicted MW=1275.4) 
detected in Asterias rubens tube foot and radial nerve tissue extract. 
The peptide was eluted at approximately 50-51% acetonitrile (ACN), 
0.1% formic acid. The smaller peaks (1276.4, 1277.4) correspond to 
larger masses representing isotopic variation in atomic carbon mass.  
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A  
B
C  
D  
 
Figure 21. Detection of NGFFFamide using HPLC-MS. 
A) Full mass spectrum showing detection of synthetic NGFFFamide 
peptide (630.3) (*).  
B) Magnified mass spectrum view of 17A, showing NGFFFamide 
synthetic peptide (603.3) (*) detected at 32.0 to 32.9 minutes.  
C) Full mass spectrum showing detection of NGFFFamide (630.3) 
(*). Spectrum obtained from sea urchin S. purpuratus body wall 
extract. 
D) Magnified mass spectrum view of 17C. Spectrum obtained from 
sea urchin S. purpuratus body wall extract. Putative NGFFFamide 
neuropeptide (630.3) (*) was detected at 32 to 32.9 minutes. 
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3.3.5   Results: Immunohistochemistry 
 
The anti-vasopressin antibody AB1565 recognized 1ng to 1μg of 
echinotocin blotted on to a nitrocellulose membrane. Both synthetic 
vasopressin and echinotocin were also found to be immunoreactive to the 
anti-vasopressin antibody PC234L when bound to a nitrocellulose 
membrane. As an additional positive control, antibody PC234L 
successfully recognized synthetic vasopressin on an immunoblot assay 
(results not shown). However, both primary antibodies preabsorbed with 
vasopressin failed to eliminate immunoreactivity to neuronal staining in the 
paraventricular and supraoptic nuclei in mouse brain sections, where 
vasopressin is synthesized (Figures 22, 23 & 24).  
 
Sea urchin tube foot and oesophagus tissues sections demonstrated 
immunoreactivity to anti-vasopressin antibodies; however, the areas of 
positive staining were not eliminated in preabsorption controls. In 
comparison to negative controls, the areas of primary staining were 
strongest in sections stained with the PC234L anti-vasopressin antibody. 
Positive staining was observed in sections of the oesophagus mucosal 
endocrine plexus and cells bordering the basiepithelial nerve plexus (Figure 
25A-E). These sections were obtained from paraffin-embedded tissue fixed 
with Bouin's fixative.  Staining was also stronger in the mucosal endocrine 
plexus and longitudinal muscle layer in frozen sections of oesophagus 
tissue (not shown). The staining was absent from negative controls, except 
for the preabsorption control. Staining in the mucosal endocrine plexus of 
the intestine was also observed in both frozen sections and sections 
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prepared from paraffin-embedded tissue (not shown). Although the staining 
was not eliminated in preabsorption controls, tube foot tissues prepared by 
cryostat showed significantly stronger staining than observed in negative 
controls without primary or secondary in both the inner and outer epithelial 
layer (not shown). 
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Figure 22. Positive control tests for the AB1565 vasopressin 
antibody. Scale bar=200 µm 
A) Anti-vasopressin AB1565 antibody immunoreactivity in the mouse 
brain, transverse section, at the PVN and SON. 
B) Preabsorption control of anti-vasopressin AB1565 antibody 
immunoreactivity in the mouse brain, transverse section, at the PVN 
and SON. 
 
  
Figure 23. Positive control tests for the AB1565 vasopressin 
antibody. Scale bar=100 µm 
A) Anti-vasopressin AB1565 antibody immunoreactivity in the mouse 
brain, transverse section, at the PVN and SON (transverse section). 
B) Preabsorption control of anti-vasopressin AB1565 antibody 
immunoreactivity in the mouse brain at the PVN and SON 
(transverse section). 
 
 
  
Figure 24. Positive control tests for the PC234L vasopressin 
antibody. Scale bar=100 µm 
A) Anti-vasopressin PC234L antibody immunoreactivity in the mouse 
brain at the PVN and SON (longitudinal section).  
B) Preabsorption control of anti-vasopressin PC234L antibody 
immunoreactivity in the mouse brain at the PVN and SON 
(longitudinal section). 
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Figure 25. Sea urchin oesophagus transverse section prepared 
from paraffin-embedded tissue stained with rabbit anti-vasopressin. 
Oesophagus fixed with Bouin's solution. Arrows indicate areas of 
staining. Scale bar=200 µm 
 A-D) Staining in the mucosal endocrine plexus and the region of the 
basiepithelial plexus in sections incubated with anti-vasopressin 
PC234L antibody (1:1000).  
E) Negative control without primary anti-vasopressin PC234L 
antibody.  
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3.3.6   Results: Characterization of NGFFFamide and echinotocin 
myoactivity 
 
The two novel putative neuropeptides echinotocin and NGFFFamide both 
caused contraction of sea urchin and oesophagus in vitro tissue 
preparations, demonstrating that both peptides have myoactive properties. 
Of the two peptides, NGFFFamide was more potent in causing contraction 
of both preparations than echinotocin, and therefore had the greater 
efficacy. Acetylcholine and carbachol also induced contraction of sea 
urchin tube foot and oesophagus tissues.  
 
3.3.6.1   Acetylcholine and carbachol 
 
Acetylcholine caused contraction of sea urchin oesophagus, intestine, 
lantern protractor muscle, lantern retractor muscle, compass depressor 
muscle, and 'semi-stripped', 'stripped', and 'unstripped' tube foot 
preparations (Table 7). 'Semi-stripped' tube feet were more responsible to 
acetylcholine and carbachol than unstripped preparations (not shown). 
'Semi-stripped' tube foot responses to acetylcholine increased in contractile 
strength with concentration (Figure 26). Contractions were observed at 
concentrations ranging from 100 nM to 300 μM. The highest average force 
was recorded from applications of 100 μM ACh (  = 0.719 mN, s.e.m. = 
0.281, n = 8). 'Semi-stripped' tube foot responses to carbachol also 
increased in contractile strength with concentration (Figure 27). 
Contractions in response to carbachol were observed at concentrations 
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ranging from 10 nM to 30 μM. The highest force was recorded from an 
application of 30 μM carbachol (0.300 mN, n=1). 
 
Starfish tissues were also responsive to acetylcholine. A. rubens stripped 
tube foot preparations also contracted in response to acetylcholine 
concentrations from 1 nM to 300 μM recorded on an isometric transducer. 
Subsidiary experiments also demonstrated that apical muscle preparations 
were responsive to acetylcholine concentrations from 1 μM to 1 mM (Gill, 
unpublished). 
 
3.3.6.2   Echinotocin and NGFFFamide 
 
Both NGFFFamide and echinotocin induced contraction of E. esculentus 
oesophagus and unstripped tube foot preparations (Figures 28 & 29). 
NGFFFamide, at a concentration of 3 μM, induced contraction of tube feet 
(  = 1.350 mN, s.e.m. = 0.210, n = 3) and at a greater magnitude than 
echinotocin (  = 0.810 mN, s.e.m. = 0.42, n = 3) (representative traces 
illustrated in Figure 28B & 29B). Similar differences in efficacy, or 
strength of contraction at a fixed concentration, were observed when testing 
both peptides on oesophagus preparations. NGFFFamide at a concentration 
of 3 µM induced contractions (  = 1.466 mN, s.e.m. = 0.230, n = 3) of a 
greater magnitude than echinotocin (  = 0.714 mN, s.e.m. = 0.01, n = 3) 
(representative traces illustrated in Figure 28A & 29A) . 
 
NGFFFamide induced dose-dependent contractions of E. esculentus 
oesophagus preparations at concentrations from 10 pM to 1 µM and of 
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unstripped tube foot preparations at a higher range of concentrations from 
10 nM to 1 µM (Figure 28C). NGFFFamide induced contraction of 'semi-
stripped' tube foot preparations at a similar range of concentrations from 10 
nM to 10 μM (Figure 30), with a highest mean contraction of 0.230 mN 
(s.e.m. = 0.129, n = 15) at a 3 µM peptide concentration. Sea urchin 
intestine also contracted in response to NGFFFamide at a concentration of 
3 μM (0.308 mN, n = 1). In subsidiary experiments, NGFFFamide was also 
found to induce contraction of starfish cardiac stomach at a concentration 
of 1 μM. 
 
Echinotocin induced dose-dependent contractions of E. esculentus 
oesophagus preparations at concentrations from 10 nM to 100 nM, before 
desensitization of the preparation, and of unstripped tube foot preparations 
at a similar range of concentrations from 10 nM to 1 µM (Figure 29C). In 
subsidiary experiments on preparations from the starfish Asterias rubens, 
echinotocin induced contraction of starfish cardiac stomach at a 
concentration of 1 μM (Navaratnam, unpublished) and stripped tube foot 
(1.39 mN, n = 1) at a concentration of 1 μM.  
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Table 7: Acetylcholine-induced contraction of sea urchin tissue  
preparations. 
 
______________________________________________________________________________________________________________________________________________________ 
 
Tissue   Concentration (µM) Force (mN)  n 
______________________________________________________________________________________________________________________________________________________ 
 
Tube foot;  
    - Semi-stripped 100   0.719  8 
    - Stripped  200   0.173  1 
    - Unstripped  100   2.622  2 
Oesophagus  3   1.653  3 
Intestine   3   1.169  1 
Lantern protractor 
muscle   5   0.437  1 
Lantern Retractor 
Muscle   3   1.209  1 
Compass Depressor 
Muscle   6   5.127  1 
 
______________________________________________________________________________________________________________________________________________________ 
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Figure 26. Acetylcholine-induced contraction of Echinus esculentus 
'semi-stripped' tube foot preparations measured using an isometric 
transducer. Tube foot preparations contracted in response to 100 
nM (n = 5), 300 nM (n = 5), 1 μM (n = 14), 3 μM (n = 15), 10 μM (n = 
15), 30 μM (n = 5), 100 μM (n = 8), and 300 μM (n = 4). 
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Figure 27. Carbachol induced contraction of Echinus esculentus 
'semi-stripped' tube foot preparations measured using an isometric 
transducer. Tube foot preparations contracted in response to 10 nM 
(n = 3), 100 nM (n = 7), 300 nM (n = 3), 1 μM (n = 8), 3 μM (n = 5), 
10 μM (n = 7), and 30 μM (n = 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 115 
 
Figure 28. NGFFFamide causes contraction of oesophagus and 
'unstripped' tube foot preparations from the sea urchin Echinus 
esculentus. Traces (A-D) show representative responses to peptide 
applications at 3x10–6 mol l–1 (arrows). 
A) NGFFFamide induced contraction of oesophagus. 
B) NGFFFamide induced contraction of unstripped tube foot. 
C) Dose-dependent effect of NGFFFamide on tube foot (filled 
squares) and oesophagus (open squares) preparations. Peptide 
concentrations were increased by a factor of ten. Data points are 
mean values (n = 4) with bars showing s.e.m.  
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Figure 29. Echinotocin causes contraction of oesophagus and 
'unstripped' tube foot preparations from the sea urchin Echinus 
esculentus. Traces (A-D) show representative responses to peptide 
applications at 3x10–6 mol l–1 (arrows). 
A) Echinotocin induced contraction of oesophagus. 
B) Echinotocin induced contraction of unstripped tube foot. 
C) Dose-dependent effect of echinotocin on tube foot (filled squares) 
and oesophagus (open squares) preparations. Oesophagus 
contractions after 100 nM were not included due to tissue 
desensitization. Peptide concentrations were increased by a factor 
of ten. Data points are mean values (n = 4) with bars showing s.e.m. 
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Figure 30. NGFFFamide induced contraction of Echinus esculentus 
'semi-stripped' tube foot preparations measured using an isometric 
transducer. Tube foot preparations contracted in response to 1 nM 
(n = 1), 10 nM (n = 6), 30 nM (n = 9), 60 nM (n = 1), 100 nM (n = 17), 
300 nM (n = 19), 1 μM (n = 24), 3 μM (n = 15), and 10 μM (n = 9). 
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3.4   Discussion 
 
Two novel putative neuropeptide precursor genes containing neurophysin 
domains have been identified in the genome of the sea urchin S. 
purpuratus. The genes identified encode the putative neuropeptides 
NGFFFamide and echinotocin, homologues of the sea cucumber 
neuropeptide NGIWYamide and vasopressin/oxytocin-type neuropeptides, 
respectively. Furthermore, two precursors of bursicon-like peptides have 
been identified. NGFFFamide is structurally-unrelated to 
vasopressin/oxytocin-like peptides and a sequence encoding the 
NGFFFamide precursor was detected in a neural EST library. Furthermore, 
a peptide with the same molecular mass as synthetic NGFFFamide was 
detected in a mass spectrometric analysis of S. purpuratus tissue extracts, 
demonstrating that the amidated pentapeptide is also expressed in sea 
urchins. Prior to this study, only vasopressin/oxytocin-like family 
neuropeptide genes have been known to encode neurophysin sequences. 
Although echinotocin expression was not detected in the neural EST library 
or through mass spectrometric analysis, the peptide may still be expressed 
in neural or endocrine sea urchin tissues. 
 
3.4.1   Sea urchin glycoprotein hormones 
 
The subunits of the insect dimeric hormone bursicon are encoded by 
separate precursors (Luo et al., 2005). Consistent with the structure of 
bursicon, the putative sea urchin bursicon-like dimer subunits appear to be 
also encoded by two separate precursors (see Figure 16). Bursicon targets 
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GPCRs characterized by leucine-rich repeat regions, which as a subgroup 
of the GPCR superfamily includes the glycoprotein gonadotropins and 
relaxin/insulin-like growth factor hormone receptors found in vertebrates 
(Luo et al., 2005).  
 
There may be other putative ligands to sea urchin glycoprotein-like and 
relaxin/insulin-like receptors. Mita et al (2009) purified gonad-stimulating 
substance (GSS) from radial nerves of the starfish Asterina pectinifera and 
identified the dimeric peptide as a member of the relaxin-like hormone 
family. Therefore, like bursicon, GSS may bind a sea urchin receptor with 
homology to vertebrate leucine-rich repeat containing GPCRs. 
Furthermore, Burke et al. (2006) reported the identification of two sea 
urchin insulin-family peptides; Sp-IGF1 and Sp-IGF2, which may also bind 
the receptors within the same subgroup. Three putative receptors were 
identified in the sea urchin genome by homology searching; Sp_115678957 
showing homology to vertebrate glycoprotein receptors, and both 
SPU_015740 and SPU_003527 showing homology to relaxin/insulin-like 
receptors) (see Figure 14, Chapter Two). However, the insulin-like growth 
factors identified may bind sea urchin tyrosine kinase receptors (Lapraz et 
al., 2006).  
 
3.4.2   Neurophysin-encoding precursors in the sea urchin genome 
 
The putative echinotocin neuropeptide is the first vasopressin/oxytocin-like 
neuropeptide to be identified in the genome of an echinoderm and the 
putative peptide may share a common ancestor with other members of the 
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vasopressin/oxytocin neuropeptide family (Figure 31). Oxytocin and 
vasopressin are neuropeptides encoded by two separate genes which are 
thought to have originated by gene duplication at least 450 mya in primitive 
jawed vertebrates. The ancestral neuropeptide precursor to both oxytocin 
and vasopressin may have encoded a peptide similar to vasotocin, a 
vasopressin-like neuropeptide expressed in non-mammalian vertebrates 
(Urano et al., 1992; Van Kesteren et al., 1992; Hoyle, 1999). The 
hypothesis is supported by the presence of only a single vasotocin-encoding 
gene in the lamprey Lampetra japonica (Suzuki et al., 1995). 
 
All described vasopressin/oxytocin-like neuropeptides have a ring structure 
formed by a disulfide bridge between two cysteine residues (C1-C6), a 
structural characteristic likely to be shared by echinotocin. With the 
exception of vasopressin/oxytocin family neuropeptides identified in the 
nematode C. elegans and urochordates Styela plicata and Ciona 
intestinalis, all vasopressin/oxytocin-like neuropeptides, including the 
echinotocin neuropeptide, have nine residues (Kawada et al., 2008; Ukena 
et al., 2008) (Figure 31). Amino acid substitutions in positions three and 
eight of the two nonapeptides affect their activity and specificity. A basic 
residue in the eighth position is common to vasopressin-like hormones, 
whereas a neutral amino acid in the same position is shared by oxytocin-
like hormones. In vertebrates a hydrophobic isoleucine residue in position 
three is essential for the stimulation of oxytocin receptors, while a basic 
arginine or lysine residue in position eight is essential for the stimulation of 
vasopressin receptors (Chini et al., 1995). Echinotocin is similar to 
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oxytocin in having a hydrophobic residue (Ile) in position three and is 
similar to vasopressin in having a basic residue (Lys) in position eight.  
 
In chordates the vasopressin/oxytocin preprohormone gene consists of three 
exons, the first encoding a signal peptide sequence, vasopressin/oxytocin, 
and the first nine residues of neurophysin, the second encoding residues 10-
76 of neurophysin and the third containing residues 77-95 of neurophysin. 
The echinotocin neurophysin domain is encoded by three exons whereas 
the NGFFFamide-associated neurophysin domain is only encoded by two. 
Alignment of the echinotocin and NGFFFamide precursors with eight other 
vasopressin/oxytocin-like peptide precursors from four different phyla 
using ClustalX is shown in Figure 32. Furthermore, NGFFFamide 
neurophysin did not cluster with any of the representative neurophysin 
sequences, suggesting that the NGFFFamide-encoding gene arose either 
through gene duplication before protostome and deuterostome divergence 
or through recent sequence divergence within the echinoderm phylum 
(Figure 33). The phylogenetic tree illustrated shows that the NGFFFamide 
neurophysin domain is no more similar to other chordate neurophysin 
domain sequences, including echinotocin neurophysin, than to neurophysin 
domains encoded by other protostome precursors. Sequence alignment 
analysis alone may be an insufficient means for generating hypotheses 
about the NGFFFamide precursor's evolutionary origin. 
 
Figure 32 also illustrates the common residues shared by the eleven 
neurophysin sequences. Putative models of NGFFFamide and echinotocin 
neurophysins were generated using the Swiss PDB Viewer (DeepView) and 
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SWISS-MODEL from the crystal structure of peptide-bound oxytocin 
(Figure 34). Neurophysins contain 14 cysteine residues forming as many as 
seven disulfide bridges (Nicolas et al., 1980; de Bree and Burbach, 1998). 
All 14 cysteine residues involved in the formation of disulfide bonds are 
crucial for tertiary structure and are structurally conserved in both 
echinotocin and NGFFFamide neurophysins. Neurophysins form stable 
dimers, a characteristic thought to be important in storing and transporting 
the bound hormone. Furthermore, neurophysin domain mutations affecting 
tertiary structure may disrupt endopeptidase-mediated cleavage of 
vasopressin/oxytocin-like peptide (Legros and Geenen, 1996; De Bree, 
2000). The ability of neurophysins to form stable dimers is greatly 
enhanced when bound to the neuropeptide (Nicolas et al., 1978). Two 
homologous regions within the neurophysin sequence are required for 
dimerization. The two regions may be linked by a single α-helix and a 
disulfide bond between C
9
 and C
53 
for echinotocin neurophysin and C
10
 and 
C
52
 for NGFFFamide neurophysin (de Bree and Burbach, 1998). 
 
The hormone-binding pocket of the neurophysin molecule is formed by the 
interaction between specific neurophysin residues (de Bree and Burbach, 
1998). The strongest interaction with the hormone occurs in a salt bridge 
between the γCOO- of a glutamate residue (Glu78 in oxytocin neurophysin), 
which is conserved in both echinotocin and NGFFFamide neurophysins, 
and the αNH3 of the peptide (de Bree and Burbach, 1998). The γCOO
-
 
group of the glutamate residue also interacts with the side chain of Arg
39
 in 
neurophysin, a residue conserved in echinotocin neurophysin but not in 
NGFFFamide neurophysin, where the position is taken by an aspartic acid 
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residue (Figures 32 & 34). Only the N-terminal three amino acids of the 
hormone are required for neurophysin binding. Most important in 
formation of the hormone-neurophysin complex is a hydrogen bond 
between a cysteine residue (C
44
 in vasotocin) and the tyrosine residue (Y
2
) 
of the neuropeptide. Echinotocin has an aromatic phenylalanine residue 
(F
2
) in position two, a characteristic shared with the molluscan 
vasopressin/oxytocin-like peptide and 'nematocin' (CFLNSCPY), a putative 
nematode vasopressin/oxytocin-like peptide from C. elegans.  The putative 
'nematocin' precursor was identified in the NCBI protein database 
(GI:86564869) and the putative peptide differs from other 
vasopressin/oxytocin-like peptides in consisting of only eight residues and 
by the absence of a C-terminal glycine residue for peptide amidation.  
NGFFFamide has a remarkably different residue structure to 
vasopressin/oxytocin-like peptides, and lacks the C1 and C6 residues 
necessary to form a disulfide bridge. However, the presence of aromatic 
phenylalanine residues in NGFFFamide may be of structural importance to 
the binding of NGFFFamide to neurophysin.  
 
Interestingly, there is remarkable conservation in the distance between 
consecutive cysteine residues in all neurophysins (Figure 32). The glutamic 
acid residue in the fourth position from the seventh cysteine in mammalian 
vasopressin/oxytocin neurophysins, which is essential for binding the 
hormone, is conserved in both the NGFFFamide and echinotocin 
neurophysins, as well as a proline residue N-terminal to the eighth cysteine 
residue (Figures 32 & 34). Interestingly an asparagine residue (N
48
 in 
vasopressin neurophysin) is also retained in echinotocin, vasopressin, Lys-
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conopressin, cephalotocin and annetocin neurophysins, but is absent from 
NGFFFamide neurophysin (Figures 32 & 34). NGFFFamide neurophysin 
deviates from the vertebrate neurophysins in two places, perhaps most 
importantly close to the residues involved in binding the hormone, and this 
is noticeable in the neurophysin homology model (Figure 34B). Between 
the seventh and eighth cysteine residues there has been a deletion of two 
residues. The second deviation of NGFFFamide neurophysin from 
vertebrate neurophysin occurs in the insertion (or deletion) of two residues 
between the twelfth and thirteenth cysteine residues. Echinotocin deviates 
from vertebrate neurophysin with a two residue insertion between the ninth 
and tenth cysteine residues. 
 
Although absent from the NGFFFamide precursor, the C-terminal region of 
the echinotocin precursor shows homology to the vertebrate glycoprotein 
copeptin.  Copeptin, which is encoded by the C-terminal region of 
vertebrate neurophysin precursor genes and typically consists of 22-39 
residues, is characterized in chordates by a conserved Leu-Leu-Arg-Leu 
hydrophobic amino acid sequence (de Bree and Burbach, 1998). It is 
separately cleaved and potentially acts synergistically in neurotransmission 
and neuromodulation (van den Hooff et al., 1990). Although this short 
conserved sequence is absent from the putative echinotocin copeptin, there 
are six strongly hydrophobic residues (LLLRLVQL) in the C-terminal 
sequence. The N-glycosylation site (N
6
-X-T
8
), conserved in chordates, but 
absent from molluscan models, is also present in the echinotocin putative 
copeptin/glycoprotein. Although the cleaved neurophysin and glycoprotein 
molecules have previously only been identified in their processed state in 
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mammalian vertebrates, a dibasic cleavage site is present between the 
echinotocin neurophysin and copeptin/glycoprotein sequences. It is still 
uncertain at what point in evolutionary history the C-terminal region of the 
precursors attained the function of a glycoprotein.  
 
Furthermore, a putative vasotocin-like G-protein coupled receptor (GPCR) 
was identified in the sea urchin genome (GI:115899360) (Chapter Two). 
Phylogenetic analysis places the putative receptor in a GPCR clade shared 
by the vasopressin and oxytocin receptors of vertebrates, suggesting the 
receptors arose through duplication during chordate evolution (Burke et al., 
2006). 
 
3.4.3   Mass spectrometric analysis: Detection of a putative 
NGFFFamide peptide 
 
The analysis was the first mass spectrometric study of echinoderm 
neuropeptides since Elphick et al. (1991a) identified the two SALMFamide 
neuropeptides from the starfish Asterias rubens and Asterias forbesi. The 
results of that experiment were successfully replicated in this study using 
the starfish Asterias rubens with a modified peptide extraction protocol. 
 
Analysis of sea urchin tissue extract using LC-MS provides evidence of the 
expression of the putative sea urchin neuropeptide NGFFFamide. The 
peptide was expressed at a greater intensity in the extract derived from the 
sea urchin body wall than in the extract derived from visceral tissues. The 
sea urchin test, or body wall, includes the radial nerve cords and axons 
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innervating the tube feet, while visceral tissue includes neurons innervating 
the enteric system, referred to as the enteric nervous system. Therefore, the 
difference in intensity may be reflective of higher levels of expression in 
the neurons of the nerve cords, test, and tube feet. 
 
The absence of echinotocin in the purified sea urchin tissue extracts may 
reflect expression at concentrations not discernible above background 
intensities when analysed using mass spectrometry, which be a 
consequence of low levels of expression outside the reproductive season 
when the tissues were dissected. It is also noteworthy that the echinotocin 
precursor cDNA was absent from both the EST neural expression library 
derived from adult radial nerve cords and a transcriptome database 
assembled as part of the sea urchin genome project 
(http://www.systemix.org/Data/Strongylocentrotus_purpuratus/Genome_tili
ng/).  
 
3.4.4   Discussion: Immunohistochemical investigation of echinotocin 
expression 
 
The immunoblot assays performed indicated that both antibodies (AB1565 
and PC234L) recognize echinotocin but not unrelated and structurally 
dissimilar peptides (Sp-GKamide and Sp-GnRH). Furthermore, antibody 
PC234L recognized synthetic vasopressin. Where positive 
immunoreactivity was evident in sections of sea urchin tissue, the staining 
was absent from negative controls but present in preabsorption controls.  
Both preabsorbed polyclonal antibodies retained immunoreactivity when 
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tested on PVN and SON sections of the mouse brain (Figures 22-24), 
suggesting that the immunoreactivity observed may be a non-specific 
marker of vasopressin-expressing neurons. The results indicate that 
expression of echinotocin may not be detectable by immunohistochemistry 
or that any specific vasopressin-like immunoreactivity detected in the E. 
esculentus sea urchin and tube foot tissues may have been masked by non-
specific staining. The results also support the possibility that the putative 
neuropeptide echinotocin may not be expressed in the sea urchin, or the 
tissues investigated, or that it may be rhythmically expressed, potentially 
coinciding with the sea urchin spawning period in the summer. Hence, 
further investigation is required to provide evidence of the expression of a 
vasopressin/oxytocin--like peptide in an echinoderm. 
 
3.4.5   Discussion: Contractile myoactivity of echinotocin and 
NGFFFamide 
 
Acetylcholine, carbachol, echinotocin, and NGFFFamide all induced 
contraction of sea urchin tube foot and oesophagus tissue preparations. The 
novel peptides NGFFFamide and echinotocin may be acting as natural 
ligands, targeting specific receptors expressed by the muscle cells of the 
tissue preparation. However, they may also be acting as full or partial non-
specific agonists, activating receptors specific for alternate ligands, or as 
physiological agonists, inducing contractile responses similar to those 
observed after applying acetylcholine by activating different receptors. 
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Myoactivity has previously proven to be a useful bioassay for the 
determination of bioactivity for several peptides for which a secondary or 
alternative primary physiological role has later been identified. For 
instance, allatotropins have physiological roles as hormone mediators 
important in arthropod development and reproduction, as well as functions 
related to myoactivity and gut contraction (Elekonich and Horodyski, 
2003). Cholecystokinin provides another example of a neuropeptide having 
a myo-regulatory role in addition to roles in the regulation of feeding 
behaviour (Dufresne et al., 2006). Furthermore, cholecystokinin is 
processed differentially in the CNS neurons of the brain to yield an active 
eight residue C-terminally truncated form (Dockray, 1980). Other brain-gut 
peptides include glucagon, gastrin, and the tachykinins. Thus, while the 
peptides predicted in this study may have myoactive properties and roles in 
the physiological regulation of echinoderm muscular tissue, the peptides 
may not be limited to such a role and may have equally important functions 
in the regulation of behaviour, reproduction, and neural integration in sea 
urchins and other echinoderms.  
 
Acetylcholine, the major neuromuscular transmitter in vertebrates, has 
previously been found to have a similar role in both protostome and 
deuterostome species where the molecule also acts as a neuromuscular 
transmitter (Twarog, 1954; Mendes et al., 1970), including echinoderms 
(Boltt and Ewer, 1963; Welsh, 1966; Pentreath and Cottrell, 1968; Florey et 
al., 1975; Florey and Cahill, 1980). Although both nicotinic and muscarinic 
acetylcholine receptor-like proteins have been identified in the sea urchin 
genome their tissue and cell-specific expression patterns are unknown 
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(Burke et al., 2006). The neurotransmitter is synthesized from choline and 
acetyl-CoA by choline acetyltransferase and degraded by 
acetylcholinesterase. Homologues of both of these proteins have also been 
identified in the sea urchin genome (Burke et al., 2006) and a 
cholinesterase has been localized on the muscle fibres of sea urchin tube 
feet (Florey et al., 1975). Florey et al. (1975) detected the neurotransmitter 
in echinoderm radial nerves and demonstrated contraction of echinoderm 
tube feet in response to acetylcholine at concentrations as low as 550 nM 
but responses were observed more frequently at micromolar concentrations. 
Carbachol was found by Florey et al (1975) to be a more effective than 
acetylcholine at contracting sea urchin tube feet. Consistent with Florey's 
observations in this study carbachol was found to be ten-fold more potent 
than acetylcholine (Figures 26 & 27). 
 
Aside from the myoactive actions of acetylcholine as an echinoderm 
neurotransmitter, other hormones and neurotransmitters have induced 
responses in in vitro bioassays prepared from echinoderm tissues. 
Noradrenaline and adrenaline induce variable responses (Welsh, 1966). 
GABA, despite being an inhibitory neurotransmitter in both vertebrate and 
arthropod neuromuscular systems, can induce either relaxation or 
contraction depending on the tissue investigated (Florey et al., 1975; 
Devlin, 2001). Alongside SALMFamide neuropeptides, nitric oxide (NO) 
has also been shown to be a powerful muscle relaxant of starfish muscle 
preparations (Elphick and Melarange, 2001).  
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The pharmacological study provides evidence that both NGFFFamide and 
echinotocin evoke contraction of sea urchin muscle preparations. 
NGFFFamide has a greater potency and efficacy than echinotocin on both 
tube foot and oesophagus tissues. NGFFFamide also induced contractions 
of 'semi-stripped' tube foot preparations. However, high variability in the 
responses of the preparations was likely to be attributable to the procedure 
involved in stripping the tube feet during tissue preparation. Starfish tube 
feet have been observed to contract on application of the sea cucumber 
neuropeptide NGIWYamide, a holothurian homologue of NGFFFamide 
(Saha et al., 2006). In that study, tube foot contractile responses at 
NGIWYamide concentrations of 100 µM were also stronger than those 
induced by acetylcholine at the same concentration, suggesting that 
NGIWYamide-like peptide may have a more important role than 
acetylcholine in the contraction of echinoderm muscle. NGIWYamide also 
caused contraction of sea urchin stripped tube foot preparations (Gill, 
unpublished), and contraction of 'semi-stripped' sea urchin tube foot at a 
concentration of 10 μM (0.215 mN, n = 1) and oesophagus at a 
concentration of 3 μM (0.111 mN, n = 1). 
 
Although NGFFFamide was found to induce contraction of starfish cardiac 
stomach, the peptide surprisingly induced relaxation of starfish stripped 
tube foot tissue at concentrations from 100 nM to 10 μM, but failed to 
induce a response from unstripped starfish tube foot (Gill & Navaratnam, 
unpublished).  
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Echinoderm tube feet have a number of behavioural and physiological 
functions, most importantly securing the organism to the substrate, but they 
may also have a role in chemosensory perception, photoreception and 
photoperiodicity (Yoshida, 1966; Blevins and Johnsen, 2004; Sodergren et 
al., 2006). To understand the physiological action of putative 
neurotransmitters or neuromodulators in causing contraction or relaxation 
of tube foot tissues a brief description of tube foot anatomy is needed. The 
layers from the lumen to the external epithelium include an inner epithelial 
layer, the circular and longitudinal muscle layers, a connective tissue layer, 
the nerve plexus, and an outer epithelial layer. Kawaguti (1964) observed 
an absence of neuromuscular synapses and, in response, Florey and Cahill 
(1977) have suggested that nerve terminals from the plexus terminate on or 
within the layer of connective tissue. Florey and Cahill hypothesized that 
acetylcholine acts on the muscle layer of echinoderm tube feet by 
traversing or diffusing across the connective tissue layer. If both 
echinotocin and NGFFFamide are secreted by neurons they may act in an 
analogous way, targeting the muscle layer from neurohormonal terminals 
located across a connective tissue barrier. Alternatively, the peptides may 
be released from neurons within the luminal epithelium or the connective 
tissue layer itself. 
 
The sea cucumber NGIWYamide neuropeptide has also been observed to 
stiffen sea cucumber dermal tissue (Birenheide et al., 1998), suggesting a 
role for the peptide in the biological phenomenon of 'mutable collagenous 
tissue'. A number of hypotheses have been suggested to explain the 
biochemical processes responsible for the phenomenon, including the 
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action of a 'tensilin' protein on collagenous tissue (Wilkie, 2002; Tipper et 
al., 2003) and neuromuscular transmission (Elphick and Melarange, 2001). 
Previous studies  have suggested a neurohormonal mechanism for 
echinoderm muscle contraction through the innervation of muscle fibres 
from the luminal epithelium (Kawaguti, 1964), from isolated 
neurosecretory granule-containing cells within the muscle layer (Coleman, 
1969; Cobb and Pentreath, 1977; Florey and Cahill, 1977; Cobb, 1978) or 
even from isolated juxtaligamental cells within a connective tissue layer 
separating the nerve plexus from the muscle layer in tube feet (Santos et al., 
2005). Localization studies of NGFFFamide expression in tube feet and 
oesophagus tissues will contribute to understanding the mechanism of the 
peptide's possible role in collagenous stiffening and muscle activity in all 
classes of echinoderm.  
 
NGIWYamide has also been identified, functionally characterized, and 
denominated 'cubifrin' in a study by Kato et al (2009). Cubifrin was found 
to induce spawning behaviour and germinal vesicle breakdown in the 
presence of ovarian wall. The effect is comparable to that of the gonad-
stimulating substance (GSS) peptide heterodimer (Mita et al., 2009). 
 
Moreover, expression of the NGFFFamide precursor gene in the radial 
nerve provides evidence that the peptide is neurosecretory. The 
NGFFFamide coding sequence is found in both radial nerve and embryonic 
EST data and has been detected by mass spectrometric analysis of S. 
purpuratus body wall and visceral tissue. Therefore, the precursor gene 
may be expressed early in sea urchin development prior to development of 
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the adult nervous system. The lack of expression data for echinotocin, by 
contrast, may be reflective of comparably low expression and of the EST 
dataset's quality, an absence of neural expression, or even of an absence of 
expression in the sea urchin. Previous studies have successfully 
investigated the expression of NGIWYamide, the possible sea cucumber 
NGFFFamide orthologue, in different classes of the echinoderm phylum. 
Saha et al., (2006) also investigated NGIWYamide expression in the 
starfish and observed NGIWYamide-like immunoreactivity in the radial 
nerves, marginal nerves, and tube feet. If NGFFFamide is functionally 
homologous, in having a similar physiological role, or even orthologous, in 
originating from a common gene, to NGIWYamide, it may have a similar 
expression distribution throughout the sea urchin nervous system. 
 
Vasopressin/oxytocin family neuropeptides appear to show functional 
homology in regulating muscle activity. The role in muscle regulation is 
often linked to the regulation of reproductive behaviour (Van Kesteren et 
al., 1995; Fujino et al., 1999; Goodson and Bass, 2000; Tessmar-Raible et 
al., 2007). Oxytocin has sex-specific roles in vertebrates, notably 
contraction of uterine smooth muscle and the mammary gland and in social 
behaviour, including pair bonding (Donaldson and Young, 2008).  
  
 Vasopressin/oxytocin-like peptides are known to have myoactive properties 
across both vertebrate and invertebrate phyla. Vasopressin is an 
osmoregulator and anti-diuretic hormone and echinotocin may demonstrate 
functional homology in the echinoderm phylum. A vasotocin-like peptide, 
Styela SOP, identified in Styela plicata of the deuterostome urochordate 
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subphylum, may have a homologous osmoregulatory role (Ukena et al., 
2008). SOP has been shown in both in vivo and in vitro preparations to 
induce contraction of the inhalant and exhalant siphons responsible for 
maintaining favourable osmotic conditions. Hypothetically, sea urchins 
may react to unfavourable hypo-osmotic conditions by contracting their 
tube feet and reducing water-flux. Hence, it is possible that echinotocin 
may have a functionally homologous role in echinoderms as an 
osmoregulator. 
 
Genes encoding neuropeptides showing structural and functional homology 
to vasopressin/oxytocin have also been identified in protostomian 
invertebrates. In molluscs the vasotocin-like neuropeptide conopressin 
causes contraction of the vas deferens (Van Kesteren et al., 1992). In 
annelids the peptide annetocin induces egg-laying behaviour (Fujino et al., 
1999). Tessmar-Raible et al. (2007) have postulated an evolutionary 
linkage between the regulation of reproductive behaviour by 
vasopressin/oxytocin-like neuropeptides observed in protostomes and 
deuterostomes and an involvement of the same secretory neurons in 
photoreception and photoperiodic behaviour and physiology. The 
hypothesis is supported by the observation of cell-specific expression of 
microRNA and transcription factors by vasopressin/oxytocin-like 
neuropeptide secreting neurons in the annelid Platynereis dimurilii and the 
zebrafish Danio rerio (Tessmar-Raible et al., 2007). Other studies have also 
suggested a link between vasopressin/oxytocin family neuropeptide 
neurosecretory cells and photoreception in organisms as distantly related as 
killifish and insects (Taylor, 1986; Thompson and Bacon, 1991; Ota et al., 
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1999; Gozdowska et al., 2006). It would be interesting to investigate 
whether a similar relationship between photoreception and neurosecretory 
neurons exists in the echinoderm, where the neurosecretory centres are 
located, and whether vasopressin/oxytocin-like peptide secretory pathways 
have acquired a modified role. Opsins have been identified in the sea urchin 
genome and it is possible that tube feet may act as photoreceptive organs. 
Therefore, photoreceptors targeting unidentified neurohormonal secretory 
centres may be located on echinoderm tube feet and, consequently, 
neurohormones including echinotocin may be involved in the regulation of 
echinoderm reproductive cycles. 
 
The full diversity of neurophysin-associated neuropeptide precursors in 
invertebrates is unrealised and the identification of two novel neurophysin-
encoding neuropeptide precursors will advance investigation into evolution 
of the gene family and into the functional roles of the associated peptides. 
Furthermore, their identification will instigate investigation of their 
function and expression in the unique echinoderm pentaradial nervous 
system. 
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 Peptide         Sequence      
 
 Echinotocin
1 
    Cys-Phe-Ile-Ser-Asn-Cys-Pro-Lys-Gly-NH2
      
 
 
 Vasopressin
2 
    Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
          
 
 
 Oxytocin
2 
       Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
          
  
 
 Arg-vasotocin
3 
  Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2 
 
 Ciona-VP
4 
       Cys-Phe-Phe-Arg-Asp-Cys-Ser-Asn-Met-Asp-Trp-Tyr-Arg 
 
 Styela-VP
5 
      Cys-Tyr-Ile-Ser-Asp-Cys-Pro-Asn-Ser-Arg-Phe-Trp-Ser-Thr-NH2 
 
 Conopressin
6 
    Cys-Phe-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2
          
 
 
 Cephalotocin
7 
   Cys-Tyr-Phe-Arg-Asn-Cys-Pro-Ile-Gly-NH2
         
 
 
 Annetocin
8 
      Cys-Phe-Val-Arg-Asn-Cys-Pro-Thr-Gly-NH2    
 
 Inotocin
9 
       Cys-Leu-Ile-Thr-Asn-Cys-Pro-Arg-Gly-NH2
     
 
 
 Nematocin
10
      Cys-Phe-Leu-Asn-Ser-Cys-Pro-Tyr 
 
 
 Figure 31. Alignment of vasopressin/oxytocin-like peptides including sea 
urchin  echinotocin and nematode 'nematocin'. Basic residues are labelled 
in blue, acidic  residues in purple, polar residue in green, nonpolar residues 
in orange, and aromatic residues in red. The sequences were obtained 
from peptide precursors isolated from 1Strongylocentrotus purpuratus (this 
study), 2Homo sapiens (Light and Du Vigneaud, 1958), 3Lethenteron 
japonicum (Suzuki et al., 1995), 4Ciona intestinalis (Kawada et al., 2008), 
5Styela plicata (Ukena et al., 2008), 6Lymnaea stagnalis (Van Kesteren et 
al., 1992), 7Octopus vulgaris (Reich, 1992), 8Eisenia foetida (Oumi et al., 
1994), 9Locusta migratoria (Proux et al., 1987; Aikins et al., 2008; 
Stafflinger et al., 2008), and 10Caenorhabditis elegans (GenBank 
NP_001033548, GI:86564869). 
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Figure 32. ClustalX multiple alignment of the putative precursor sequences of the 
S. purpuratus NGFFFamide precursor, the S. purpuratus echinotocin precursor 
and precursors of vasopressin/oxytocin-like peptides in other species. Signal 
peptides are shown in blue, neuropeptides are shown in red, dibasic cleavage 
sites are shown in green and neurophysin-like domains, including co-peptin-like 
sequence, are shown in purple. The conserved cysteine residues in the 
neurophysin-like domains are underlined and numbered 1–14. The precursors of 
vasopressin/oxytocin-like peptides from other species include precursors of 
human vasopressin and oxytocin (Mohr et al., 1985), vasotocin from the lamprey 
Lethenteron japonicum (Suzuki et al., 1995), an oxytocin-like peptide (SOP) from 
the urochordate Styela plicata (Ukena et al., 2008), Lys-conopressin from the 
mollusc Lymnaea stagnalis (Van Kesteren et al., 1992), cephalotocin from the 
mollusc Octopus vulgaris (Reich, 1992), annetocin from the annelid Eisenia 
foetida (Oumi et al., 1994) and inotocin from the arthropod (insect) Tribolium 
castaneum  (Aikins et al., 2008; Stafflinger et al., 2008). Also included is a 
precursor from the nematode Caenorhabditis elegans (GenBank: NP_001033548, 
GI:86564869) that has not been reported previously in the literature. The 
nematode precursor contains an unusual putative oxytocin-like peptide comprising 
just eight residues (CFLNSCPY), which has been named `nematocin'. 
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Figure 33. Neighbour-joining tree (with bootstrap values) based on a 
ClustalX multiple alignment of neurophysin (NP) sequences, 
incorporating residues from the first to the fourteenth conserved 
cysteines. The tree shows that the neurophysin domain of the S. 
purpuratus NGFFFamide precursor does not have a higher level of 
overall sequence similarity with the neurophysin domain of the S. 
purpuratus echinotocin precursor than with the neurophysins from 
other species. 
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Figure 34. Homology models of echinotocin (A) and NGFFFamide (B) 
neurophysin molecules. The models were produced using DeepView and 
structural alignment to the crystal structure of peptide bound oxytocin-
neurophysin. In the NGFFFamide neurophysin model there has been a deletion of 
two residues. The structures are highly conserved and residues structurally 
equivalent to those in the oxytocin neurophysin sequence may be important for 
peptide binding. Peptide-neurophysin interactions include a salt bridge between a 
glutamate carboxylate side-chain (GLU84 in A and GLU222 in B) and the alpha 
amino group of the peptide and an interaction with an arginine residue (conserved 
ARG45 in A, but substituted with an aspartic acid residue ASP183 in B). A 
hydrogen bond is located between the second tyrosine residue of the peptide 
(corresponding to the phenylalanine residue in echinotocin, and possibly one of 
the phenylalanine residues in NGFFFamide) and a neurophysin cysteine residue 
(CYS81 in A and CYS219 in B). Conserved residues between the seventh and 
eighth cysteine residues include; proline (PRO90 in A, PRO226 in B), asparagine 
(ASN85 in A, but missing in B). 
  
 
 
 
 140 
 
Chapter 4 
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4.1   Introduction: Identification of sea urchin neuropeptides using a 
cDNA library 
 
In the studies reported in this chapter a sea urchin neural expression EST 
library was used to identify echinoderm neuropeptide precursor genes and 
seven putative precursors were identified. The use of a smaller dataset 
representative of neural expression has circumvented some of the problems 
associated with searching larger genomic databases, such as an 
unmanageable set of sequence matches resulting from a short BLAST 
search query. Crucial to the analysis, however, was the use of both 
neuropeptide precursor structural criteria and homology searching against 
the NCBI protein database for annotated neuropeptide sequences from 
other phyla homologous to the putative peptides identified.  
 
The characteristic criteria used in this study are generally applicable to 
neuropeptide precursors. Because the characteristics can be recognized 
from the full precursor amino acid sequence by itself, they lend themselves 
to bioinformatic or 'in silico' investigative techniques. Neuropeptide 
preproprotein sequences tend to be of short length, generally less than 500 
residues (Liu et al., 2006) and encode repeated variable copies of the 
bioactive peptide. An N-terminal signal peptide sequence is essential for 
directing the translated preproprotein to the endoplasmic reticulum prior to 
processing by endopeptidases and structural modification of the peptide. 
Endopeptidases cleave bioactive peptides from the proprotein at monobasic 
and dibasic residue cleavage sites (e.g. Lys-Lys or Lys-Arg) found within 
the precursor. Lastly, many neuropeptides are amidated, which requires a 
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glycine residue at the C-terminus of the processed peptide (Bradbury et al., 
1982). 
 
Using all of these characteristics to manually search for neuropeptide 
precursors in an S. purpuratus neural Expressed Sequence Tag (EST) 
library, seven putative neuropeptide precursors have been identified and 
designated spp-1 to spp-7. Four of the putative neuropeptides encoded by 
the precursors show clear homology to known neuropeptides in the animal 
kingdom, including SALMFamide neuropeptides, calcitonin/CGRP, 
gonadotropin-releasing hormone, and thyrotropin-releasing hormone. The 
three others may represent members of previously undescribed echinoderm 
neuropeptide families.  
 
4.2   Methods 
 
 
4.2.1   Identification of novel neuropeptide precursors 
 
 
 
Analysis involved the separation and identification of putative neuropeptide 
precursors from a set of ESTs (Figure 35). ESTs are full or partial reads of 
copy DNA sequences derived from the mRNA of a particular cell or tissue. 
The ESTs sequences used in this study were derived from sea urchin adult 
radial nerve cord cDNA reads by Cameron et al. (2000) and consisted of 
999 five prime reads and 1026 three prime reads, all approximately 1,000 
nucleotides in length. Analysis was restricted to the set of 999 five prime 
EST because the signal peptide used to identify a potential precursor 
sequence is located five prime to the proprotein coding sequence. Five 
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prime ESTs are also more likely to contain coding nucleotide sequences as 
five prime untranslated regions (UTRs) are typically shorter than the three 
prime UTRs (Pesole et al., 1997). Peptide cleavage sites were identified by 
monobasic or dibasic motifs with a glycine residue as a substrate for C-
terminal amidation, including GKR, GRR, GR, GRK, GKK, KR, KR, RR, GK, 
RK, KK, and R (Liu et al., 2006). 
 
EST sequences with homology to larger proteins from the NCBI database 
were eliminated as an initial stage of the analysis. These included matches 
to proteins forming a set of ‘hypothetical proteins’ determined by the 
Gnomon gene prediction programme and used as part of the automated 
genome annotation process for S. purpuratus (Sodergren et al., 2006) 
(Figure 35). Therefore, Gnomon gene predictions of less than 500 residues 
represented within the EST set were included in the analysis. The online 
programme, Signal P (DTU, Denmark) 
(http://www.cbs.dtu.dk/services/SignalP) was used to identify likely signal 
peptide regions in the N-terminal region of each gene prediction.  
 
The second stage of analysis involved grouping together the remaining 185 
five prime ESTs sharing a coding sequence with a corresponding three 
prime EST. A second gene prediction programme, GenScan (MIT) 
(http://genes.mit.edu/GENSCAN.html) was used to identify Open Reading 
Frames (ORFs) within genomic DNA covering the two overlapping reads.  
 
The third stage of the analysis involved BLAST searching the set of 302 
remaining five prime ESTs against the set of official gene predictions 
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determined by the Glean3 gene prediction algorithm prior to searching the 
sequences for neuropeptide precursor characteristics. The online BLAST 
search facilities were accessed at the Baylor College of Medicine Sea 
Urchin Genome Project website 
(http://www.hgsc.bcm.tmc.edu/projects/seaurchin/).  
 
4.2.2   Detection of the putative neuropeptides in sea urchin tissue 
using mass spectrometry 
 
Like the synthetic echinotocin and NGFFFamide peptides used in Chapter 
Three, the peptides reported in this chapter were synthesized by the 
Advanced Biotechnology Centre at Imperial College London for the 
standardization of mass spectrometric analysis of sea urchin tissue extract. 
Mass spectrometric parameter settings were determined using the synthetic 
peptides and the same samples of S. purpuratus body wall and visceral 
tissue that were used for the detection of echinotocin and NGFFFamide 
were used as analyte for the detection of in vivo expression. Furthermore, 
the same procedures as described in Chapter Two were used to investigate 
myoactivity of the peptides on sea urchin oesophagus and tube foot tissues 
using pharmacological in vitro bioassays. 
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Figure 35. Identification of putative neuropeptide precursors from an 
adult sea urchin (S. purpuratus) radial nerve EST dataset. The 
search for neuropeptides in the EST library was restricted to 999 five 
prime reads containing coding regions. Thirty-four short putative  
genes encoding neurosecretory peptides were identified. The 
putative precursors were defined by an N-terminal signal peptide, 
the presence of monobasic and dibasic cleavage sites and a length 
of less than 500 amino acid residues. 
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4.3   Results 
 
4.3.1   Results: Identification of putative sea urchin neuropeptide 
precursors 
 
A set of 34 neural putative peptide-encoding cDNAs containing cleavage 
sites, an N-terminal signal peptide, and a length of less than 500 residues 
were identified (Appendix E). Of these, seven showed either homology to 
known neuropeptide or peptide sequences or to putative peptides encoded 
by the same precursor gene as repeated variable sequences (Figure 36). The 
epithet spp (Strongylocentrotus purpuratus peptide) was used to label each 
precursor gene. One Gnomon predicted ‘hypothetical protein’ (spp-1) 
(Figures 36 & 37) appears to encode two peptides with similar C-terminal 
amino acid sequences. Both of these were recognized as SALMFamide 
family neuropeptides and denominated SpurS8 (NMGSIHSHSGIHF-NH2) 
and SpurS9 (MRLHPPGLLF-NH2), thereby continuing the system of S. 
purpuratus SALMFamide peptide nomenclature begun by Elphick & 
Thorndyke (2005). Although the putative SpurS8 peptide has 13 residues, 
an equally possible peptide sequence could be truncated at the N-terminus, 
incorporating a further four residues including the suggested dibasic 
cleavage site (GGKKNMIGSIHSHSGIHF-NH2). 
 
Precursor spp-2 was identified by a protein BLAST search of the NCBI 
database as a putative homologue to gonadotropin-releasing hormone 
(GnRH) (Figures 36 & 38). The precursor’s closest GnRH-like alignment 
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was with Oryzias latipes preprogonadoliberin II (GI:34098706). Similar to 
other GnRH-like peptides, the putative sea urchin GnRH-like peptide 
identified has a pyroglutamate residue at the N-terminus. The peptide 
(pyroGlu-Val-His-His-Arg-Phe-Ser-Gly-Trp-Arg-Pro-Gly-NH2) was 
denominated Sp-GnRH. The precursor is also represented by one read from 
a set of larval ESTs (GI:34745970).  
 
Precursor spp-3 contains seventeen repeats of a putative thyrotropin-
releasing hormone (TRH)-like tetrapeptide (Glu-Tyr-Pro-Gly-NH2) and 
was denominated Sp-TRH (Figures 36 & 39). Like vertebrate TRH all 
peptide repeats are encoded by the third exon of a three exon precursor. The 
gene is also represented by one read from a set of mesenchyme ESTs. The 
Glean3 prediction for this gene (Glean3_08352; SPU_008352) has a 
different exon structure from the Gnomon prediction and one that lacks the 
coding region for an N-terminal signal peptide. The EST data, however, 
confirms the structure of the former Gnomon prediction.  
 
Precursor spp-4 contains a putative peptide sequence displaying homology 
to calcitonin/CGRP and has been denominated Sp-CGRP (Figures 36 & 
40). Spp-4 is also represented by two reads from a set of larval ESTs.  
 
Some of the sequences lacked homology to known neuropeptides, yet 
displayed characteristics typical of neuropeptide precursors. Precursor spp-
5, automatically annotated by NCBI as arginine/serine-rich splicing factor 
4, resembles a novel neuropeptide precursor containing thirteen similar 
repeats of a putative undecapeptide (Ala-Asn-Met-Phe-Arg-Ser-Arg-Leu-
 148 
Arg-Gly-Lys-NH2) and was denominated Sp-GKamide (Figures 36 & 41). 
Precursor spp-6 weakly aligns with molluscan pedal peptide 2 
(GI:94434888) (Aplysia californica). Although the precursor contains 22 
variable repetitions of a non-amidated putative peptide, the gene deviates 
from the structural criteria in being 510 residues long. The peptide 
consensus sequence (Gly-Phe-Asn-Ser-Gly-Ala-Met-Glu-Pro-Leu-Gly-Ser-
Gly-Phe-Ile) was denominated Sp-PPLN1 (Figures 36 & 42). The gene is 
also expressed in ESTs derived from the blastula stage of sea urchin 
development, the adult lantern and the primary mesenchyme.  
 
Lastly, precursor spp-7 displays homology to the pedal peptide-like spp-6 
gene but without a Gnomon gene prediction corresponding to the EST 
(Figure 36). The Glean3_24381 (SPU_024381) was identified by 
submitting the EST as a BLAST search query against the Glean3 set of 
gene predictions. Interestingly, the exon encoding the signal peptide 
sequence and the exon encoding the peptide are located on different 
scaffolds. The gene is also represented by one read from a set of larval 
ESTs. The larval EST contains coding sequences from both exons, 
confirming that expression of both sequences is combined in a single 
mRNA strand.  
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A) Spp-1 (GI:115711933; GI:115946155) (encoding SpurS8 and SpurS9). 
MQVQQITVFLVACTLSVLVVAYAQEDAETVLLNRLRDIAARAAAGELPDFFADVDDYKRG.GKKNMGSIHSHSGIH
FGKRRDSESSERARNTKRMRLHPPGLLFGKRAPVQKWDQWQAQDTYNPDWELGQFN 
 
              
 
B) Spp-2 (GI:72011734; GI:115975296; SPU_019680) (encoding Sp-GnRH) 
MKQIITSLVSISAALLLFVLISEYTPRCNGQVHHRFSGWRPGGKKRSDAAEVNSNKITIERPQLPICQTTEERQL.
LEGDSDILGDLRRAANRMRLLQLFNLSKTRLN.DLNDATSNEVDERPVYGDYLGTGL 
 
             
 
C) Spp-3 (GI:115657896; SPU_008352) (encoding Sp-TRH) 
MWACILGYVTWGGAALPTILGKELVLSENDGP.EIADWVQGKEIPLRNQYWGDVAEEEEEEELGMLSPDSEKRQYP
GGKRQYPGGKRQYPGGKRQYPGGKRQFPAGKRQFVGGELIPSPELRQWPGGKRQWPGGKRQWPGGKRQYPGGKRQY
PGGKRQWPEVKRQYPGGKRSEDDQDLLPMEIRQYPGGKRQWPGGKRQYPGGKRQYPGGKRQFPGGKRQFVGGEALE
QESNINKRFAPEDDTMDFFRLSQLYDTNDNIVADEGELALEDLLDDIMVDTRPEFEDPRDLLLGNVDQEDVLALDL
SALLGDRNPNNGW* 
 
               
 
D) Spp-4 (GI:115767208; GI:115945640) (encoding Sp-CGRP) 
MKSTVIVTLTICCLLYQTTRAASLTN.RDGLSRQDILDLLQLYEEPIRQEGGDKRSKGCGSFSGCMQMEVAKNRVA
ALLRNSNAHLFGLNGPGKRRRSVDDLPQVNDAETE 
 
 
 
E) Spp-5 (GI:115933326; GI:115963862; SPU_018666) (encoding Sp-GKamide 
peptides) 
MSRNAYLWAGLLLGALCLLITTTSIKADGEVTEDVDKRANYFRGRGRKPGKRDEPDAALVPDDDLSEDKRANMFRS
RLRGKGKRDDPDAAMLPGDWDEEKRANMFRSRLRGNGKRDDPDAAMLPGDWDEEKRANMFRSRLRGKGKRDEPDAA
EALVPGDWEEEKRANMFRSRLRGKGKRDDPDAAEALVPGDDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGDDL
SEEKRANMFRSRLRFKGKRDDPDAAEALVPGGDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGGDLSEEKRANM
FRSRLRGKGKRDDPDAAEALVPGDWDEEKRANMFRSRLRGKGKRDDPDAALVGDDFGDEFVDEEKRANMFRSRLRG
NGKRDDPDAALVDEFMDEEKRANYFRGRGRRPGKRDEPDAALVEDEKRANFRARQRPKLGK* 
 
   Ex 1      Ex 2                             Ex 3 
5'  3' 
 
F) Spp-6 (GI:72008820; SPU_03108) (encoding Sp-PPLN1 peptides) 
MKFSGNGRGAFLVVNLIFVLCLVDHMAECRPARKTRDVDE.DLEKEEDSLINALEKVLADEEVIDNAENDSDDETG
ITDRELSLMLSMLRDDVSPSRLRGYFGGKWRPAYYPSESLHVGALEPLATGFLPSRYSGQKKRFLTGALEPLSSGF
IKKGFNTG.AMEPLGSGFIKKGFNSGMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSG
AMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGMEPLGSGF
IKKGFNSGAMEPLGSGFIKKGFNNGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKGFNTG
AMEPLGSGFIKKGFNSGAMEPLGSGFIKKDFNTGAMEPLGSGFIKKGFNSGAMEPLGAGFFKKGFHAGAMEPLSSG
FIDGKRGFYNGAMEPLSAGFHQGKRGFHEGEMDKDKKGFHNGAMEPLKSGFLKD* 
 
           Ex 1                       Ex 2                                Ex 3 
5' 
 
3' 
 
g) Spp-7 (SPU_024381) (encoding Sp-PPLN2 peptides) 
MNNYAFLFCLACAIGQVWTLPIEDK.DGLDIEDQEEAEKRFGSMNMEPLVSGFYKRFGSGLDSMQSGFYKKNFGSG
LNMEPMQSGFYKKNFGGSMEPMQSGFYKRFGGAMEPMSSGFYKRFGSGSLEPMSSGFYKKNFGGSLEPMQSGFYKR
FGGANEPMRSGFFKRFGSGSLEPMSSGFYKKNFGGSLDAMQSGFYKRSQEETD* 
  Ex 1         Ex 2  
  
5'  3' 
Figure 36. Putative neuropeptide precursor sequences (spp-1 to 
spp-7; A-G). Peptide sequences are shown in blue and cleavage 
sites in green. Full stops in the amino acid sequence indicate the 
position of intron splice sites in the coding sequence. Exon and 
intron structure are shown beneath each precursor sequence. Black 
infilling denotes a coding region within an exon. 
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Figure 37. spp-1; the putative SpurS8 (NMGSIHSHSGIHF-NH2) and 
SpurS9 (MRLHPPGLLF-NH2) neuropeptide precursor nucleotide 
and amino acid sequence in full. The signal peptide sequence is 
shown in blue, the peptide sequence in dark red, and the basic 
residue cleavage sites in green. An alternative SpurS8 peptide 
sequence might incorporate a further four residues N-terminal to the 
predicted sequence (GGKKNMGSIHSHSGIHF-NH2). Introns were 
identified by an intron N-terminal GT sequence and C-terminal AG 
sequence and the intron splice sites are underlined in the exon 
nucleotide sequence. 
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Figure 38. spp-2; the putative Sp-GnRH (pEVHHRFSGWRPG-NH2) 
neuropeptide precursor nucleotide and amino acid sequence in full. 
The signal peptide sequence is shown in blue, the peptide sequence 
in dark red, and the basic residue cleavage sites in green. Introns 
were identified by an intron N-terminal GT sequence and C-terminal 
AG sequence and the intron splice sites are underlined in the exon 
nucleotide sequence. 
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Figure 39. spp-3; the putative Sp-TRH (pEYPG-NH2) neuropeptide 
precursor nucleotide and amino acid sequence in full. The signal 
peptide sequence is shown in blue, the peptide sequence in dark 
red, and the basic residue cleavage sites in green. Introns were 
identified by an intron N-terminal GT sequence and C-terminal AG 
sequence and the intron splice sites are underlined in the exon 
nucleotide sequence. 
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Figure 40. spp-4; the putative Sp-calcitonin/CGRP-like 
(SKGCGSFSGCMQMEVAKNRVAALLRNSNAHLFGLNGP-NH2) 
neuropeptide precursor nucleotide and amino acid sequence in full. 
The signal peptide sequence is shown in blue, the peptide sequence 
in dark red, and the basic residue cleavage sites in green. Introns 
were identified by an intron N-terminal GT sequence and C-terminal 
AG sequence and the intron splice sites are underlined in the exon 
nucleotide sequence. 
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Figure 41. spp-5; the putative Sp-GKamide (consensus sequence 
ANMFRSRLRGK-NH2) neuropeptide precursor nucleotide and 
amino acid sequence in full. The signal peptide sequence is shown 
in blue, the peptide sequence in dark red, and the basic residue 
cleavage sites in green. Introns were identified by an intron N-
terminal GT sequence and C-terminal AG sequence and the intron 
splice sites are underlined in the exon nucleotide sequence. 
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Figure 42. spp-6; the putative Sp-PPLN1 (consensus sequence  
GFNSGAMEPLGSGFI) neuropeptide precursor nucleotide and 
amino acid sequence in full. The signal peptide sequence is shown 
in blue, the peptide sequence in dark red, and the basic residue 
cleavage sites in green. Introns were identified by an intron N-
terminal GT sequence and C-terminal AG sequence and the intron 
splice sites are underlined in the exon nucleotide sequence. 
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4.3.2   Results:  MS analysis of sea urchin body wall and visceral tissue 
 
 
 
Peptide sequences were selected from the identified putative neuropeptide 
genes including Sp-GnRH, Sp-TRH, as well as peptides representing 
consensus sequences from Sp-GKamide and Sp-PPLN-1 precursors. All of 
the peptides were synthesized with an amidated C-terminal with the 
exception of PPLN-1. In accordance with the structure of human TRH and 
GnRH, both Sp-GnRH and Sp-TRH were constructed with an N-terminal 
pyroglutamate residue. Where multiple forms of a peptide were encoded by 
a precursor gene a representative consensus sequence was chosen. The 
following sequences, including molecular masses in brackets, were 
synthesized. 
 
 Sp-GnRH (1444.6019)  pEVHHRFSGWRPG-NH2 
 Sp-TRH (444.4675)  pEYPG-NH2 
 GKamide ( 1334.6151)  ANMFRSRLRGK-NH2 
 PPLN-1 (1483.6653)  GFNSGAMEPLGSGFI 
 
Detection of each of the synthetic peptides using HPLC-MC was 
standardized, using a 20 μL injection of a 10 μM peptide solution and using 
several different gradients of organic solvent. The peptides were also 
subjected to the same extraction protocol that proved effective for detection 
of the SALMFamide neuropeptides from Asterias rubens extracts, and for 
NGFFFamide from Strongylocentrotus purpuratus extracts.  
A summary of detection standardization can be found in Table 8. 
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The synthetic peptide masses identified by mass spectrometry, in 
protonated form, are compared to the calculated masses in Table 9. As for 
the detection of NGFFFamide and echinotocin, expert parameters were 
optimized for each peptide by injecting the mass spectrometer directly with 
a 1 μM peptide solution, bypassing separation on the HPLC column 
(Appendix D). Thus, the final method was set up with different voltage 
settings across an organic gradient corresponding to the point at which the 
synthetic peptides were found to elute.  
 
Peaks were identified corresponding to Sp-TRH, PPLN-1 (peak average 
intensity of 2.2x10
5
) (Figure 43) and a smaller peak corresponding to Sp-
GnRH (at 18.4-19m). The peptide with a mass corresponding to Sp-TRH 
was detected in the body wall extract at an average intensity of 1.25x10
5
 
and 1.5x10
5
, but not in the visceral extract (Figure 44).  
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Table 8: Standardization of synthetic peptide elution points on 
an acetonitrile (ACN) gradient, including elution points for 
echinotocin and NGFFFamide. 
 
______________________________________________________________________________________________________________________________________________________ 
Peptide  Elution Point (% ACN) 
 
  0.5%/min 1%/min  1.67%/min 2%/min 
______________________________________________________________________________________________________________________________________________________ 
GKamide  -  10-40  -  25-35 
NGFFFamide 39-46  44-46  -  44-47 
Echinotocin  -  32-39  37-39  ~42 
Sp-TRH  41-46  16-19  13-19  10-25 
PPLN1  41.4-45  -  42-44  - 
Sp-GnRH  47-60  -  -  - 
______________________________________________________________________________________________________________________________________________________ 
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Table 9: Predicted and observed synthetic peptide masses of 
Sp-GnRH, Sp-TRH, GKamide, PPLN-1 detected using HPLC-
MS. The difference observed between observed and 
calculated mass gave an error range of 0.082%. Sp-TRH was 
also identified at high intensity as a sodium-adduct dimer. 
 
______________________________________________________________________________________________________________________________________________________ 
Peptide  Calculated Mass Observed Mass(es) of Synthetic 
Peptide 
______________________________________________________________________________________________________________________________________________________ 
 
Sp-GnRH 1445.6019 (H
+
)  1445.6 (H
+
) 
Sp-TRH 445.4675 (H
+
)  446.22 (H
+
) 
     913.34 (dimer H
+
 Na
+
) 
GKamide 1335.6151 (H
+
)   1334.7 (H
+
) 
     667.85 (2H
+
) 
     445.57 (3H
+
) 
PPLN-1  1484.6653 (H
+
)   1483 (H
+
) 
 
______________________________________________________________________________________________________________________________________________________ 
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A  
B  
C  
D   
 
Figure 43. Detection of PPLN-1 consensus sequence peptide using 
HPLC-MS. 
A) Full mass spectrum indicating detection of PPLN-1consensus 
sequence synthetic peptide (1484.6) (*). 
B) Magnified mass spectrum view of 37A. PPLN-1 consensus 
sequence synthetic peptide (1483.6) detected at 31.6 to 31.8 
minutes (*).  
C) Full mass spectrum indicating detection of PPLN-1peptide 
(1483.7) (*). Spectrum obtained from sea urchin S. purpuratus body 
wall extract.  
D) Magnified mass spectrum view of 37C. Spectrum obtained from 
sea urchin S. purpuratus body wall extract. Putative PPLN-1 peptide 
(1483.7) detected from 31.6 to 31.8 minutes (*).
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A  
B
C  
D  
 
 
Figure 44. Detection of Sp-TRH using HPLC-MS. 
A) Full mass spectrum indicating detection of Sp-TRH peptide 
(446.2) detected at 9.5 to 10.3 minutes (*) 
B) Magnified mass spectrum view of 34A. Sp-TRH synthetic peptide 
(446.2) detected at 9.5 to 10.3 minutes (*). 
C) Full mass spectrum indicating detection of Sp-TRH peptide 
(446.2) (*). Spectrum obtained from sea urchin S. purpuratus body 
wall extract.  
D) Magnified mass spectrum view of 38C. Spectrum obtained from 
sea urchin S. purpuratus body wall extract. Putative Sp-TRH 
neuropeptide (446.2) detected from 9.5 to 10.3 minutes (*). 
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4.3.3   Results: Pharmacology 
 
Sp-GnRH caused contraction of sea urchin oesophagus at a similar efficacy 
to echinotocin at 3 µM. The peptide caused contraction at a concentration 
of 3 μM with an average force of 0.657 mN (n = 7) on an isometric 
transducer (representative traces are illustrated in Figure 45). However, the 
synthetic peptide had no observable effect on unstripped sea urchin tube 
foot preparations (n = 6). When tested on starfish muscle preparations the 
peptide caused contraction of starfish oesophagus and stripped tube foot 
preparations at concentrations from 100 nM to 3 μM recorded using an 
isotonic transducer (Gill, unpublished), but had no observable effect on 
unstripped preparations (Navaratnam, unpublished).  
 
Sp-TRH caused contraction of sea urchin unstripped tube foot tissue but 
with lower potency than both echinotocin and NGFFFamide. The peptide 
caused contractions at concentrations from 3 μM (0.139 mN, n = 1) to 100 
μM (0.493 mN, n = 1). The average force of contraction at a concentration 
of 10 μM Sp-TRH was 0.637 mN (n = 11) (representative traces are 
illustrated in Figure 46). However, the peptide did not induce contractions 
of sea urchin oesophagus preparations.  
 
GKamide did not induce contraction of any of the sea urchin preparations 
tested, including unstripped tube foot (1 μM, n = 5; 10 μM, n = 1), stripped 
tube foot (3 μM, n = 4), and oesophagus (3 μM, n = 3). PPLN1 also did not 
induce contraction of the sea urchin preparations tested, including stripped 
tube foot (1 μM, n = 2), unstripped tube foot (1 μM, n = 2), and oesophagus 
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(3 μM, n = 2). However the peptide caused contraction of starfish apical 
muscle at 1 μM (0.959 mN, n = 2) and 3 μM (2.502 mN, n = 1), and 
unstripped tube foot at 20 μM (0.400 mN, n = 1). 
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Figure 45. Four representative traces illustrating Sp-GnRH (3μM) 
induced contraction of E. esculentus oesophagus preparations. The 
mean force of contraction was 0.657 mN (s.e.m. = 0.142, n = 7). The 
individual forces of the contractions illustrated were calculated from 
displacement on an isometric transducer; 0.626 mN (A), 0.702 mN 
(B), 0.598 mN (C), and 1.307 mN (D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 165 
 
 
Figure 46. Four representative traces illustrating Sp-TRH (3 μM) 
induced contraction of E. esculentus tube foot tissue. The mean 
force of contraction was 0.637 mN (s.e.m. = 0.171, n = 11). The 
individual forces of the illustrated contractions were calculated from 
displacement on an isometric transducer; 0.361 mN (A), 0.452 mN 
(B), 0.292 mN (C), and 0.959 mN (D). 
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4.4   Discussion 
 
Ten putative neuropeptide precursor genes have now been identified in the 
sea urchin genome, including genes encoding homologues of vasotocin and 
NGIWYamide, reported by Elphick & Rowe (2009), and the SALMFamide 
family neuropeptides identified by Elphick & Thorndyke (2005). The novel 
putative neuropeptides precursors reported in this chapter include 
homologues of the SALMFamide neuropeptides, gonadotropin-releasing 
hormone (Sp-GnRH), thyrotropin-releasing hormone (Sp-TRH), calcitonin-
gene related peptide (Sp-CGRP), and three novel precursor genes unrelated 
to known neuropeptides.  
 
4.4.1   SpurS8 & SpurS9: two peptides encoded by a second putative 
sea urchin SALMFamide neuropeptide precursor 
 
The identification of a second SALMFamide neuropeptide family precursor 
gene confirms the presence of at least two genes from this neuropeptide 
family in the sea urchin genome and constitutes the first evidence of 
SALMFamides being encoded by more than one precursor in an 
echinoderm.  
 
The two peptides encoded by the gene were recognised by alignment to a 
consensus sequence suggested by Elphick and Melarange (2001); 
SxL/FxFamide, where x is a variable residue. However each putative 
neuropeptide differs from the consensus sequence (Figure 47). If the new 
peptides are to be considered members of the SALMFamide neuropeptide 
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family, the consensus sequence may need revising. SpurS8 has an 
isoleucine residue in the third position from the C-terminus and SpurS9 has 
a proline residue in place of the serine. Following the sequential 
nomenclature suggested by Elphick and Thorndyke (2005) for the other sea 
urchin SALMFamides, the two novel SALMFamide peptides were denoted 
SpurS8 and SpurS9.  
 
Figure 47 compares the sequences of all currently known SALMFamide 
family neuropeptides. The first four residues of the SpurS9 nonapeptide 
resembles the first four residues (Met-Arg-Tyr-His) of a peptide purified 
from a sea urchin Echinus esculentus peptide and exhibiting 
immunoreactivity to an antiserum raised against starfish SALMFamide 2 
(S2) (Elphick and Thorndyke, 2005). Although the sequence is incomplete, 
the fragment aligns with the N-terminal region of the novel SpurS9 peptide. 
A single residue substitution, leucine in place of tyrosine, differentiates the 
two homologues. However, the organisms belong to two separate sea 
urchin families thought to have separated during the Eocene epoch (30-50 
mya). Therefore, some variation in amino acid sequence might be expected 
(Smith, 1988; Littlewood and Smith, 1995). Although two SALMFamide 
peptides have been identified in two separate sea cucumber species, in 
Holothuria glabberima (Díaz-Miranda et al., 1995) and Apostichopus 
japonicus (Ohtani et al., 1999), the lack of similarity between the peptides 
may suggest that homologues may be encoded by separate genes in each 
species. By comparison with the other echinoderm SALMFamide family 
members, two structural sub-families have emerged depending on the 
identity of the third residue from the C-terminus, in the first instance a 
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hydrophobic residue and in the second instance an aromatic phenylalanine 
residue. On the basis of this structural division one might predict a second 
asteroid SALMFamide gene encoding peptides defined by the presence of 
two C-terminal aromatic residues. 
 
SALMFamide neuropeptides were originally identified by FMRFamide 
antibody cross-reactivity (Chapter One) (Elphick et al., 1991a). 
FMRFamide was originally isolated from the clam Macrocallista nimbosa 
and is partially identical to met-enkephalin opioid peptide (YGGFMRF) 
(Price and Greenberg, 1977). Subsequently five C-terminal amidated Arg-
Phe (RFamide) neuropeptides potentially related to molluscan FMRFamide 
have been identified in vertebrates. The RFamide peptides appear to have 
functional homology in the regulation of both protostome and deuterostome 
feeding behaviour (reviewed in Dockray, 2004). A comprehensive BLAST 
search of the radial nerve tissue ESTs using the motif RFGxx (where xx 
represents a basic residue cleavage site) failed to identify RFamide peptide 
C-terminal consensus sequences in the radial nerve tissue EST sequences, 
suggesting RFamide neuropeptides may have diverged in sequence 
structure or may have been entirely lost in the divergence of echinoderms 
from other deuterostomes. Interestingly, the C-terminal seven residues of 
SpurS6 align with those of the vertebrate RFamide 26RFa 
(GGSAFVF/GGFSFRF), particularly in the conservation of two C-terminal 
aromatic residues, and that the terminal four residues of SpurS9 align with 
those of vertebrate RFamide kisspeptin (GLRF/GLHF), with a basic 
histidine in place of a basic arginine residue. Notwithstanding the 
possibility of convergent evolution, the opioids, protostome and 
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deuterostome RFamides, and echinoderm SALMFamides, may form a 
super-family of related neuropeptides. 
 
4.4.2   Sea urchin gonadotropin-releasing hormone-like peptide 
 
Sea urchin homologues of gonadotropin-releasing hormone (GnRH) and 
thyrotropin-releasing hormone (TRH) have been identified. Both vertebrate 
peptides were amongst the first neuropeptides to be identified in the animal 
kingdom. Although the peptides share functional homology as vertebrate 
hypothalamic releasing hormones their secretion and expression appears to 
be unrelated (Hokfelt et al., 2000). 
  
Similar to other protostome and deuterostome GnRH-like peptides, Sp-
GnRH may have a C-terminal Pro-Gly-NH2 and an N-terminal pyro-
glutamate (Rastogi et al., 2002; Tsai, 2006). Figure 48 illustrates a 
comparison of GnRH-like peptide sequences from a range of bilaterian 
phyla. All peptide sequences show a high level of homology. Chordate 
GnRH-family neuropeptides all consist of ten residues, but there is 
variation in the length of non-vertebrate GnRH-like peptides. Ten GnRH-
like peptides have been identified in a chordate deuterostome, the sea squirt 
Ciona intestinalis (reviewed by Tsai, 2006). Only one non-chordate 
protostome GnRH-like peptide (Oct-GnRH) has been sequenced, from the 
mollusc Octopus vulgaris (Iwakoshi et al., 2002). Like Sp-GnRH, Oct-
GnRH is a dodecapeptide with a conserved C-terminal residue sequence of 
Gly-Trp-Arg/His-Pro-Gly-NH2. 
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The human GnRH precursor consists of three coding exons, a pattern that is 
conserved across vertebrate GnRH-like peptide precursors. An additional 
gonadotropin-associated peptide (GAP) of 52 residues, and of a currently 
unknown function, is encoded by all three exons. The echinoderm GnRH-
like peptide precursor also consists of three coding exons. Furthermore the 
precursor encodes a C-terminal peptide of 85 residues, although the peptide 
has little sequence homology to vertebrate GAP. 
 
Prior to this study the only protostome GnRH-like peptide to be sequenced 
comes from the octopus Octopus vulgaris (Iwakoshi et al., 2002). 
Localization studies of oct-GnRH also suggest a reproductive regulatory 
role in cephalopods (Di Cosmo and Di Cristo, 1998; Di Cristo et al., 2002; 
Iwakoshi et al., 2002; Iwakoshi-Ukena et al., 2004), bivalves (Pazos and 
Mathieu, 1999; Gorbman et al., 2003) and gastropods (Goldberg et al., 
1993; Young et al., 1999; Zhang et al., 2000; Wayne et al., 2004), where 
GnRH IR has been observed in the innervation of the vas deferens and 
muscle of the preputium, or as a neuromodulator (Tsai et al., 2003). In a 
study by Pazos and Mathieu (1999) on the effects of vertebrate GnRH 
peptides on bivalve gonad the effective concentration was as low as 10 pM, 
indicating highly conserved receptor affinity irrespective of peptide 
sequence divergence. Although protostome GnRH-like peptides have only 
been identified in molluscs the peptides may be related to insect 
adipokinetic hormones. Adipokinetic hormones have been shown to bind 
nematode GnRHR-like receptors and an adipokinetic/GnRH-like peptide 
has recently been identified in the genome of the nematode C. elegans 
(Lindemans et al., 2009) (Figure 48). The non-amidated putative nematode 
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adipokinetic/GnRH-like peptide bears structural similarity to arthropod 
adipokinetic hormone in having nine residues, four of which are identical 
matches, and a pyroglutamate residue at the N-terminal. 
 
Several studies have hypothesized a cross-phyletic and conserved role for 
GnRH-like peptides in the direct and indirect regulation of reproduction 
(Gorbman and Sower, 2003; Tsai, 2006). For example, octopus GnRH-like 
peptide has been shown to target the optic gland in cephalopods and the vas 
deferens and preputium muscle in gastropods (Di Cosmo and Di Cristo, 
1998; Young et al., 1999). In tunicates, GnRH-like peptide 
immunoreactivity has been found in the nerve plexus that innervates the 
gonad and gonoducts (Mackie, 1995).  
 
Molluscs have two GnRH sequences, one distributed in the molluscan 
CNS, immunoreactive to an antiserum raised against Tunicate-I GnRH, and 
the other immunoreactive to an antiserum raised against mammalian 
GnRHs and distributed in the osphradium. The osphradium is one of three 
major chemosensory organs in the mollusc, the others being rhinophores 
and tentacles.  
 
In vertebrates the role of GnRH is well established as a regulator of 
gonadotropin release. In mammals GnRH is involved in stimulating the 
secretion of LH and FSH from the anterior pituitary. However the peptide 
is also expressed in the central nervous system, originating from progenitor 
cells in the vertebrate olfactory placode, thereby also suggesting an 
ancestral role in chemosensory perception (reviewed by Tsai, 2006). Given 
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the radical morphological divergence exhibited by echinoderms, the 
functional roles described by the above studies and the observation of 
contractile myoactivity on sea urchin oesophagus tissue can only be 
suggestive until further studies are able to localize GnRH expression in the 
sea urchin adult and embryo. 
 
4.4.3   Sea urchin thyrotropin-releasing hormone-like peptide 
 
Echinoderm thyrotropin-releasing hormone-like peptide (Sp-TRH) 
(pEYPG-NH2) has four residues as opposed to the three residues common 
to all vertebrate TRH peptides (pEHP-NH2). It also deviates from a 
consensus sequence universally observed across chordate TRH 
neuropeptides in possessing an aromatic residue in the place of a basic 
histidine residue and an additional C-terminal amidated glycine residue. 
Furthermore, a peptide corresponding to the predicted structure based on 
Sp-TRH (pEYPG-NH2) was detected in S. purpuratus body wall extract, 
suggesting the presence of an N-terminal pyroglutamate residue and C-
terminal amidation. Although weakly contractile compared to echinotocin, 
NGFFFamide, and Sp-GnRH, the peptide's myoactivity when tested on sea 
urchin tube foot tissues provides an indication of bioactivity. 
 
TRH secreting neurons are found throughout the vertebrate nervous system, 
being particularly concentrated in the hypothalamus where axons target the 
median eminence. The neuropeptide targets TRH-specific GPCRs 
expressed by cells of the anterior pituitary through a phosphatidyinositol 
second-messenger system (Gershengorn and Thaw, 1985). The anterior 
 173 
pituitary cells respond by secreting thyroid-stimulating hormone (TSH) and 
prolactin. The peptide also acts on hypoglossal motor neurons via a G 
protein-mediated Ca
2+
-independent second messenger pathway (Bayliss et 
al., 1994). 
 
Hsieh et al. (1990) have reported TRH immunoreactivity in the shrimp and 
TRH-like receptors have been identified in the Drosophila genome (Hewes 
and Taghert, 2001), however TRH-like peptides have not yet been 
identified in protostome or non-chordate species. Therefore, Sp-TRH is the 
first putative TRH-like peptide to be identified in a non-chordate.  
 
4.4.4   Sea urchin calcitonin/CGRP-like peptide 
 
Like vertebrate calcitonin peptides, the sea urchin calcitonin/CGRP peptide 
sequence (38 residues) has an amidated C-terminal proline residue and may 
have an N-terminal disulfide bonded ring structure formed by C
4
 and C
10
. 
Immunoreactivity to calcitonin-like peptides has been shown in both 
vertebrates and invertebrates (Sasayama et al., 1991). Figure 49 provides a 
structural comparison of peptide sequences for vertebrate calcitonin, 
vertebrate CGRP, echinoderm Sp-calcitonin/CGRP, and two arthropod 
diuretic hormones (Dippu-DH31 and Drome-DH31) with relatively low 
sequence similarity to CGRP  neuropeptides identified in vertebrates 
(Furuya et al., 2000; Coast et al., 2001; Johnson et al., 2005). Although 
CGRP-like peptides have been reported in molluscs (Fouchereau-Peron, 
1993; Duvail et al., 1997; Lafont et al., 2007), their structure and sequence 
is not yet known. 
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Vertebrate calcitonin and calcitonin gene-related peptide are encoded by 
the same gene. Alternate splicing to produce calcitonin (32 residues) 
involves the first four exons, whereas the processing of the precursor to 
produce CGRP (37 residues) involves exons one to three and five and six. 
The putative echinoderm CGRP precursor (spp-4) has five exons, the fourth 
of which encodes the peptide sequence (Sp-calcitonin/CGRP) (38 amino 
acids) (Figure 40). There were no other calcitonin-like sequences found in 
proximity to the gene. The presence of a single calcitonin/CGRP-like 
peptide sequence in the precursor suggests that calcitonin may have arisen 
as a later evolutionary development in vertebrates, as suggested by Lafont 
et al (2007), however, unlike other vertebrate CGRP neuropeptides the sea 
urchin calcitonin/CGRP-like peptide has an amidated proline residue at the 
C-terminus (Figure 44). 
 
Calcitonin gene-related peptide (CGRP) has a role as a neuromediator and 
neurohormone in the nervous systems of invertebrates and chordates, and a 
role that may have been secondarily-acquired as a regulator of ionic 
exchange mechanisms in protostomes (Lafont et al., 2007). 
Immunoreactivity to calcitonin-like receptors has been demonstrated in the 
gill and mantle of molluscs, leading Lafont et al. (2007) to hypothesise an 
ancestral role for the peptide in ionic regulation. Interestingly, activity-
modifying proteins, such as RAMPs (receptor activity-modifying proteins) 
and RCP (receptor coupled protein), are involved in the transport and 
activity of human CGRP receptors. Protein homologues to RAMP were 
absent from the Drosophila genome (Hewes and Taghert, 2001), although 
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Johnson et al. (2005) report functional interaction between Drosophila RCP 
(receptor coupling protein) and a calcitonin-like receptor. A putative 
calcitonin receptor, a member of the secretin family of G-protein coupled 
receptors, was identified in the Strongylocentrotus genome (SPU_018314). 
However, a BLAST search of the sea urchin genome failed to identify 
proteins showing homology to human RAMP1 or to Drosophila RCP 
(CG4875). If Sp-CGRP is related to vertebrate CGRP and the Drosophila 
neuropeptide DH31, either the regulatory subunits are unnecessary for 
physiological activity in the sea urchin or there may be unknown sea urchin 
receptor-associated regulatory subunits lacking clear homology to those 
previously described in arthropod and mammalian studies. 
 
4.4.5   Two novel pedal peptide-like peptide precursor genes 
 
Precursor Spp-6 encodes 22 variable repeats of a non-amidated 
pentadecapeptide and precursor spp-7 encodes ten variable repeats of a 
non-amidated 14 residue peptide (consensus sequence Asn-Phe-Gly-Gly-
Ser-Leu-Glu-Pro-Met-Gln-Ser-Gly-Phe-Tyr). The peptides encoded by 
these last two genes were denominated pedal peptide-like peptide by virtue 
of weak structural similarity to 'pedal peptide', a neuropeptide unique to 
molluscs. The peptides share a Ser-Gly-Phe sequence and a non-amidated 
C-terminus with the three pedal peptide family neuropeptides identified in 
Aplysia (Lloyd and Connolly, 1989; Pearson and Lloyd, 1989; Moroz et al., 
2006). A peptide corresponding to the synthetic PPLN1, with a sequence 
representing a consensus of spp-6 peptide structures, was detected in S. 
purpuratus body wall tissue extract using mass spectrometry. Furthermore, 
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although the peptide did not exhibit myoactivity when tested on sea urchin 
muscle preparations, subsidiary studies have revealed that the peptide 
appears to be potent in contracting starfish apical muscle at a concentration 
of 1 µM (0.959 mN, n = 2).  
 
4.4.6   GKamide: a novel sea urchin peptide 
 
The neuropeptides described in this study were selected on the basis of 
sequence homology to known neuropeptides and by the presence of 
homologous peptide repeats. Of the latter, spp-5 encodes 13 variable 
repeats of a putative arginine-rich amidated undecapeptide denoted 
GKamide. Interestingly, although structurally dissimilar, the allatostatin 
precursor from the American cockroach Periplaneta americana encodes 14 
allatostatin peptides, a similar number to that encoded by the S. purpuratus 
GKamide precursor. Like PPLN1, the synthesized peptides did not exhibit 
myoactivity when tested on sea urchin muscle preparations. Although the 
peptide was not detected using mass spectrometry, it is important to note 
that GKamide was not identifiable in the standard solutions used for 
identification of the peptides, suggesting difficulties in retaining the peptide 
on the column which may have exacerbated over the duration of the study. 
 
Some of the neuropeptides identified in this chapter do provide evidence of 
the remarkable conservation of neuropeptide sequence structure. However 
neuropeptides can assume multifunctional roles over evolutionary history, 
often differentially expressed to fulfil specific functions within an 
organism. It remains for future research to investigate the neural expression 
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of these peptides with the hope of elucidating some of their 
neurobiological, behavioural and physiological functions.  
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Peptide            Sequence                          Species 
 
EscS9 (partial)           Met-Arg-Tyr-His…                    E. esculentus (Echinoidea) 
SpurS9                  Met-Arg-Leu-His-Pro-Gly-Leu-Leu-Phe-NH2       S. purpuratus (Echinoidea) 
SpurS8   Asn-Met-Gly-Ser-Ile-His-Ser-His-Ser-Gly-Ile-His-Phe-NH2       S. purpuratus (Echinoidea) 
Kisspeptin  (partial)…Tyr-Tyr-Trp-Tyr-Ser-Phe-Gly-Leu-Arg-Phe-NH2       H. sapiens (Mammalia) 
S1                            Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2       A. rubens (Asteroidea)  
S2            Ser-Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2       A. rubens (Asteroidea)  
GFSKLYFamide                      Gly-Phe-Ser-Lys-Leu-Tyr-Phe-NH2  H. glaberrima (Holothuroidea)
 
SGYSVLYFamide                 Ser-Gly-Tyr-Ser-Val-Leu-Tyr-Phe-NH2  H. glaberrima (Holothuroidea) 
GYSPFMFamide                      Gly-Tyr-Ser-Pro-Phe-Met-Phe-NH2  S. japonicus (Holothuroidea) 
FKSPFMFamide                      Phe-Lys-Ser-Pro-Phe-Met-Phe-NH2  S. japonicus (Holothuroidea) 
SpurS1            Pro-Pro-Val-Thr-Thr-Arg-Ser-Lys-Phe-Thr-Phe-NH2  S. purpuratus (Echinoidea) 
SpurS2                        Asp-Ala-Tyr-Ser-Ala-Phe-Ser-Phe-NH2  S. purpuratus (Echinoidea)
 
SpurS3                            Gly-Met-Ser-Ala-Phe-Ser-Phe-NH2  S. purpuratus (Echinoidea)
 
SpurS4                            Ala-Gln-Pro-Ser-Phe-Ala-Phe-NH2  S. purpuratus (Echinoidea) 
SpurS5                        Gly-Leu-Met-Pro-Ser-Phe-Ala-Phe-NH2  S. purpuratus(Echinoidea) 
SpurS7                            Gly-Asp-Leu-Ala-Phe-Ala-Phe-NH2  S. purpuratus (Echinoidea)
 
SpurS6                    Pro-His-Gly-Gly-Ser-Ala-Phe-Val-Phe-NH2  S. purpuratus (Echinoidea)
 
26RFamide (partial)              …Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2  R. esculenta (Amphibia) 
[Met5]Enkephalin-Arg6-Phe7         Tyr-Gly-Gly-Phe-Met-Arg-Phe      H. sapiens (Mammalia) 
 
Figure 47. SALMFamide neuropeptide family sequences assembled from studies of sea urchins (E. esculentus, S. purpuratus) (this study, 
Elphick and Thorndyke, 2005), starfish (A. rubens) (Elphick et al., 1991a), and holothurians (H. glaberrima, S. japonicus) (Díaz-Miranda et 
al., 1995; Iwakoshi et al., 1995). For point of comparison the sequences of human Met-enkephalin-Arg-Phe (GI:49456613), amphibian 
26RFamide (GI:50400830), and kisspeptin/metastin (GI:160110095) have been included. Nonpolar residues are labelled in orange, polar 
residues in green, acidic residues in purple, basic residues in blue, and aromatic residues in red.
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Class     Sequence 
 
Mammalia1                  pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 
Chicken-I2                         pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2 
Chicken-II
3 
               pyroGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2 
Actinopterygii4            pyroGlu-His-Trp-Ser-Tyr-Gly-Trp-Leu-Pro-Gly-NH2 
Chondrichthyes5            pyroGlu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2 
Lamprey-I6                 pyroGlu-His-Tyr-Ser-Leu-Glu-Trp-Lys-Pro-Gly-NH2 
Lamprey-III7               pyroGlu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2  
Tunicate-I GnRH8           pyroGlu-His-Trp-Ser-Asp-Tyr-Phe-Lys-Pro-Gly-NH2 
Tunicate-II GnRH9          pyroGlu-His-Trp-Ser-Leu-Cys-His-Ala-Pro-Gly-NH2 
Tunicate-III GnRH
9            
pyroGlu-His-Trp-Ser-Tyr-Glu-Phe-Met-Pro-Gly-NH2 
Tunicate-IV GnRH9         pyroGlu-His-Trp-Ser-Asn-Gln-Leu-Thr-Pro-Gly-NH2 
Tunicate-V GnRH9          pyroGlu-His-Trp-Ser-Tyr-Glu-Tyr-Met-Pro-Gly-NH2 
Tunicate-VI GnRH9         pyroGlu-His-Trp-Ser-Lys-Gly-Tyr-Ser-Pro-Gly-NH2 
Tunicate-VII GnRH9        pyroGlu-His-Trp-Ser-Tyr-Ala-Leu-Ser-Pro-Gly-NH2 
Tunicate-VIII GnRH9       pyroGlu-His-Trp-Ser-Leu-Ala-Leu-Ser-Pro-Gly-NH2 
Tunicate-IX GnRH9         pyroGlu-His-Trp-Ser-Asn-Lys-Leu-Ala-Pro-Gly-NH2 
Tunicate-X GnRH
9
          pyroGlu-His-Phe-Ser-Asn-Trp-Trp-Ile-Pro-Gly-Ala-Pro-Gly-Tyr-Asn-Gly-NH2 
Echinoidea Sp-GnRH10       pyroGlu-Val-His-His-Arg-Phe-Ser-Gly-Trp-Arg-Pro-Gly-NH2  
Cephalopoda Oct-GnRH11     pyroGlu-Asn-Tyr-His-Phe-Ser-Asn-Gly-Trp-His-Pro-Gly-NH2  
Arthropoda BomAKH   pyroGlu-Leu-Thr-Phe-Thr-Ser-Ser-Trp-Gly-NH2 
Nematoda AKH-GnRH   pyroGlu-Met-Thr-Phe-Thr-Asp-Gln-Trp-Thr 
 
Figure 48, A comparison of GnRH-like neuropeptide sequences from four chordate classes, as well as one molluscan GnRH-like peptide, and the 
putative echinoderm neuropeptide Sp-GnRH. For point of comparison with adipokinetic hormones, Bombyx adipokinetic hormone and an AKH-GnRH-
like peptide from C. elegans have been included. Hydrophobic residues are shown in orange, hydrophilic residues are shown in green, aromatic 
residues are shown in red, acidic residues are shown in purple, and basic residues are shown in blue. GnRH-like peptides sequences were obtained 
from 
1
Homo sapiens (GI:31956, Hayflick et al., 1989), 
2
Gallus gallus (GI:124249294, King and Millar, 1982), 
3
Gallus gallus (GI:89274005), 
4
Oncorhyncus nerka (GI:1030714, Ashihara et al., 1995), 
5
Squalus acanthias (GI:121520, Lovejoy et al., 1992), 
6
Petromyzon marinus (GI:8698621, 
Suzuki et al., 2000), 
7
Petromyzon marinus (GI:37542417, Silver et al., 2004), 
8
Chelyosoma productum (Powell et al., 1996), 
9
Ciona intestinalis (Tello et 
al., 2005; review by Tsai, 2006), 
10
Strongylocentrotus purpuratus, 
11
Octopus vulgaris (GI:19697930, Iwakoshi et al., 2002), 
12
Bombyx mori 
(GI:193248566, Roller et al., 2008), and 
13
Caenorhabditis elegans (GI:3329621, Lindemans et al., 2009). 
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   Gene              Sequence 
 
H. sapiens CT1       CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 
Sp-CT/CGRP2       SKGCGSFSGCMQMEVAKNRVAALLRNSNAHLFGLNGP-NH2 
Rana CGRP
3
          ACNTATCVTHRLADFLSRSGGMAKNNFVPTNVGSKAF-NH2 
S. scrofa CGRP4     SCNTATCVTHRLAGLLSRSGGMVKSNFVPTDVGSEAF-NH2 
Dippu-DH315             GLDLGLSRGFSGSQAAKHLMGLAAANYAGGP-NH2 
Drome-DH316             TVDFGLARGYSGTQEAKHRMGLAAANFAGGP-NH2 
 
Figure 49. Calcitonin and CGRP-like peptide sequences from 
1human (GI:179820), 2sea urchin (S. purpuratus), 3anuran (R. 
ridibunda) (GI:399232) (Conlon et al., 1993), 4pig (Sus scrofa) 
(GI:156447412) (Kimura et al., 1987), 5cockroach (Dippu-DH31) 
(Diploptera punctata) (GI:8928102) (Furuya et al., 2000), and 6fruit 
fly (Drome-DH31) (D. melanogaster) (GI:17647327). Nonpolar 
residues are labelled in orange, polar residues in green, acidic 
residues in purple, basic residues in blue, and aromatic residues in 
red. The underlined conserved cysteine residues may join to form a 
disulfide bond. 
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Nine putative neuropeptide precursors were identified in the genome of the 
Californian sea urchin Strongylocentrotus purpuratus using bioinformatic 
techniques and several of the putative peptides identified were detected 
using mass spectrometry. Six of the putative peptides were synthesized and 
demonstrated myoactivity on in vitro muscle preparations from sea urchin 
(Echinus esculentus) and starfish (Asterias rubens). The identified genes 
include the precursors to the peptides echinotocin, NGFFFamide, Sp-TRH, 
Sp-GnRH, SALMFamides S8 and S9, Sp-calcitonin/CGRP and PPLN1, 
PPLN2 peptides, and GKamide. 
 
Before the current post-genomic era, immunological methods were used to 
detect the presence of peptides immunoreactive to antibodies raised against 
known neuropeptides as a prologue to the identification and sequencing of 
novel peptides (Robb et al., 1989; Díaz-Miranda et al., 1991; Keller, 1992; 
Ghyoot et al., 1994). Bioinformatic 'in silico' approaches to neuropeptide 
identification have found 22 putative neuropeptide-encoding genes in the 
Drosophila genome (Hewes and Taghert, 2001; Vanden Broeck, 2001b) 
and up to 35 putative neuropeptide-encoding genes in the Anopheles 
gambiae genome (Riehle et al., 2002). MALDI-TOF MS has been used to 
identify and sequence neuropeptides from invertebrate neurosecretory 
tissues, including the atrial gland of the sea slug Aplysia californica (Li et 
al., 1999b) and the crustacean pericardial organs of the crustacean Cancer 
borealis (Li et al., 2003). Subsequently a total of 119 putative arthropod 
neuropeptides have been identified in the Drosophila genome (Liu et al., 
2006).  
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Nematode neuropeptides  have also been identified using a combination of 
genomic and biochemical techniques (Husson et al., 2005; Husson et al., 
2007). An 'in silico' approach, including the use of preproprotein 
characteristics as identifying criteria, was used by Nathoo et al (2001) to 
identify 32 putative neuropeptide-like genes in the Caenorhabditis elegans 
genome. The neuropeptides identified in the roundworm genome show 
considerable diversification and expansion and have been divided into 
several novel gene families, including two large families of FMRF-related 
neuropeptides and insulin-like neuropeptides. 
 
A second putative SALMFamide neuropeptide precursor 
 
In this study, a second putative SALMFamide neuropeptide precursor gene 
was identified in the Strongylocentrotus genome, encoding two novel 
SALMFamide peptides, S8 and S9. The two putative neuropeptides 
supplement the seven encoded by the other SALMFamide neuropeptide 
identified in the sea urchin genome (Elphick and Thorndyke, 2005). The 
family may be unique to the echinoderm phylum. However the new 
sequences identified modify the consensus SALMFamide neuropeptide 
sequence previously suggested by Elphick & Melarange (2001), 
SxL/FxFamide, to one set of SALMFamide neuropeptides defined by a 
hydrophobic residue in the third position from the C-terminus (S8 & S9) 
and a second set defined by an aromatic residue in the third position from 
the C-terminus (S1-S7). The presence of similar peptide sequences 
identified in both holothurians and asteroid species supports the hypothesis 
of two separate SALMFamide neuropeptide precursors.  
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The SALMFamide neuropeptide family may be evolutionarily linked to the 
FMRFamide-related peptides and -RFamides, which have been identified in 
both vertebrates and invertebrates and have been shown to have multiple 
roles in behaviour and physiology (Dockray, 2004). There were no putative 
-RFamide neuropeptides identified in the sea urchin genome, although a 
number of receptors homologous to vertebrate -RFamide receptors were 
identified. Although the physiological roles of the SALMFamide 
neuropeptides are not yet known in the sea urchin, the family members 
have been shown to be myoactive in other echinoderms, notably inducing 
relaxation of starfish stomach tissue (Elphick and Melarange, 2001). 
However, the sea urchin genome encodes nine putative SALMFamide 
peptides, some of which may not be myoactive and all of which may vary 
in physiological role. The roles of the SALMFamides in sea urchins and the 
variation in peptide structure and function of the SALMFamides across the 
five echinoderm classes remains to be determined.  
 
Neurophysin-containing neuropeptide precursors: echinotocin and 
NGFFFamide 
 
One NGIWYamide-like peptide, NGFFFamide, has been identified. Both of 
the peptides may represent another family of neuropeptides unique to 
echinoderms. However it is unclear if NGFFFamide is a true functional 
orthologue of holothurian NGIWYamide without further pharmacological 
characterization of the neuropeptide in both sea urchins and starfish. Most 
interestingly NGFFFamide may be related to the vasopressin/oxytocin 
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family of neuropeptides because the NGFFFamide precursor gene also 
encodes a C-terminal neurophysin domain. Furthermore, the precursor to a 
vasotocin-like peptide was identified and denominated echinotocin. 
Consistent with all known vasotocin-like peptide precursors a neurophysin 
domain was also identified C-terminal to the peptide encoding region. The 
echinotocin neurophysin molecule is sequentially similar to the oxytocin 
neurophysin molecule however the NGFFFamide neurophysin molecule 
lacks important residues in its peptide binding region, which may reflect 
modifications essential for binding NGFFFamide. Phylogenetic analysis of 
neurophysin sequence structure and the absence of other neurophysin-
associated peptides in both echinoderms and other protostomes suggest that 
the neurophysin-associated peptide may have originated during echinoderm 
evolution. It remains to be determined whether other neurophysin domains 
not associated with vasopressin/oxytocin-like peptides are to be found in 
the genomes of species from other echinoderm classes or even within the 
genomes of other invertebrate species.  
 
NGFFFamide was detected in both the neural EST library and in S. 
purpuratus body wall extract using mass spectrometry. Due to the small 
size of the radial nerve EST library and the low sensitivity of the mass 
spectrometric analysis, the peptide may be expressed at high quantities 
throughout the sea urchin nervous system. Interestingly echinotocin was not 
identified in the EST library, the transcriptome database, or the body wall 
or visceral extracts analysed using mass spectrometry, suggesting that the 
peptide may not be expressed, or may only be expressed at low levels, and 
not necessarily as a neurohormone or neurotransmitter. Pharmacological 
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investigation demonstrates that both NGFFFamide and echinotocin induce 
contraction of sea urchin tube foot and oesophagus tissues but 
NGFFFamide was the more potent of the two peptides. The observations of 
myoactivity are similar to the responses induced by the holothurian 
NGIWYamide on both holothurian, echinoid and asteroid tissue (Inoue et 
al., 1999; Saha et al., 2006).  The effects of both NGFFFamide and 
echinotocin on tissues from other echinoderm classes await thorough 
investigation. 
 
Putative novel neuropeptides homologous to vertebrate neuropeptides 
 
GnRH-like peptides are expressed throughout the animal kingdom and one 
GnRH-like peptide encoding precursor was identified in the sea urchin 
genome. In vertebrates the peptide indirectly regulates reproduction via the 
release of glycoprotein hormones from the pituitary. The peptide is also 
associated with reproduction in molluscs. Sp-GnRH is the first GnRH-like 
neuropeptide identified in echinoderms. The echinoderm peptide has 
myoactive properties, inducing contraction of sea urchin oesophagus tissue. 
It remains to be determined whether the peptide has similar myoactive 
properties in other echinoderm classes. 
 
Homologues to TRH, another tropic hormone released by the pituitary, 
heretofore have not been identified in non-chordates. The TRH-like peptide 
identified in this study bears resemblance to vertebrate TRH in the 
relatively high copy number encoded by the precursor, precursor structure 
and residue similarity, including C-terminal amidation and an N-terminal 
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pyroglutamate residue. Furthermore, the peptide was identified in a 
pyroglutamated and amidated form by mass spectrometric analysis of body 
wall tissue extract. The peptide induced contraction of sea urchin tube feet, 
but at a lower potency than both NGFFFamide and echinotocin. 
 
A gene encoding a putative neuropeptide homologous to 
calcitonin/calcitonin-gene related peptide was identified. In vertebrates both 
calcitonin and CGRP are encoded by the same gene however a CGRP-
encoding gene is thought to have been the common ancestor of the peptides 
before modification through intragenic duplication (Lafont et al., 2007). 
Thus, the identification of a single calcitonin/CGRP-like peptide in a 
deuterostome species provides additional evidence that the duplication 
event producing calcitonin and CGRP may have occurred in the vertebrate 
lineage. Immunohistochemical and pharmacological studies will be needed 
to address the role of Sp-calcitonin/CGRP in the sea urchin and whether the 
peptide has a role as a neuromediator and/or regulator of calcium 
metabolism. 
 
Putative novel sea urchin neuropeptide families 
 
Three more putative neuropeptide-encoding precursors were identified by 
virtue of their structural characteristics. The three putative precursors may 
encode neuropeptides representing novel echinoderm neuropeptide 
families. However, two precursors encode peptides showing structural 
similarity to molluscan pedal peptide. One of the pedal peptide-like 
peptides was detected in S. purpuratus tissue extract analysed using mass 
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spectrometry. Two of the peptides were synthesized for pharmacological 
investigation, but neither demonstrated myoactivity when tested on sea 
urchin muscle preparations.  
 
Conclusions 
 
Investigation of the expression and function of the novel neuropeptides will 
benefit future echinoderm neurobiological, physiological and behavioural 
research. Echinoderms are a global economic resource. Sea urchin roe and 
sea cucumbers are both important in luxury regional cuisines of Japan, 
South East Asia, China, France, and Peru with approximately 80% of sea 
urchin consumption occurring in Japan (Yokota, 2002). However, as active 
predators of marine bivalves, introduced echinoderms transported by ballast 
water, including the starfish Asterias amurensis and Acanthaster planci, 
have damaged the shellfish industry and the endemic fauna of coral reefs in 
the South Pacific. 
 
Neuropeptides and their receptors are likely to play a role in the regulation 
of echinoderm reproductive behaviour. Studies suggest that both 
SALMFamide and NGIWYamide-like peptides may have a role in the 
regulation of reproduction (Maruyama, 1985; Mita et al., 2004; Mita et al., 
2009). Both NGIWYamide and the dimeric gonad-stimulating substance 
(GSS) stimulate follicle cells surrounding oocytes and the GSS pathway has 
been well defined. Oocyte meiosis is triggered by the release of maturation-
inducing substance (MIS), α1-methyl adenine, by the follicle cells which 
then binds to the oocyte membrane initiating a pathway involving a 
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maturation-promoting factor, conserved across eukaryotes (Kanatani, 1983; 
Shirai, 1986; Yoshikuni et al., 1988; Tadenuma et al., 1992; Okumura et al., 
2002; Hiraoka et al., 2004). A full understanding of the neurohormonal 
regulation of echinoderm reproduction may be of benefit both to the control 
of echinoderms as introduced ecological pests and as organisms for 
aquaculture. 
 
Furthermore, echinoderms have been vital model organisms for research 
into the early stages of animal development (Briggs and Wessel, 2006; 
Burke et al., 2006) and several of the putative neuropeptides identified in 
this study are also expressed by the developing echinoderm larva.  
 
The role of neuropeptides in understanding neural signalling in both 
vertebrates and invertebrates cannot be underestimated. Neuropeptides are 
important to understanding the processes of neuromodulation (Brinton, 
1990), the biochemical mechanisms involved in intercellular signalling and 
GPCR activation, immunity, stress (Herman et al., 2003), development 
(Briggs and Wessel, 2006; Howard-Ashby et al., 2006) and social 
behaviour. Both oxytocin and vasopressin have been shown to have roles in 
the regulation of social behaviour in vertebrates, including vasopressin in 
facilitating aggression and in the maintenance of monogamous pair bonding 
(Winslow et al., 1993; Caldwell et al., 2008) and oxytocin in maternal-
infant bonding and the regulation of social interaction (Donaldson and 
Young, 2008). Variation in vasopressin and oxytocin receptor structure may 
be responsible for pathological social behavioural traits in humans (Israel et 
al., 2008).  
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Understanding the biochemical activity of neuropeptides and their receptors 
will be integral to understanding the processes of neural integration and 
signal processing. Alongside other signalling molecules, neuropeptides may 
serve as molecular synchronization molecules in neural networks 
generating rhythmic output, including central pattern generators, in 
circadian rhythm synchronization, and in learning and memory. For 
example, neuropeptides released by the pericardial organs may be involved 
in regulation of the crustacean stomatogastric ganglion (Li et al., 2003) and 
pigment-dispersing factor is an integral component to the regulation of 
Drosophila circadian rhythms (Taghert and Shafer, 2006). Circadian 
abnormalities have a disruptive and detrimental effect on longevity, 
development, and reproductive success. The identification of rhythmic 
centres regulating periodicity in reproduction and motor action in the 
dispersed echinoderm nervous system will assist in unravelling the 
mysteries of echinoderm neural integration.  
 
There is an argument that neuropeptides are amongst the most ancestral 
neurotransmitters in animals, which is apparent by the presence of a host of 
cnidarian neuropeptides with neurotransmitter capabilities (Anctil and 
Grimmelikhuijzen, 1989; McFarlane et al., 1991; Schmutzler et al., 1992). 
Comparative studies of neuropeptide function and expression will continue 
to inform studies of molecular and morphological evolution. Future 
comparative studies of neuropeptide structure and function will also benefit 
from novel and expanded techniques, including reverse pharmacology, for 
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the identification of endogenous ligands to orphan GPCRs, and MALDI-
TOF, for the identification of novel bioactive neuropeptides.  
 
In summary, the thesis reports the identification of two novel neuropeptide 
families, homologous peptides to three vertebrate neuropeptides, and one 
novel precursor encoding two members of the echinoderm SALMFamide 
neuropeptide family. Since the divergence of echinoderms from other 
deuterostomes in the late Precambrian supereon, neuropeptides and their 
receptors in echinoderms are likely to have expanded and acquired novel 
structures and diverse functions necessary for a highly divergent and 
unusual morphology and physiology. It may be that, notwithstanding the 
comparative advantages of a relatively close ancestral relationship to 
vertebrates, the value of echinoderm neuroendocrine research lies in 
understanding how radically different echinoderms are from vertebrates in 
anatomy, physiology, and biochemistry, and how related signalling 
molecules have acquired novel structures and functions. This project 
introduces a number of candidate molecules for the regulation of 
echinoderm physiology and behaviour which will be of high importance to 
future students and researchers investigating the complexities of 
echinoderm biology. 
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Appendix B: Putative sea urchin voltage-gated ion channel 
genes. 
 
The VGIC gene predictions are arranged by ion selectivity and type 
(Gutman et al., 2005). 
 
______________________________________________________________________________________________________________________________________________________ 
 
Putative sea urchin K+ voltage-gated ion channels 
______________________________________________________________________________________________________________________________________________________ 
 
Kv1   SPU_026003, SPU_006470 
Kv3    SPU_019341, SPU_006470,   
   SPU_009204 
Kv4   SPU_012871 
Kv7   SPU_004907 
Kv10   SPU_000092 
Kv11   SPU_016505 
Kv12   SPU_010067 
______________________________________________________________________________________________________________________________________________________ 
 
Putative sea urchin Ca2+ voltage-gated ion channels 
______________________________________________________________________________________________________________________________________________________ 
 
L-type   SPU_007770 
N/P/Q/R-type SPU_011692 
T-type   SPU_017773, SPU_025833 
______________________________________________________________________________________________________________________________________________________ 
 
Putative sea urchin Na+ voltage-gated ion channels 
______________________________________________________________________________________________________________________________________________________ 
 
Na+ VGIC   SPU_025997 
______________________________________________________________________________________________________________________________________________________ 
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Appendix C: Human neuropeptides organized by receptor  
family 
 
Neuropeptides binding secretin-family GPCRs 
 
Calcitonin (CT) 
 CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 
Corticotropin-releasing hormone (CRH) 
 SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2  
Glucagon 
 HSQGTFTSDYSKYLDSRRAQDFVQWLMNT 
Gastric inhibitory polypeptide (GIP) 
 YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ 
Glucagon-like peptide-1 
         HDEFERHAEGTFTSDVSSYLEGQAAKEFI 
Glucagon-like peptide-2 
           HADGSFSDEMNTILDNLAARDFINWLIQTKIT 
Growth-hormone releasing hormone (GHRH) 
 YADAIFYNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARAR
L-NH2 
Pituitary adenylyl cyclase-activating protein (PACAP) 
 PACAP 27 HSDGIFTDSYSRYRKQMAVKKYLAAVL 
 PACAP 38         HSDGIFTDSYSRYRKQMAVKKYLAAVLG 
   KRYKQRVKNK-NH2 
Parathyroid hormone 
 SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAP
RDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ 
Secretin 
 HSDGTFTSELSRLREGARLQRLLQGLV-NH2 
Vasoactive intestinal peptide (VIP) 
 HSDAVFTDNYTRLRKQMAVKKYLYLNSILN-NH2 
 
Neuropeptides binding rhodopsin-family GPCRs (α) 
 
Melanocortins; 
Adrenocorticotropin  (ACTH)  
 SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF 
Alpha-MSH 
 SYSMEHFRWGKPV-NH2 
Beta-MSH 
 DEGPYKMEHFRWGSPPKD 
 
Neuropeptides binding rhodopsin-family GPCRs (β) 
 
Orexin/hypocretin 
 QPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 
 RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 
Neuropeptide FF 
 SQAFLFQPQRF-NH2 
Tachykinins; 
Substance P (SP)                   
 RPKPQQFFGLM-NH2 
Neurokinin A (NKA)  
 HKTDSFVGLM-NH2 
N eurokinin B (NKB)                    
 DMHDFFVGLM-NH2 
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Cholecystokinin 
 KAPSGRMSIVKNLQNLDPSHRISDRDY(-SO3)-MGWMDF-NH2 
Neuropeptide Y 
 YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 
Pancreatic polypeptide (PP) 
 APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 
Peptide YY (PYY)  
 YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 
Gastrin-releasing peptide 
 VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 
Neuromedin C  
 GNHWAVGHLM-NH2 
Neuromedin B  
 GNLWATGHFM-NH2 
Bombesin  
 pEQRLGNQWAVGHLM-NH2 
Neurotensin 
 pELYENKPRRPYIL 
Neuromedins; 
Thyrotropin-releasing hormone (TRH) 
 pEHP-NH2 
Ghrelin  
 GS-S(n-octanoyl)-FLSPEHQRVQQRKESKKPPAKLQPR 
Gonadotropin-releasing hormone 
 pEHWSYGLRPG-NH2 
Arginine vasopressin 
 CYFQNCPRG-NH2 
Oxytocin 
 CYIQNCPLG-NH2 
 
 
Neuropeptides binding rhodopsin-family GPCRs (γ) 
 
Galanin 
   GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS 
Kisspeptin/metastin 
              -APQGAVLVQREKDLPNYYWYSFGLRF-NH2 
Somatostatin-28 
   SANSNPAMAPRERKAGCKNFFWKTFTSC 
Endogenous opioids; 
Met-enkephalin  
 YGGFM 
Leu-enkephalin  
 YGGFL 
Dynorphin A (1-17)  
 YGGFLRRIRPKLKWDNG 
Neuropeptide W 
   WYKHVASPRYHTVGRAAGLLMGLRRSPYLW 
Melanin-concentrating hormone 
 DFDMLRCMLGRVYRPCWQV 
Angiotensin 1 
 DRVYIHPFHL 
Bradykinin 
 RPPGFSPFR 
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Neuropeptides binding delta rhodopsin GPCRs 
 
Chorionic gonadotropin alpha (CGA) 
 APDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRS
KKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCS
TCYYHKS 
Follicle-stimulating hormone beta (FSH) 
NSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPK
IQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDS
DSTDCTVRGLGPSYCSFGEMKE 
Thyroid-stimulating hormone beta (TSH) 
FCIPTEYTMHIERRECAYCLTINTTICAGYCMTRDINGKLFLPKYA
LSQDVCTYRDFIYRTVEIPGCPLHVAPYFSYPVALSCKCGKCNT
DYSDCIHEAIKTNYCTKPQKSYLVGFSV 
Luteinizing hormone-releasing hormone (LHRH) 
   pEHWSYGLRPG-NH2 
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Appendix D: Mass Spectrometry Expert Parameter Settings 
 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
MS Expert Parameter  Peptides 
 
Settings     NGFFFamide Echinotocin Sp-GnRH Sp-TRH GKamide PPLN1 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Capillary (V)   -4500  -4500  -4500  -4500  -4500  -4500 
Skimmer (V)   49.84  38.69  100  27.54  52.62  37.3 
Capillary Exit (V)  205.74  300  300  103.28  189.34  300 
Octopole 1 DC   16.86  14.3  10.05  20  17.15  9.25 
Octopole 2 DC   0  0  3.97  3.02  0  4.67 
Trap Drive    57.99  64.14  124.17  103.41  62.5  128.41 
Oct RF    267.21  300  300  300  226.23  226.23 
Lens1     -6.64  -6.89  -4.18  -6.89  -5.9  -5.56 
Lens 2    -52.79  -69.02  -66.07  -91.15  -58.69  -79.34 
 
______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
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Appendix E: 34 Putative Sea Urchin Neuropeptide Precursors 
 
 
Spp-1 GI:115711933 gi:115946155 
 
MQVQQITVFLVACTLSVLVVAYAQEDAETVLLNRLRDIAARAAAGELPDFFADVDDYKRG
GKKNMGSIHSHSGIHFGKRRDSESSERARNTKRMRLHPGLLFGKRAPVQKWDQWQAQDTY
NPDWELGQF 
 
Spp-2 GI:72011734 gi:115975296 Glean3_19680 
 
MKQIITSLVSISAALLLFVLISEYTPRCNGQVHHRFSGWRPGGKKRSDAAEVNSNKITIE
RPQLPICQTTEERQLLEGDSDILGDLRRAANRMRLLQLFNLSKTRLNDLNDATSNEVDER
PVYGDYLGTGL 
 
Spp-3 GI:115657896 Glean3_08352 
 
MWACILGYVTWGGAALPTILGKELVLSENDGPEIADWVQGKEIPLRNQYWGDVAEEEEEE
ELGMLSPDSEKRQYPGGKRQYPGGKRQYPGGKRQYPGGKRQFPAGKRQFVGGELIPSPEL
RQWPGGKRQWPGGKRQWPGGKRQYPGGKRQYPGGKRQWPEVKRQYPGGKRSEDDQDLLPM
EIRQYPGGKRQWPGGKRQYPGGKRQYPGGKRQFPGGKRQFVGGEALEQESNINKRFAPED
DTMDFFRLSQLYDTNDNIVADEGELALEDLLDDIMVDTRPEFEDPRDLLLGNVDQEDVLA
LDLSALLGDRNPNNG 
 
Spp-4 GI:115767208 gi:115945640 
 
MKSTVIVTLTICCLLYQTTRAASLTNRDGLSRQDILDLLQLYEEPIRQEGGDKRSKGCGS
FSGCMQMEVAKNRVAALLRNSNAHLFGLNGPGKRRRSVDDLPQVNDAETE 
 
Spp-5 GI:115933326 gi:115963862 Glean3_18666 
 
MSRNAYLWAGLLLGALCLLITTTSIKADGEVTEDVDKRANYFRGRGRKPGKRDEPDAALV
PDDDLSEDKRANMFRSRLRGKGKRDDPDAAMLPGDWDEEKRANMFRSRLRGNGKRDDPDA
AMLPGDWDEEKRANMFRSRLRGKGKRDEPDAAEALVPGDWEEEKRANMFRSRLRGKGKRD
DPDAAEALVPGDDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGDDLSEEKRANMFRSR
LRGKGKRDDPDAAEALVPGGDLSEEKRANMFRSRLRGKGKRDDPDAAEALVPGGDLSEEK
RANMFRSRLRGKGKRDDPDAAEALVPGDWDEEKRANMFRSRLRGKGKRDDPDAALVGDDF
GDEFVDEEKRANMFRSRLRGNGKRDDPDAALVDEFMDEEKRANYFRGRGRRPGKRDEPDA
ALVEDEKRANFRARQRPKLGK 
 
Spp-6 GI:72008820 Glean3_03108 
 
MKFSGNGRGAFLVVNLIFVLCLVDHMAECRPARKTRDVDEDLEKEEDSLINALEKVLADE
EVIDNAENDSDDETGITDRELSLMLSMLRDDVSPSRLRGYFGGKWRPAYYPSESLHVGAL
EPLATGFLPSRYSGQKKRFLTGALEPLSSGFIKKGFNTGAMEPLGSGFIKKGFNSGAMEP
LGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKG
FNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPLGAGFFKKGFNSGAMEPL
GSGFIKKGFNSGAMEPLGSGFIKKGFNNGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKGF
NSGAMEPLGSGFIKKGFNTGAMEPLGSGFIKKGFNSGAMEPLGSGFIKKDFNTGAMEPLG
SGFIKKGFNSGAMEPLGAGFFKKGFHAGAMEPLSSGFIDGKRGFYNGAMEPLSAGFHQGK
RGFHEGEMDKDKKGFHNGAMEPLKSGFLKD 
 
Spp-7 Glean3_24381 
 
MNNYAFLFCLACAIGQVWTLPIEDKDGLDIEDQEEAEKRFGSMNMEPLVSGFYKRFGSGL
DSMQSGFYKKNFGSGLNMEPMQSGFYKKNFGGSMEPMQSGFYKRFGGAMEPMSSGFYKRF
GSGSLEPMSSGFYKKNFGGSLEPMQSGFYKRFGGANEPMRSGFFKRFGSGSLEPMSSGFY
KKNFGGSLDAMQSGFYKRSQEETD 
 
Spp-8 GI:115764725 GI:115935324  
 
MANRQLLALAFIVSLALAVVEARNFHAAMGGPRPWQAGMKQQSALPDKGTNPFLKRLKQI
VFQPDGFYDPGMDHFAFGEAFNADE 
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Spp-9  
 
MRSSLAVLLLACLAAIISRESPVQAVPRIRPAILQHGMPFGKRGYSGNNARDCFHRALND
DKNSEELVNLIEAWYRMKVEDGLSCMNGLSAFDEAAA 
 
Spp-10 GI:115647054 GI:115936357 
 
MKSVYQVVLAFLAVLVCVAWTCQAYGLDQDEYRRGAAENALDEQEIYEIIESLEHAMSKR
GSVKHLGLANVDNWRMMKNVNRLRNLLNSGKRSDQQLDSQ 
 
Spp-11 GI:115666438  GI:115939808 
 
MNSLILVVMGLLLLTAELIPAAPAPYFDEDAMDLMDPVFNFKDDSAVKRSPMLQKSCIYT
CLACSKNTQMTMPECIYGCQSAGRDPSQARAYNACHKYLHSGR 
 
Spp-12 GI:115620334 GI:115939916 
 
MDSNMTVRSLVILSVLLLAVVSCHAHNTFSFKGRSRYFPGKRAITDGSAVDTASQRFESI
NLDDFQKPESQLTLREMLTELRGYCDFLLKLLDGVRPDLPQQRK 
 
Spp-13 GI:115660734 GI:115930865 
 
MTTSTTMELRLFLLVVLFCALATSLPANLARERRTTNPVLRDKGRESMKTKQFRIGYRYG
RAWQPPTTLDDNVYGADNYDNEAFQFRNLPLLEKLIAQLEKADENGGY 
 
Spp-14 GI:115958765  
 
MEPHQLTLTVFILSLSVLMAVTSTGAFPQEVRGDRTGHMIDGFSNDIDLLPLQETALIRL
LSNLQSSSSEYASGEDETYPMVASKRSRSGRKLRFCMDVIRNTWRLCRNTRSN 
 
Spp-15 GI:115920974 GI:115978337 
 
MNTLSQYLLLICSLLVFIQSYALPTYDKQNVDELQGDNDIDEQQLEMWDAMQGGDNDDVF
SRLTRGGEAFSRDRRRVCVSDCSFCHSFFPTYKLGNCFHGCRKGFHDLGCKQFRY 
 
Spp-16 GI:115898497 
 
MNLTTCYLAILAAILAVAAGRTLDLGLPVMELQEEDFPQMQEQNMEHQSMRDMVSARLWS
IIQRLKMDQAVDLKDELDTLDQGAEKMLSEDFNKRGRRPARKICINDIWKGRGGGLRCN 
 
Spp-17 GI:115751547 GI:115977303 
 
MNSTISTLLSLAALLIIAVQMSSALSITEGPQGGSAWALEDNEEPVDYRSVLKLMKYEIL
LKLMNDLCDELDMCPPSQVPARQAPVVRRGDNNQERRRGGAHLFWRTGVLNKSPIMKAAN 
 
Spp-18 GI:115839524 GI:115976432 
 
MQPNSIISVAVVMTLATLFTQAVCSLQFETTQDRVPAKRLFWVDKKDHPVDTDFFTVRAN
DAEEVLDCFVEVCIADFVNCAKKCLFYENGNTCLPTCRHTRSICSVQCFKRYDVDVSDSV
H 
 
Spp-19 GI:115722995 GI:115946386] 
 
MRCYTWVFTVSVFLTSAVLAIASPRWPGGNSQQRPRWELGDADFSSPITDTSFVKRLLGR
IHEDLRQKSNQAADLRDATSRGFETVDLKQLSDNGAGLQVHGVRQTRGKCMGRFGPYMLN
CKRSGPTTI 
 
Spp-20 GI:115899431 GI:115955088 
 
MQSSLVVISAVFAAVLLGLATATDVLPQQRERRAPSDEMEGFEPGTWDDAEEVEDFRTNE
FAKRIADNDFAAMRHQERSNSMRRTRLLQAMNEMLAKAGKRSSTDKRSLAQNDYMMVRQD
LANGRLYRSLMDRMLSEAGKR 
 
Spp-21 GI:115916164 GI:115944736 Glean3_03170 
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MYVNALTFPLAVAIFLVGLAILPGMLAEDGMELTHDEQPLNAMEIRSPQDEQIDLRYLLQ
NFLDNRDTRSWSPLRNSKQCIGDKCRYAWKRGFETPASSRINSRGAPAWATSQFSNGGCS
GSSCLTGWKRGFRVLPQLNDDDN 
 
Spp-22 GI:115611897 GI:115611899 GI:115615405 GI:115615407 
 
MLSYGQVGFVAVSMLFLLQIVTGLNIHRLTQSQDPVQSAAEQEIAHLLQRYPEQQVLDRN
KRFPKFLTCETDDDCARLDRPACCAKSVMGPFWVCKALGELNAACNSYSMPHMWGGQRNG
HFCPCKQHLACVGHRRGGCDLISDK 
 
Spp-23 GI:72015992 GI:115940672 Glean3_14142 Glean3_03878 
 
MTSQLVTLVLAVFVCSAAVVYSQSPSSPPSASPPTVLATEPITTPRPAVATTPPPVDNGT
PAPSANGTDAPTPVVTDAPMTSAKDGDDDGMKGDGDGQKGHDDDEEGGGGLRRGDIALAI
LATILVVAVICTFIGLCYWKYKGNSYVTVTADTTYRQ 
 
Spp-24 GI:115640656 Glean3_14640 
 
MAVSTPKWLLVGGFLVAALAIISSRGAWAEGIRAADAMDAINSGKQQFLQGLRGALAAVA
AQKDNLVEELLADVEDEEENEEEEVEKIEEELGVLDPPNVKTVEIRLPNAEIAESGTTLC
TSTSLTEALQDIVGFSPLINQNAVTHMALYGCPDQAASTQDYW 
 
Spp-25 GI:115674678 GI:115709525 
 
MKLTICFIISVILFTPSLGIFEFWHDIRDHGGHGSPVYHLSIDLLYLECNVPPAYRGLKF
KKGKRDVRVGKRVLNHSMVYFRGKTYEFGANSLVLHEGGVGRTNPTSCPTVRKTTAGRSL
CTEYQATELAVRYHQDHNFNLFSKNCHMFAEWLINRLLNNKCTI 
 
Spp-26 GI:115749015 
 
MGYERRILRTLLSILIVLASFVTVYGERDSNFMQHKLFRNIVPSPLIQKWRENRMGPAEE
KTSNEQWRDELLSNLRNVLRKHNASPSSRSIDRSDITGYGLQEPMQQLPADVTADQLFIL
EGAVNSPTENYEEETPIDEDKRNGFFFGKRNGFFFGKRSDSDASSTKMDDDRLPKYKS 
SGSFDKCRPCGPGRQGTMRNGX 
 
Spp-27 GI:115627958 GI:115940296 Glean3_20714 
 
MNKKCIVTATHILLFLQALSSINALPILPEEPEHDVVHDYHYETSFVTPYEEIDELAHLK
WSVDYTTSLLRYMLSVPLFDDVTADDAGSRSENFPALSRAGREWLAVGMSPYGASTDADM
VTFIRGSNGEVTILDTYTDENGVLTVDDKQDYKLWNAWIRQPLGEDISDDEDDHR 
VKRKELVIEYGRQIDTCDDKDYLVEVRFISI 
 
Spp-28 GI:115747988 GI:115918610 Glean3_02352 
 
MGMLEWKLPLLLLLIVHVAQQAPVDPKPAEEDRDQNEGEGIAGEEILNIAEGDGIADLGL
EYEGYLREVIQVLEADPEMKSHMDEMDTNDLLVKTSIGNAPISKNEMEALITNHVKEYVL
TIKYIMITILQGNRLLIDIFGKLVYLLTGKFGKQLNNVGSHIRGQLDELKKKEIQRLRII
ARKAMEQQALGKAKPADQKFLDNLIGHLDPSSMDAFSPDDITKLIQKVDNY 
 
Spp-29 GI:72007133 GI:115946242 Glean3_15798 
 
MWYVILSMLLLGALASSEYSGMSLRDRIALRNLLMNSNYYDFPLAPSQRDLENTATNSKV
VIPPLTFIAGGAGEGVQHLGAEGDIPNRQNPIPEVSSQYDNPPNPCPPGGELTGKVKVYS
KVHRHQVCACEKGWEAGERRDCSSAPKCCLPNMPNDAEFVNQYQLSERSLKNRQLFTQTR
NKYSVGDKRSDHMAKKSPVYKRSINSYLPGDMVRHVSKKSAYPIRTYVNPYTYNQPHLKS
VVAKKAPVYSGAKPIM 
 
Spp-30 GI:115650747 Glean3_21555 
 
MRVLVALALCLCFIAPSPVLSFTMPEEKFVENKMADVGEEGTGQNNINSIAKSLIREVFG
AAEEREMEAENEAEDEAELSLSKRTTGSTRPQREIRARAQYAARRPPVTTRSKFTFGKRS
SPTPVISRPLAEQLLEELQRNAEMSDDWRESDKLALLNDAALYDSLVDSHQVQKDAYSAF
 224 
SFGKRGMSAFSFGKRAQPSFAFGKRGLMPSFAFGKRPHGGSAFVFGRRDWAPREQDFANA
AEESGPYKRGDLAFAFGKREDQ 
 
Spp-31 GI:115762091 GI:115953199 
 
MGYLVPLHVLVTLVLVSGTVSTNQNVETVFIQDRVPSLLCMPKNSSDSAGKVASHYDVEN
EPYGSDMDCTFTMNAKQGQRINIRFDYFDVARSYDSREGRCRSEGDSLSIYESGNIFLIK
SNILTPEVRLCGGTGKFPDDYQSVSNVVTVRFKTDEYPSPDNGIKFTYTAFLQPQERTPE
CFMCNDGTMCIDPLLTCNGMPNCNDDSDEEPSNCKASTNIFEKGIETLGVPVMAAIGAAV
GLLLLCLIVLCIVCCCCCSKRNNPSDQKAQYRAPPTPRPGSYPSHNSNYSSYSSQASNGN
TNGTAGRPYPNFPPGYPPFHNGGYSVGYNYENGRMEFPQKV 
 
Spp-32 Glean3_14973 
 
MSMYVFVLIFLTFNRPSACTIIHVREGEEAKLNFSYPCNITKTTLQHSSQAPFYSSVNPG
SNPLPPRYELANHTKSDDDTTCFILLIIDPILRNDVGTYILLVYNHSQLLLEYPKIDLRV
AYPPGKASCESSSNHVDGAWIKLQCTAPLGNLAGQIVCYQNGMRLPPLGTPVENGRRLSQ
VILARIADHSVRCCSSTLDQTKTLQQCRDCGWDPIQNIALKDITDLSTTVSPTQHSKSTQ
NFTLEGETPSSPPHMITNMATNKDVWSNFKRPVYIALSFLISSYVIYSITLLLKQVKTRC
LKRSLIPQRDPVTLCQILKQNSGFSSCCNDNFNPLVFDRIPHPHLRSKLHYQGIRGDSLR
WTMSLLANRLQAVVVNGACSAWMPVTSGVPQGSVIGQLLFLLYINDIKLKSICR 
 
Spp-33 GI:115741907 GI:115741905 Glean3_08863 
 
MEIMGLSIYIALCSVLLLFLGAPRAEGCSCEGAHPQQQFCRASYVIGARVLKREYIPKNP
RGLGFSTGLLGSDHAAIEPLGERTRPYPGTGLHRLPDERLPSEQFGDGGRQLQDLEPLEP
LPYPDGLGPPILPEAADPFQNDGLFAPIPQSDGLQPYPQNDGLEPFPQPAGLQPLQQPEG
LQPLPFEGGPEPLGQPEGLLPLPHPEGLQPLPEEPHTHEALPPLPLPEDMKPLEDTITTL
TTPPPDLVMTDESHTMTTLPPQEKPSNETVLLEPTIGAEEPIAEEERIIDPESMEAWNYK
IIYTLKLSHIYKTGMGQEGWKQGDEVQVDSSAASSLCGKTDLKTGKNYLIAGSSANQVVL
CDWVQEHHKLTTRQKQGLKTIYGKSCDVCQIHSCTSSRHCKKPKENRATTCLYDASQVHI
GDAYSPYDCIASHSRCTMRHGHKCKWQKNNDYHKCVKHQLP 
 
Spp-34 GI:115966309 Glean3_26982 
 
MCCGLGALACCFGTAACSCCCSACPSCKNSTSTRIVYGLFLLVGAVVSAVFLIPQVDQAL
SNSPLLCKDVAVVGQLIPSEVsCERLAGYRSVYRVSFGVAAFFFLLSLIMINVKSSKDPR
SPIQNGFWFFKFLVMCGLCVAAFFIPNGSFENVFMYFGMVGAFAFIIIQLVLLVDFAHSW
NESWVGRMEETEHKGWYCALMSSTVVMYLIALTGFILFFIFYIGTGKECSLHKFFISFNL
VLCVVMSVISILPKVQEAMPRSGLLQSAVISMYTMYLTWSAMSNNPDDTCNPSITTIIQT
IGPSGNNTNVHNQDVGSAENWASFAIWLICLIYACIRTASTNNVGKLTGSEDNLQYGTNE
KTLLGSTNSSGGDSKPADGDAEKWGQEVYDNEEDTVSYSYTFFHIMLMLAAFYMMMTLTS
WFQPAGANFDSLAANSGAMWVKISSSWVCVALYVWTLVAPIILSEREFS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
